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Salmonella enterica serovar Typhimurium es una bacteria gram-negativa que causa 
enfermedades gástricas y sistémicas en una gran variedad de organismos, incluyendo la 
especie humana. La invasión del epitelio intestinal es un proceso crítico en la infección por 
Salmonella y requiere funciones codificadas en una región del cromosoma bacteriano 
adquirida por transferencia horizontal, conocida como isla de patogenicidad 1 (SPI-1). Otro 
locus que Salmonella ha adquirido por transferencia horizontal es el operón std, implicado en 
la formación de fimbrias que participan en la colonización del intestino del hospedador. 
La expresión del operón std se encuentra reprimida en condiciones de laboratorio y se activa 
en el intestino. Estudios previos han mostrado que esta represión es causada principalmente 
por la metilación Dam y en menor medida por el represor RosE. La transcripción del operón 
std en los mutantes Dam– requiere HdfR, un factor de transcripción poco conocido de tipo 
LysR. Estos mismos estudios han sugerido la posibilidad de que la expresión de std esté 
sujeta a biestabilidad o cambio de fase. Recientemente se ha visto que el producto de los dos 
genes distales del operón, stdE y stdF, es responsable de la represión de los genes de SPI-1 en 
mutantes Dam–, que muestran un fenotipo de baja invasión en células epiteliales.  
En base a estos antecedentes, esta Tesis se inició con el objetivo de investigar si la expresión 
del operón std está sujeta a biestabilidad en condiciones de laboratorio. La existencia de 
heterogeneidad fenotípica en poblaciones clonales es un concepto relativamente reciente, 
pero cada vez son más los ejemplos encontrados. Para determinar si el operón std mostraba 
biestabilidad se construyeron fusiones GFP en stdA y se usó citometría de flujo para analizar 
su expresión en células individuales. De estos experimentos se ha podido concluir que existe 
una expresión bimodal del operón std en condiciones de laboratorio. La expresión de std tiene 
lugar en un 0,3-3% de la población, generando dos subpoblaciones: StdON y StdOFF. 
Otro objetivo de esta Tesis era entender el mecanismo molecular que controla la transcripción 
de std generando una expresión bimodal del mismo. Se ha puesto de manifiesto el papel 
esencial de HdfR para la expresión de std, no solo en fondo Dam– como ya se había descrito 
sino también en fondo silvestre. La subpoblación StdON desaparece en ausencia de HdfR y 
aumenta de tamaño si hdfR se expresa constitutivamente. Además, igual que ocurre en otros 
factores transcripcionales de tipo LysR, hemos demostrado la existencia de un proceso de 
autorregulación (represión) que mantiene la transcripción de hdfR en niveles constantes.  
 La metilación Dam es el principal represor de la expresión del operón std, pero existen otros 
represores previamente descritos como RosE o SeqA. En colaboración con el grupo de la Dr. 
Delgado del Instituto Superior de Investigaciones Biológicas (INSIBIO) CONICET-UNT en 
Argentina, se ha identificado un nuevo represor de la expresión de std, RcsB. La expresión 
constitutiva de rcsB reprime la expresión de std en fondo Dam– y también en fondo silvestre. 
Se han realizado ensayos de retardo en gel para corroborar la unión de RcsB a la región 
promotora de std. El análisis bioinformático identifica un posible sitio de unión de RcsB en la 
región -35 del promotor de std.   
Con el fin de identificar otros posibles reguladores de la transcripción del operón std, se  
realizaron escrutinios genéticos. Los resultados obtenidos mostraron una autorregulación 
positiva del operón std, de la que son responsables los genes distales del operón std: stdE y 
stdF. Ensayos realizados mediante citometría de flujo corroboran los resultados del 
escrutinio. La expresión de stdE y stdF mantiene la subpoblación StdON y una expresión 
constitutiva de stdE y stdF aumenta el tamaño de dicha subpoblación.  
La expresión bimodal del operón std en fondo silvestre nos llevó a pensar en la existencia de 
patrones de metilación distintos para cada una de las subpoblaciones. Para demostrar la 
existencia de dichos patrones de metilación se han realizados ensayos de Southern Blot tras 
digestión del DNA con isosquizómeros de enzimas de restricción que reconocen la misma 
secuencia en el DNA (GATC) pero difieren en su sensibilidad al estado de metilación de la 
diana. Los tres sitios GATC de la región reguladora se hallan metilados cuando el promotor 
está inactivo (la subpoblación StdOFF es mayoritaria en un fondo silvestre). Resultados de 
citometría de flujo sugieren un patrón de metilación distinto para la subpoblación StdON, ya 
que la hipermetilación disminuye dicha subpoblación. 
Anteriormente se había descrito que StdE y StdF controlan la expresión de hilD a nivel 
postranscripcional. Teniendo en cuenta que nuestros resultados indican que StdE y StdF son 
reguladores autógenos de la transcripción de std, nos planteamos la posibilidad de que estas 
proteínas tuvieran un papel regulador. Con objeto de identificar posibles dianas de regulación 
del regulón StdEF se realizó un análisis transcriptómico usando un microarray de S. enterica 
serovar Typhimurium. Los datos obtenidos nos han permitido identificar a StdE y StdF como 
reguladores globales de la transcripción en Salmonella, ya que no sólo reprimen la isla de 
patogenicidad 1 (SPI-1) sino también genes flagelares y de quimiotaxis. Por otra parte, StdE 
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y StdF activan la expresión de genes del plásmido de virulencia y del gen hdfR, que codifica 
el factor de transcripción esencial para la expresión del operón std.  
Para tratar de determinar el mecanismo regulador de estas proteínas, hemos realizado un 
ensayo de ChIP-seq (inmunoprecipitación de cromatina seguida de secuenciación masiva), 
que permite identificar sitios de unión al DNA de las proteínas analizadas. Los resultados 
obtenidos confirman el papel de StdE y StdF como reguladores transcripcionales de la 
expresión en Salmonella. StdE parece tener un papel principal, uniéndose a regiones 
promotoras del DNA. Por otro lado, los resultados del ChIP-seq sugieren un papel secundario 
o accesorio de StdF en la regulación, quizá favoreciendo la actuación de StdE. El análisis 
global de la unión de StdE y StdF al genoma de Salmonella ha proporcionado información 
acerca de la autorregulación del operón std. Como ya se ha mencionado, StdE y StdF 
favorecen la expresión de std, aumentando el tamaño de la subpoblación StdON. Según los 
datos del ChIP-seq, es StdF quien se encuentra en la región promotora, favoreciendo la 
expresión de std. Queda por determinar si StdF tiene un papel principal en la regulación de 
std o, como en otros sitios de regulación, actúa de modo auxiliar, tal vez favoreciendo la 
unión de HdfR o impidiendo la actividad de la metilasa Dam.  
Todo parece indicar que nos encontramos frente a un sistema de regulación global pero con 
expresión bimodal. La expresión del operón std, con la consiguiente formación de fimbrias, 
tiene lugar en una pequeña fracción de la población en condiciones de laboratorio, y 
mayoritariamente en condiciones de adherencia al epitelio intestinal. En dichas condiciones, 
la bacteria mantiene reprimidos los genes implicados en virulencia, expresión del flagelo o 
quimiotaxis, y los genes reguladores del operón std son los encargados de coordinar estos 
procesos. Por otro lado la expresión del operón std favorece la activación del sistema 
conjugativo del plásmido de virulencia y garantiza el mantenimiento del mecanismo 
autorregulador de expresión del propio operón std al activar el factor de transcripción HdfR y 
al ejercer de reguladores transcripcionales uniéndose a la región promotora del propio operón 
std.  
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The genus Salmonella 
The genus Salmonella includes facultative anaerobic Gram-negative, rod-shaped bacteria that 
are able to infect a variety of animal hosts including amphibians, reptiles, birds and 
mammals. Salmonellae are usually motile and produce peritrichous flagella. Salmonella 
belongs to Enterobacteriaceae family in the γ-proteobacteria subdivision and is a close 
relative of the genera Escherichia, Shigella and Citrobacter. 
Currently, the genus Salmonella is divided into 2 species, known as Salmonella enterica and 
Salmonella bongori (Tindall et al., 2005). Salmonella enterica comprises 6 subspecies 
(McQuiston et al., 2008): enterica (subsp. I), salamae (subsp. II), arizonae (subsp. IIIa), 
diarizonae (subsp. IIIb), houtenae (subsp. IV) and indica (subsp. VI). 
Salmonella subspecies are further divided into serovars (also known as serotypes). Serovars 
are defined by the antigen properties of the polysaccharide chain of LPS (O-antigens) and of 
the proteinaceous flagella (H antigens) (Grimont & Weill, 2007; McQuiston et al., 2004). 
There are more than 2,500 Salmonella serovars, most of them belong to the subsp. enterica 
(Popoff et al., 2004). Only serovars of this subspecies are able to colonize warm-blooded 
vertebrates (McClelland et al., 2001), accounting for 99% of human infections caused by 
Salmonella, while the remaining subspecies of Salmonella enterica and members of 
Salmonella bongori are usually associated to cold-blooded vertebrates or to the environment 
(Bäumler et al., 1998).  
Differences in host specificity and types of diseases produced are found among serovars 
belonging to subsp. enterica. Some serovars are able to infect a wide variety of animals, 
while others are host-specific (Bäumler & Fang, 2013). Serovars of subsp. enterica produce a 
variety of diseases that ranges from self-limiting gastroenteritis to life-threatening systemic 
infection, and the outcome of the disease depends on the specific serovar-host combination. 
For example, the human-restricted serovar Typhi produces typhoid fever, while the generalist 
serovar Typhimurium produces mild gastroenteritis in humans but causes a systemic 
infection similar to human typhoid fever when infecting mice (Velge et al., 2012). For this 
reason, the interaction between serovar Typhimurium and mice has been widely used as a 
model for human typhoid fever (Santos et al., 2001a), and most pathogenicity studies in 
Salmonella have employed this serovar. In this work we have used the mouse-virulent strain 
 Salmonella enterica subsp. enterica serovar Typhimurium SL1344, from the B.A.D. Stocker 
collection. For simplicity, it will be often abbreviated as Salmonella typhimurium.  
Evolution of Salmonella pathogenesis 
Salmonella is a close relative of Escherichia. They diverged 120-160 million years ago 
(Ochman & Wilson, 1987). Almost 25% of the genetic material in the Salmonella genome is 
absent in Escherichia coli (McClelland et al., 2001; Porwollik & McClelland, 2003). The 
evolution of Salmonella pathogenicity (Figure I. 1) has involved the sequential acquisition of 
genetic elements, each contributing to different aspects of its lifestyle (Groisman & Ochman, 
1997; Kelly et al., 2009). Among those elements are the Salmonella pathogenicity islands 
(SPIs), which are clusters of virulence genes in the chromosome. More than 10 SPIs have 
been described (Hensel, 2004) including some that are serotype-specific. These regions 
usually have a different G+C content than the rest of the Salmonella chromosome, and are 
absent in other Enterobacteriaceae, suggesting that they have been acquired by horizontal 
gene transfer (Kelly et al., 2009; Porwollik & McClelland, 2003). 
 
Figure I. 1 Phylogeny of the genus Salmonella. The acquisition of SPI-1 and SPI-2, and the ability to infect warm-blooded 
vertebrates are indicated. Modified from (Ellermeier & Slauch, 2006). 
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Salmonella pathogenicity island 1 (SPI-1) and Salmonella pathogenicity island 2 (SPI-2) are 
the best characterized SPIs. SPI-1 was first acquired by the common ancestor of Salmonella 
bongori and Salmonella enterica, and is involved in the invasion of epithelial cells in the 
animal intestine (Que et al., 2013). SPI-1 acquisition provided Salmonella the ability to 
invade eukaryotic cells and to become an intracellular pathogen, likely associated with cold-
blooded vertebrates (Ellermeier & Slauch, 2006). SPI-2 allows Salmonella to survive in 
macrophages and colonize deeper tissues (Ochman et al., 1996), and its acquisition resulted 
in the split of the two Salmonella species (Ellermeier & Slauch, 2006). Consequently, only 
members of Salmonella enterica are able to reach deep tissues and organs producing systemic 
infection.  
The ancestor of subsp. enterica acquired the capacity to infect warm-blooded vertebrates, and 
different strains subsequently evolved to colonize a variety of hosts. Although the mechanism 
of host specificity is not fully understood, the presence of a virulence plasmid in certain 
serovars of subsp. enterica has suggested the potential contribution of plasmid functions 
(Bäumler et al., 1998). Another trait that may be involved in host specificity is the presence 
of different sets of fimbrial operons in different serovars (Bäumler et al., 1998; Townsend et 
al., 2001).  
Salmonella infection 
Salmonella enterica is found mostly in the intestine of animal hosts and the infection is 
usually transmitted by the fecal-oral route. Infection normally starts via ingestion of 
contaminated water or food. Salmonella must endure adverse conditions along the digestive 
track, which serves as a protective barrier against bacterial infections.  
The acid pH in the stomach destroys the majority of microorganisms (Tennant et al., 2008). 
However, Salmonella responds with the activation of the acid tolerance response, a complex 
adaptive system, which allows the bacterial population to endure periods of severe acid stress 
(Foster & Hall, 1990; Lee et al., 1995). 
High concentrations of bile are secreted in the small intestine, in particular in the duodenum, 
during digestion. Bile has two main antibacterial actions: as a detergent disrupting the cell 
envelope (Gunn, 2000) and as DNA damaging agent producing DNA rearrangements and 
 point mutations (Prieto et al., 2004). Nevertheless, like other enteric bacteria, Salmonella is 
intrinsically resistant to high concentrations of bile (Gunn, 2000). 
Once in the distal small intestine, Salmonella has the ability to penetrate inside epithelial 
cells. In a first step, adhesins and fimbriae are necessary to mediate the adherence (Wagner & 
Hensel, 2011); afterwards the bacterial population is able to invade the intestinal epithelium 
through three different routes (Figure I. 2): (i) by inducing a phagocytosis-like process in 
non-phagocytic enterocytes, (ii) through specialized epithelial M cells, and (iii) through 
dendritic cells that intercalate epithelial cells by extending protrusions into the gut lumen 
(Finlay & Brumell, 2000; Grassl & Finlay, 2008). The two first routes are mediated by the 
virulence-associated type III secretion system encoded on Salmonella pathogenicity island 1 
(SPI-1) (Zhou & Galán, 2001), with invasion of M cells being the predominant route of 
intestinal traversal (Watson & Holden, 2010). 
 
Figure I. 2 Diagram of Salmonella infection. The three main routes of Salmonella invasion of the intestinal epithelium are 
represented: direct invasion of intestinal epithelial cells (1), adhesion and translocation through M cells (2), and capture by 
dendritic cells (3). Adapted from (Fàbrega & Vila, 2013; Sansonetti, 2004). 
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Depending on the serovar and the host, Salmonella infections may have three different 
outcomes after invasion of intestinal epithelial cells: gastroenteritis, systemic infection, or 
asymptomatic chronic carriage.  
In gastroenteritis, the infection is localized in the intestine. Invasion of intestinal epithelial 
cells triggers an inflammatory reaction in the intestinal mucosa. Liquid accumulation in the 
intestinal lumen leads to diarrhea (Nunes et al., 2010; Santos et al., 2001b).  
In systemic infection, the pathogen crosses the epithelial barrier and is able to survive inside 
phagocytes due to functions encoded in SPI-2. Salmonella disseminates through the 
lymphatic system reaching deep tissues and colonizing target organs, particularly the spleen, 
the liver, the gall bladder and the bone marrow, where bacteria can proliferate, eventually 
causing death upon septic shock (Bäumler et al., 2011). 
A fraction of individuals that has survived systemic infection becomes asymptomatic, life-
long carriers of Salmonella, acting as reservoirs for future infections. In humans, serovar 
Typhi can undergo chronic carriage in the gall bladder (Bäumler et al., 2011). 
Salmonella virulence factors 
The interaction between Salmonella and the host requires a complex bacterial machinery to 
colonize and succeed in a variety of host environments, all of them challenging. This 
machinery includes genes required for chemotaxis, motility, adhesion, invasion, replication 
and survival within host cells covering the whole pathogenic process from the intestinal step 
to systemic dissemination. The virulence factors employed by the pathogen to achieve the 
infection process are described below. 
Type III secretion systems (TTSSs) 
Type III secretion systems (TTSSs) are specialized organelles whose main role is to inject 
bacterial proteins, called effectors, into eukaryotic cells (Cornelis & Van Gijsegem, 2000; 
Galán, 1999; Galán & Collmer, 1999), representing the principal virulence factors for 
Salmonella pathogenicity (LaRock et al., 2015). TTSSs are evolutionarily related to the 
flagellar export apparatus and are present not only in bacteria pathogenic for animals and 
plants but also in symbionts for plants or insects (Galán, 2001).   
 TTSSs are usually composed of more than 20 proteins (Galán, 2001) that form a needle-like 
structure that spans both the inner and outer membranes of the bacterial envelope (Kubori et 
al., 1998). It is composed of a basal body localised in the bacterial membrane, a needle that 
protrudes outside the cell, and a translocon that can cross the eukaryotic plasmatic membrane 
(Moest & Méresse, 2013).  
Salmonella enterica encodes two TTSSs, and the corresponding genes are located in 
pathogenicity islands (SPI-1 and SPI-2). Each TTSS exerts its function at a different stage of 
the infection process. Salmonella pathogenicity island 1 (SPI-1) is located at centisome 63 of 
the chromosome (Galán, 1999) and is required for the initial interaction of Salmonella with 
intestinal epithelial cells (Galán, 2001). Salmonella pathogenicity island 2 (SPI-2) is located 
at centisome 31 and it is required for survival within macrophages during systemic infection 
(Hensel, 2000). 
Regulation of Salmonella pathogenicity island 1 (SPI-1) 
SPI-1 is a 40 Kb region of the Salmonella chromosome that contains all the genes necessary 
to produce a functional TTSS, several secreted effectors, and transcriptional regulators of 
bacterial invasion (Ellermeier & Slauch, 2007). The control of invasion involves regulators 
encoded both inside and outside SPI-1 that are able to integrate environmental signals and 
molecular factors (Bajaj et al., 1996).  
SPI-1 is tightly regulated by four transcriptional activators encoded within SPI-1 (HilA, HilC, 
HilD, and InvF) and by another regulators encoded outside the island such as RtsA or HilE. 
HilA belongs to the OmpR/ToxR family and hast raditionally been considered the master 
regulator of SPI-1, playing a central role in invasion (Bajaj et al., 1995). In support of this 
view, deletion of hilA is phenotypically equivalent to a deletion of the entire SPI-1 locus 
(Ellermeier et al., 2005). HilA controls genes encoding all the components necessary to build 
a functional TTSS (Bajaj et al., 1995; Lostroh & Lee, 2001) and indirectly regulates effector 
proteins by activating invF transcription (Bajaj et al., 1995; 1996; Darwin & Miller, 1999). 
Expression of hilA is controlled by the AraC-like activators HilD, HilC, and RtsA (Ellermeier 
& Slauch, 2003; Schechter & Lee, 2001). These regulators act by binding to the hilA 
promoter, as well as by inducing their own expression or activating other regulators 
(Boddicker et al., 2003; Ellermeier et al., 2005).  
Introduction 
27 
Figure I. 3 Diagram of the regulatory network of SPI-1. Lines ending in arrowheads indicate positive effects, whereas 
blunt lines indicate negative regulatory effects. Adapted from (Espinosa Alfaro, 2015).  
Recent studies describe HilD as one of the most relevant regulators of SPI-1, regulating SPI-1 
expression at different levels. HilD is able to regulate the expression not only of hilA but also 
of hilC, invF and rtsA upon binding upstream their promoters (Akbar et al., 2003; 
Olekhnovich & Kadner, 2002; Schechter & Lee, 2001). Various environmental signals, 
sensed by these regulatory systems, are integrated at the level of HilD production. Together 
with HilC and RtsA, HilD is involved in a complex feed-forward regulatory loop that can 
amplify the activation signal and act as a switch for hilA transcription (Ellermeier & Slauch, 
2007). The synthesis of HilD is subjected to tight regulation at the transcriptional and 
postranscriptional levels. RtsA, HilC, and HilD itself mediate hilD transcriptional regulation 
by binding to the hilD promoter (Ellermeier et al., 2005; Olekhnovich & Kadner, 2002). SirA 
and StdEF regulate HilD at the postrancripitonal level (López-Garrido & Casadesús, 2012; 
Teplitski et al., 2003). Recently, it was shown that the long 3’UTR of hilD mRNA mediates 
its decay, and it has been described as a target for the Hfq chaperone and for the Salmonella 
degradosome (López-Garrido et al., 2014). FliZ positively regulates SPI-1 at the level of 
HilD protein. HilE, a negative SPI-1 regulator, interacts with HilD interfering with its 
function (Baxter et al., 2003). HilD activity is not limited to SPI-1 regulation. Crosstalk 
Type III Secretion 
System
Effector proteins
 between SPI-1 and SPI-2 through HilD has been previously reported (Bustamante et al., 
2008; la Cruz et al., 2015). HilD also activates transcription of the flagellar master operon 
flhDC, which is essential for Salmonella motility (Singer et al., 2014). Recently, novel targets 
for HilD have been described, many of them outside SPI-1 (Petrone et al., 2014; Smith et al., 
2016).  
Flagellum and chemotaxis  
The bacterial flagellum permits bacterial motility in liquid environments. The general 
structure and organization of the flagellum are well conserved among Gram-negative 
bacterial species. The flagellum constitutes a supramolecular complex formed by at least 
three parts: the basal body (reversible motor), which is joined to the filament (helical 
propeller) by the hook (universal joint). Four rings and a rod compose the basal body. The 
rings C, MS, P, and L are located in the cytoplasm, cytoplasmic membrane, peptidoglycan 
layer and outer membrane respectively. The rod is a drive shaft that traverses the periplasmic 
space. In response to chemotactic signals, the flagellar motor can operate in both the counter-
clockwise and clockwise directions, switching the direction of motor rotation (Minamino & 
Imada, 2015).  
The assembly and function of the flagellar and chemotaxis systems require the expression of 
more than 50 genes, divided in operons (Macnab, 2003) that are regulated at several levels in 
response to environmental and flagellar development signals (Chilcott & Hughes, 2000). In 
Salmonella, the flagellar, motility and chemotaxis genes form a regulon, and they are 
classified into three temporally regulated transcription classes: early, middle and late. 
(Kutsukake et al., 1990). The corresponding promoters are referred to as class 1, class 2 and 
class 3, respectively.  Class 1 includes a single promoter that transcribes the flhDC operon. 
FlhD and FlhC are active as an heterotetramer which is a key transcriptional activator of 
middle class promoters. This transcription responds to many environmental cues. Expression 
of middle class genes is necessary for the synthesis and assembly of the hook-basal body, and 
the transcriptional regulators FlgM and σ28 (fliA) are necessary for expression of late genes 
(Chilcott & Hughes, 2000). Late genes encode proteins later required in the assembly 
process, including flagellin, hook-associated proteins, stator components and chemosensory 
systems. Expression of late genes is a critical step for flagella production. FliA and FlgM 
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regulate, positively and negatively, class 3 promoters respectively (Gillen & Hughes, 1991; 
Kutsukake & Iino, 1994).   
Reduced motility has been observed in Dam– mutants in E. coli (Oshima et al., 2002) and 
Salmonella (Balbontín et al., 2006). Despite the increased expression of some flagellar genes 
like fliC or fliD in Dam– strains, reduced halo formation on motility plates is observed in 
Dam– mutant background (Balbontín et al., 2006). 
Flagellar and motility genes are expressed at the early exponential growth phase, and their 
expression is subject to crosstalk with other Salmonella virulence determinants. For example, 
the flagellar activator FliZ (middle gene class) has been reported to increase hilA 
transcription in a HilD-dependent manner, suggesting that FliZ activates hilA at 
postranscriptional level controlling HilD (Chubiz et al., 2010) and simultaneously repressing 
fimbrial genes (Saini et al., 2010).  
The Salmonella enterica virulence plasmid  
In Salmonella and in other bacteria such as E. coli, Shigella or Yersinia, certain virulence 
factors important for pathogenesis are encoded on plasmids. In Salmonella, plasmids have 
been found in a few serovars belonging to the subspecies I. These plasmids, called “serovar-
specific” have sizes of 50 to 90 Kb. They are very stable and their copy number is usually 1 
or 2 copies per cell (Rotger & Casadesús, 1999).  
The virulence plasmid in S. Typhimurium, pSLT (Jones et al., 1982), was shown to be 
mobilizable (Ahmer et al., 1999; García-Quintanilla & Casadesús, 2011; Jones et al., 1982; 
Ou et al., 1990; Sanderson et al., 1983) and self-transmissible by conjugation (Ahmer et al., 
1999). 
Expression of the transfer region (tra), encoded in the pSLT (Figure I. 4), permits pilus 
biogenesis, mating pair stabilization, DNA transfer, and surface exclusion. During the 
conjugation process, a donor cell build a conjugative pilus that recognizes a recipient cell, 
retracts, and brings the two cells to close contact. Plasmid DNA is then transferred to the 
recipient cell through the mating pore, converted to double-strand DNA, re-circularized, and 
established in the recipient cell. pSLT transfer increases in the ileum, the distal portion of the 
small intestine (García-Quintanilla et al., 2008), which may compensate plasmid loss during 
 intestinal passage (García-Quintanilla et al., 2006). The virulence plasmid also contains the 
pef (plasmid-encoded fimbriae) locus, which is involved in bacterial adhesion to intestinal 
epithelial cells (Bäumler et al., 1996). The spv (Salmonella plasmid virulence) region, 
required for the systemic phase of disease (Gulig et al., 1993), is also encoded in the pSLT 
plasmid, among others loci (Figure I.  4A) 
 
Figure I. 4 pSLT genetic map in Salmonella enterica. A. Linear genetic map of the pSLT virulence plasmid of Salmonella 
enterica serovar Typhimurium. B. tra region in pSLT plasmid in S. enterica. Arrows represent transcripts initiated at the 
highlighted promoter. Adapted from (Bäumler et al., 1998; Espinosa Alfaro, 2015). 
Regulation of tra operon expression is complex and involves regulatory proteins encoded on 
both the host chromosome and the plasmid. Host-encoded factors involved in mating and pili 
synthesis include global regulators such as ArcA (Silverman et al., 1991), H-NS (Starcic-
Erjavec et al., 2003; Will et al., 2004), Lrp (Camacho & Casadesús, 2002), or Dam 
methylation. Dam methylation represses tra operon expression by controlling Lrp-mediated 
activation of traJ transcription (Camacho & Josep Casadesús 2002) and by maintaining high 
levels of FinP RNA (Torreblanca et al., 1999), among others.  
FinOP fertility inhibition system controls conjugation at the postranscriptional level. 
Synthesis of TraJ is controlled by FinP, an antisense RNA that inhibits traJ mRNA 
translation (Firth et al., 1996; Zatyka & Thomas, 1998). FinP binds to traJ mRNA 
sequestering its ribosomal binding site (RBS) and preventing its translation (Koraimann et 
al., 1996). The duplex FinP/traJ mRNA formed is then rapidly degraded by the RNase III.  
B
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FinO binds FinP preventing its degradation by RNase E (Jerome et al., 1999) and allowing 
the FinP concentration to increase to sufficient levels to mediate traJ repression.  
On the other hand, TraM is essential for nicking and unwinding the plasmid DNA during 
conjugation . In additon, TraM binds its own promoter and represses its transcription.  
 
Figure I. 5 Regulatory circuit of the tra region. Synthesis of TraJ is controlled by the antisense RNA, FinP (RNA 
molecules are represented with wave-shaped lines). FinP binds traJ mRNA, preventing its translation. TraM binds its own 
promoter and represses its transcription. Promoter positions and transcription are indicated by straight arrows. Arrows 
denote activation and blunt lines denote inhibition. Adapted from (Espinosa Alfaro, 2015; Gubbins et al., 2002). 
Adhesins 
Interaction between the pathogen and host cells is required for colonization. This process is 
mostly mediated by adhesins on the surface of the microbe. The adhesins are responsible for 
recognizing and binding to specific receptor moieties of host cells. This interaction involves 
diverse changes in both the bacterium and the host as a result of the attachment. S. enterica 
has different adhesion systems that have been divided into two categories, non-fimbrial and 
fimbrial adhesins, which differ in their assembly pathway. Additionally, the flagellum and 
type III secretion system (TTSS), whose main functions are not involved in adhesion, also 
contribute to attachment and colonization of host tissues (Soto & Hultgren, 1999).  
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 Non-fimbrial adhesins 
This category comprises an heterogeneous group of proteins either secreted via type I 
secretion systems (SiiE and BapA) or autotransported across the bacterial membranes (ShdA, 
MisL, SadA) (Wagner & Hensel, 2011). 
Fimbrial adhesins 
Among the adhesion systems, fimbrial adhesins include the majority of Salmonella adhesins. 
Fimbriae are proteinaceous structures extending form the surface of a bacterial cell, and 
appear in several copies per cell. These structures facilitate adhesion to abiotic and biotic 
surfaces. Three pathways for the assembly of fimbrial adhesins have been described. 
I. Chaperon-usher dependent assembly Pathway (CUP).  Fimbrial subunits are directed to 
the periplasm through the general secretion pathway via an N-terminal secretion sequence 
that is cleaved off during transport. In the periplasm, chaperones prevent the premature 
assembly of fimbrial subunits and their degradation by proteases, and direct fimbrial subunits 
to the usher, which coordinates the assembly of the fimbriae. On the tip of the completed 
fimbriae, a receptor-binding site interacts with its host receptor. Based on the usher protein 
(the most conserved fimbrial protein), fimbriae belonging to the chaperone-usher pathway 
can be divided into 6 groups (γ, κ, π, β,  and σ) (Nuccio & Bäumler, 2007). Several 
chaperon/usher-type fimbrial operons present in S. enterica serotype Typhimurium belong to 
this group. 
II. Nucleator-dependent assembly pathway. The fimbrial subunits are transported into the 
periplasm via the general secretion pathway. Polymerization of the fimbrial subunits occurs 
outside of the bacterial cell envelope (Wagner & Hensel, 2011). In Salmonella, the fimbrial 
adhesins assembled through this pathway are designated as “thin aggregative fimbriae” or 
“curli”, and are encoded by the operons csgDEFG and csgBA. These fimbriae are known to 
mediate binding to proteins like fibronectin (Olsén et al., 1989) and are involved in biofilm 
formation (Brombacher et al., 2003; Gerstel & Römling, 2003; Prigent-Combaret et al., 2001) 
III. Assembly pathway for type IV fimbriae. In S. enterica, type IV pili are only encoded 
by SPI-7 in the strictly human-adapted serovar Typhi (Zhang et al., 1997; 2000). The 
subunits for the pilus formation are assembled in the periplasm at the inner membrane, and 
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are extruded through a secretin in the outer membrane as an intact pilus (Wolfgang et al., 
2000). 
As it was mentioned before, fimbriae expression involves crosstalk and participates in the 
coordination of the sequential expression of SPI-1, flagellar and fimbrial systems. Non-
fimbrial adhesins are also subject to crosstalked regulation, as it happens with the SPI-4-
encoded sii operon which is regulated by the SPI-1 SprB regulator (Saini & Rao, 2010).  
Hybridization analyses have shown high presence of fimbrial DNA sequences in multiple 
Salmonella serovars. Additionally, each serovar harbors a particular repertoire of fimbrial 
genes (Townsend et al., 2001). The selective pressure responsible for this uneven distribution 
is unknown (Humphries et al., 2001) and several tentative explanations have been proposed. 
On top of their role in attachment, it has been shown the contribution of fimbriae to biofilm 
formation (Ledeboer et al., 2006). Competitive infection experiments have revealed the 
participation of fimbriae in long-term colonization in mice (Weening et al., 2005). Each 
fimbrial operon appears to attach a specific target cell type (Bäumler et al., 1996), enabling 
the bacterial cell to distinguish among different epithelial cell types. Redundancy of fimbrial 
tools may counterbalance the loss of a single fimbrial operon, since the inactivation of an 
individual fimbrial operon results in only moderate attenuation (van der Velden et al., 1998). 
On the other hand, fimbrial appendages could, at the same time, pose a problem for the 
bacterium to evade the host immune system, since the fimbrial subunits likely act as antigens 
during host-pathogen interaction. This aspect could explain why fimbrial expression is 
commonly regulated by phase variation, generating fimbriated and non-fimbriated 
subpopulations (Humphries et al., 2001). Phase variation will be described below in more 
detail.  
The std fimbrial operon  
In S. enterica serotype Typhimurium, the elaboration of fimbriae on the surface of cells 
grown in nutrient broth and their ability to agglutinate yeast or red blood cells, was described 
in 1966 (Duguid et al., 1966). So far, laboratory-grown cultures of S. enterica have only been 
shown to elaborate type 1 fimbriae (Duguid et al., 1966), encoded by the fim operon (Clegg et 
al., 1987), and thin curled fimbriae (Grund & Weber, 1988; Stolpe et al., 1994), encoded by 
the csg operon (Römling et al., 1998). However, nine additional fimbrial operons, named bcf 
 (Tsolis et al., 1999), stf (Emmerth et al., 1999; Morrow et al., 1999), saf (Folkesson et al., 
1999), stb, stc, std, sth, sti, and stj (McClelland et al., 2001), have been later identified by 
sequence analysis.  
The std fimbrial operon was first identified in S. enterica serovar Typhi (Townsend et al., 
2001) and later found in other Salmonella enterica serovars, including Typhimurium (Anjum 
et al., 2005; Chan et al., 2003; Humphries et al., 2001; Porwollik et al., 2004). However, it 
has not been detected in related enterobacterial species, suggesting an acquisition mediated 
by horizontal transfer (Porwollik et al., 2002). The std operon belongs to the π-fimbriae 
group. Members of the same group are well-characterized virulence factors such as 
pyelonephritis-associated (P) fimbriae of E. coli and the Mannose-resistant/Proteus-like 
(MR/P) fimbriae of Proteus mirabilis (Nuccio & Bäumler, 2007).  
Std fimbriae contribute to cecal colonization by binding to α (1,2) fucose residues, which are 
abundant in the cecal mucosa (Chessa et al., 2009), facilitating Salmonella attachment to the 
intestinal epithelium. Expression of the std operon, as many of the putative fimbrial operons, 
is tightly repressed under laboratory conditions (Humphries et al., 2003), and derepression 
occurs in the intestine of infected animals, where Std fimbriae are synthesized. Deletion of 
stdAB results in a competitive defect in colonizing the caecum of mice and in being shed with 
the faeces (Weening et al., 2005). Results from adhesion assays of Salmonella enterica 
serovar Enteritidis to intestinal epithelial cells as well as to the small intestine and caecum of 
poultry reveal decreased adhesion of the stdA mutant (Shippy et al., 2013). 
Recently, the std operon (Figure I. 6) was defined to contain 6 genes (stdA-F), all of them 
transcribed by the promoter located upstream the first gene (stdA; (López-Garrido & 
Casadesús, 2012)). 
 
Figure I. 6 Diagram of the std operon. std operon contains 6 genes (stdA-F), all of them transcribed by the promoter 
located upstream the first gene (PstdA). 
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The mechanisms that prevent std expression outside the animal environment remain 
unknown, but some of the bacterial functions involved in this regulation have been identified. 
Lack of RosE, an homolog to the E. coli ArgR repressor, allows std expression under 
laboratory conditions (Chessa et al., 2008). Dam methylation also prevents expression of the 
std operon, and Dam– mutants were found among Std-expressing isolates induced by 
transposon mutagenesis (Chessa et al., 2008). It was previously shown that the GATC-
binding protein SeqA is a repressor of the std operon, and that the poorly known HdfR 
protein (a LysR-like protein) is required for std expression in S. enterica Dam– mutants 
(Jakomin et al., 2008). The possibility that HdfR might activate std transcription in a Dam-
dependent manner is supported by the existence of three GATC sites upstream the std 
promoter, and unpublished results from our group suggest that HdfR binds the std promoter 
in a Dam methylation-dependent manner.  
Flow cytometry experiments in Dam- and SeqA- mutants show the existence of two 
subpopulations of Std cells: Std+ and Std– (Jakomin et al., 2008). The authors suggest the 
possibility of bistable or phase-variable std expression in the animal environment, and 
speculate that the competition between HdfR and SeqA or RosE might be the responsible for 
subpopulation formation. 
As in other fimbrial operons, structural and regulatory fimbrial proteins are encoded in the 
same operon. Recently, it was described that the Dam-dependent regulation of SPI-1 requires 
the last two genes of the std operon: stdE and stdF. Both genes repress SPI-1 expression 
through HilD at the postranscriptional level (López-Garrido & Casadesús, 2012). Lowered 
expression levels of the SPI-1 activator HilD would explain the reduced capacity of Dam– 
mutants to invade epithelial cells (García-Del Portillo et al., 1999).  
 HdfR 
HdfR is a poorly known protein that belongs to the widely distributed LysR-type family of 
transcriptional regulators (LTTRs). LTTRs are the largest group of prokaryotic DNA-binding 
proteins (Maddocks & Oyston, 2008), and act as homodimers or homotetramers (Zaim & 
Kierzek, 2003). LTTRs control the transcription of multiple operons involved in disparate 
functions such as amino acid metabolism, oxidative stress, nitrogen fixation, degradation of 
aromatic compounds, and bacterial virulence (Schell, 1993). Based on the secondary 
 structure, a helix-turn-helix (HTH) motif has been proposed to conform the DNA-binding 
domain (Kullik et al., 1995). This type of transcriptional regulators often needs a small ligand 
acting as a coinducer. The binding site of the inducer has been mapped to the C-terminal part 
(Lahiri et al., 2009).   
Many LTTRs activate the expression of target genes but repress their own expression, 
frequently by the use of divergent promoters (Zaim & Kierzek, 2003). In E. coli, HdfR was 
shown to negatively control flhDC expression through direct binding to its promoter, while 
hdfR expression was negatively regulated by H-NS (Ko & Park, 2000).  In Salmonella few 
information is available aside from their role as an activator of std transcription in Dam– and 
SeqA– mutants (Jakomin et al., 2008).  
RcsCDB phosphorelay system 
The Rcs phosphorelay system appears to be conserved in the family Enterobacteriaceae 
(Pescaretti et al., 2009) and it is implicated in gene expresssion of a huge variety of genes, 
such as those controlling the biosynthesis of colanic acid (Stout & Gottesman, 1990), 
regulation of flagellum synthesis (Francez-Charlot et al., 2003), motility (Cano et al., 2002) 
or O-antigen chain length determination (Delgado et al., 2006), among others.  
Rcs regulon is activated by cell interaction with surfaces (conditions that lead to biofilm 
formation) and plays a role in later stages of biofilm formation (Danese et al., 2000; 
Majdalani & Gottesman, 2005). Perturbation in the cell surface induces the Rcs system. 
Mutations in rfa genes (synthesis of lipopolysaccharide) or mdo genes (membrane derived 
oligosaccharides or periplasmic glucans) implicate induction of Rcs system (Ebel et al., 1997; 
Majdalani & Gottesman, 2005). In Salmonella typhimurium, mutations in tolB (periplasmic 
component of Tol system) were found to increase Rcs regulon activity (Mouslim & 
Groisman, 2003).   
The Rcs system is composed by three proteins: RcsC, RcsD, and RcsB. Environmental 
signals are transmitted to RcsC, the sensor kinase, which in turn transfers a phosphate to a 
conserve aspartate on RcsB, the cognate response regulator. RcsD is the intermediary in the 
phosphoryl transfer (Majdalani & Gottesman, 2005). The main rol of RcsB is as a  positive 
transcriptional regulator of a wide range of genes (capsule synthesis, membrane proteins), but 
Introduction 
37 
it has also been reported to behave as a negative regulator (flagellar synthesis) (Francez-
Charlot et al., 2003). RcsB may act alone or in combination with other regulators, such as 
RcsA. RcsA is an unstable regulatory protein that acts with RcsB as an auxiliary regulator in 
some processes such as the capsule (cps loci) synthesis in E. coli, where the overexpression 
of rcsB is sufficient to increase cps levels in the absence of RcsA (Brill et al., 1988). On the 
other hand, RcsB is essential, independendly of RcsA levels (Majdalani & Gottesman, 2005).  
Dam methylation 
Base methylation at specific DNA sequences by DNA methyltransferases is a DNA 
modification common in all kingdoms of life. In α-Proteobacteria and γ-Proteobacteria, 
postreplicative N6 methylation in adenosine moieties lowers the thermodynamic stability of 
DNA (Engel & Hippel, 1978) and alters DNA curvature (Diekmann, 1987), influencing the 
interaction between DNA-binding proteins and their cognate DNA sequences (Wion & 
Casadesús, 2006). The methylation state of such sites can be used as a signal, thereby 
permitting spatial or temporal control of the interaction between DNA binding proteins and 
DNA (Messer & Noyer-Weidner, 1988). 
In bacteria, two types of DNA methyltransferases perform base modifications: DNA 
methyltransferases associated with restriction-modification systems (Bickle & Krüger, 1993; 
Loenen et al., 2014) and solitary DNA methyltransferases (Wion & Casadesús, 2006). Dam 
methylase of γ-proteobacteria is a solitary methyltransferase. 
Dam methylation is found in the orders Enterobacteriales, Vibrionales, Aeromonadales, 
Pasteurellales, and Alteromonadales (Løbner-Olesen et al., 2005). In E. coli and Salmonella, 
dam mutations produce pleiotropic defects but viability is not (or very little) impaired 
(Torreblanca & Casadesús, 1996). However, in Vibrio cholerae and in some strains of 
Yersinia Dam methylation is essential (Julio et al., 2001; Marinus, 1996). 
The Dam methylase transfers a methyl group from S-adenosyl-methionine to the N6 amino 
group of the adenosine moiety of 5’-GATC-3’ sites (Marinus, 1996). Methylation occurs 
shortly after DNA replication, and methylates transiently hemimethylated GATC sites.  
Nevertheless, the Dam enzyme can methylate both hemimethylated and nonmethylated 
GATC sites with similar efficiency (Marinus, 1996). Flanking sequences of the GATC sites 
 influence the DNA binding ability of the Dam methylase and/or the efficiency of methyl 
group transfer (Peterson & Reich, 2006).  
The Dam protein shares significant identity with DpnII, MboI and other DNA 
methyltransferases that are part of restriction-modification systems (Low et al., 2001; 
Løbner-Olesen et al., 2005). This relatedness suggests that Dam has evolved from an 
ancestral restriction-modification system. An essential difference, however, is that the Dam 
methylase is highly processive, being able to achieve several methylation reactions without 
dissociating from the DNA molecule, while restriction-modification methylases are 
distributive (Urig et al., 2002).  
N6-methyl-adenine is used as a signal for genome defense, DNA replication and repair, 
nucleoid segregation, regulation of gene expression, control of transposition, and host-
pathogen interactions (Low et al., 2001; Løbner-Olesen et al., 2005; Marinus, 1996) (Figure 
I. 5). 
                 
Figure I. 7 Roles of N6-methyl-adenine in enteric bacteria. Methylation-sensitive DNA-binding proteins involved in each 
process are indicated. Adapted from (Wion& &Casadesús,&2006). 
Dam methylation plays an important role in the initiation of chromosome replication in E. 
coli. Chromosome replication starts when DnaA, the initiator protein, binds the oriC 
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replication origin, and separates the two strands of the double helix. DnaA binding is only 
possible if the oriC GATCs are methylated; a hemimethylated origin is inactive (Boye et al., 
2000). The oriC region contains 11 GATC sites in 254 bp, a density ten fold higher than the 
average expected in the E. coli chromosome (Zyskind & Smith, 1992). 
The GATC sites of the oriC remain hemimethylated for up to one-third of the cell cycle after 
DNA replication (Campbell & Kleckner, 1990). The protein SeqA avoids further rounds of 
replication by binding to hemimethylated GATC sites (Taghbalout et al., 2000). SeqA also 
binds to newly synthesized hemimethylated GATC sites along the chromosome, organizing 
the daughter chromosomes into nucleoid domains (Han et al., 2003). 
During DNA replication, mismatched base pairs errors are common. Dam methylation has an 
important role in mismatch repair by permitting the identification of the template DNA strand 
(Hsieh, 2001). The new strand is temporarily nonmethylated. MutS protein recognizes the 
mismatched base pair and recruits and assembles the MutHLS complex. This assembly 
activates the endonucleasa activity of MutH, which cleaves the nonmethylated DNA strand at 
the nearest hemimethylated GATC site, ensuring that the parental template strand is not cut 
(Friedhoff et al., 2003).  
As it was mentioned before, in E. coli and Salmonella, dam mutations produce pleiotropic 
defects such as lower colonization capacity, reduced motility, envelope instability, ectopic 
expression of fimbriae, sensitivity to bile salts, lower expression of virulence genes, and 
altered LPS O-antigen chain length (Cota et al., 2015; López-Garrido & Casadesús, 2010; 
Marinus & Casadesús, 2009). These pleiotropic virulence-related defects may explain the 
extreme attenuation of Dam– mutants upon oral inoculation in the mouse model (Badie et al., 
2007; García-Del Portillo et al., 1999). 
Gene regulation by Dam methylation can be divided into two main categories (Low & 
Casadesús, 2008) : 
 I.  Clock-like controls, in which the methylation state of the DNA is used as a signal 
to couple gene expression to a specific stage of the cell cycle. Hemimethylation may activate 
transcription (conjugal transfer gene, traJ (Camacho & Casadesús, 2005)) or repress it 
(chromosome replication gene, dnaA (Kücherer et al., 1986).  
  II. Switch-like controls, in which differential methylation patterns of GATC sites, 
typically found at or near the promoters of phase variation systems, modulate gene 
expression (van der Woude, 2011). Binding of proteins to DNA may prevent Dam 
methylation of certain GATCs, generating hemimethylated GATCs, and nonmethylated 
GATCs if the block persists during two consecutive DNA replication rounds (Casadesús & 
Low, 2006). DNA sequences surrounding specific GATCs sites may also decrease the 
processitivity of Dam methylation (Peterson & Reich, 2006). 
Phase variation systems regulated by Dam methylation  
As mentioned above, some envelope structures such as fimbriae, flagella or the LPS O-
antigen show phase variation and are under epigenetic control (Cota et al., 2015; Cummings 
et al., 2006; Kingsley et al., 2002; Nicholson & Low, 2000). In phase variation systems, gene 
expression alternates between active (ON phase) and inactive (OFF phase) states, and often 
depends on differential DNA methylation patterns (Switch-like controls). Binding of certain 
transcriptional regulators hinders Dam methylation and creates heritable DNA methylation 
patterns (Figure I. 8). 
pap  
The pap operon encodes pyelonephritis-associated pili that mediate adhesion of 
uropathogenic E. coli to the urinary mucosa (Hernday et al., 2004). Synthesis of Pap pili is 
subjected to phase variation, and Dam methylation controls the switching between ON and 
OFF states (Hernday et al., 2002).  
The regulatory region of the pap operon contains six binding sites for the leucine-responsive 
regulatory protein, Lrp. Sites 5 and 2 contain GATC motifs known as GATCdist and 
GATCprox, respectively. In the OFF state, Lrp binds cooperatively and with high affinity to 
sites 1-3 avoiding RNA polymerase binding (Casadesús & Low, 2006; Hernday et al., 2002; 
2004). Lrp binding at sites 1-3 reduces the affinity of Lrp for sites 4-6, and preserves the 
nonmethylated state of GATCprox while GATCdist remains methylated. The high affinity of 
Lrp for nonmethylated GATCprox and its incapability to bind a methylated GATCdist generates 
a feedback loop that propagates the OFF state (Hernday et al., 2002; 2004). Switching to the 
ON state needs translocation of Lrp to sites 4-6. Translocation involves the auxiliary protein 
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PapI. The PapI/Lrp complex has higher affinity for GATC sites 4-6 than for 1-3 GATCs 
(Hernday et al., 2003). Binding of Lrp to sites 4-6 hinders methylation of GATCdist and 
permits methylation of GATCprox, favoring the propagation of the ON state (Hernday et al., 
2004).  
agn43 
The agn43 gene of E. coli encodes Agn43, an autotransporter protein whose expression is 
subjected to phase variation under control of Dam methylation and OxyR (Henderson & 
Owen, 1999; Henderson et al., 1997). Three GATC sites are contained within the binding site 
of OxyR at agn43 regulatory region (Wallecha et al., 2002). OxyR binding to nonmethylated 
agn43 GATCs represses transcription and prevents GATC methylation. On the other hand, 
methylation of GATC sites avoids OxyR binding (Haagmans & van der Woude, 2000; 
Henderson et al., 1997; Waldron et al., 2002). agn43 expression thus depends on the 
competition between OxyR binding and Dam methylation, and switching may occur upon 
DNA replication (Waldron et al., 2002; Wallecha et al., 2002).  
opvAB 
The Salmonella enterica opvAB operon shows phase variation and creates bacterial lineages 
with standard (OpvABOFF) and shorter (OpvABON) O-antigen chains in the 
lipopolysaccharide. Transcription of OpvAB is controlled by the LysR-type factor OxyR and 
by Dam methylation. The opvAB regulatory region contains four sites for OxyR binding 
(OBSA-D), and four GATC motifs (GATC1-4) which are targets for Dam methylation. 
OpvABOFF and OpvABON cell lineages present opposite DNA methylation patterns in the 
opvAB regulatory region: (i) in the OpvABOFF state, GATC1 and GATC3 are non-methylated, 
whereas GATC2 and GATC4 are methylated; (ii) in the OpvABON state, GATC2 and GATC4 
are non-methylated, whereas GATC1 and GATC3 are methylated (Cota et al., 2015).  
The OBSA and OBSC sites of opvAB are identical to the consensus sequence for OxyR 
binding while OBSB and OBSD are not. This difference may explain the higher stability of 
the OpvABOFF lineage, resulting in a ∼600-fold difference in the ON→OFF and OFF→ON 
transition rates. The predominant OFF state involves binding of OxyR to the OBSA and 
OBSC sites, which protects GATC1 and GATC3 from methylation. In this configuration, 
 GATC2 and GATC4 are unprotected and therefore are methylated by Dam. In the ON state, 
OxyR binds to the OBSB and OBSD sites. As a consequence, GATC2 and GATC4 are 
protected from methylation and remain non-methylated, while GATC1 and GATC3 are 
methylated. RNA polymerase is successfully recruited to the opvAB promoter and 
transcription of opvAB takes place. RNA polymerase may contact OxyR and other LysR-type 
transcription factors within the DNA region occupied by the regulator (Zaim & Kierzek, 
2003). Additional factors involved in the formation of OpvAB cell lineages are the GATC-
binding protein SeqA (which contributes to the stability of the OpvABOFF lineage) and the 
nucleoid protein HU (which contributes to the OpvABON lineage) (Cota et al., 2015). 
 
Figure I. 8 Diagrams for Dam methylation-dependent regulation of pap, agn43 and opvAB phase variation. For 
simplicity, binding sites, Dam methylase and RNA polymerase are not represented. Adapted from (Broadbent et al., 2010; 
Cota et al., 2015). 
Phenotypic heterogeneity in bacteria population 
Reversible bistability or phase variation involves switching of gene expression from OFF to 
ON and vice versa (van der Woude, 2006; 2011; van der Woude & Bäumler, 2004). Phase 
variation can be generated by diverse mechanisms, either genetic (homologous or site-
specific recombination, slipped strand mispairing at DNA repeat tracks) or epigenetic (DNA 
methylation) (Bayliss, 2009).  
Switching between the ON and OFF states is a stochastic event, but may be modulated by 
external factors (van der Woude & Bäumler, 2004).  
ON OFF
methylated GATC
non methylated GATC
Lrp
PapI
OxyR
pap
opvAB
agn43
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Bimodal gene expression generates phenotypic heterogeneity in the population. This strategy, 
often observed in loci encoding envelope components or proteins involved in the envelope 
modification, has been considered a way of avoiding immune responses during animal 
infection or a way to generate variants with altered ability to colonize niches in the host (van 
der Woude, 2011; van der Woude & Bäumler, 2004).  
The biological significance of bacterial subpopulations can be understood as the consequence 
of two different strategies: cooperation and bet-hedging (Ackermann, 2013; Lambert et al., 
2014; Veening et al., 2008). Cooperation implies that there is an interaction between different 
phenotypes, so that, in a given environment, both subpopulations together are fitter than any 
of them separately. Bet-hedging or risk spreading occurs when each subpopulation is fitter 
than the other in a particular environment, so that the population as a whole is fitter in a 
variety of conditions and is prepared to adapt to a sudden environmental change.  
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When this Thesis work started, the literature contained very little information on the std 
operon. The pioneering study that had described the existence of the operon in the genome of 
Salmonella enterica serovar Typhimurium had also reported that std expression occurs in the 
large intestine of animals but not in the laboratory (Humphries et al., 2003). An independent 
study had shown that repression of std expression under laboratory conditions is mainly 
exerted by DNA adenine (Dam) methylation (Jakomin et al., 2008) and to a lesser extent by a 
repressor named RosE (Chessa et al., 2008). Transcription of the std operon in Dam– mutants 
had been shown to require a poorly known LysR-type transcription factor known as HdfR 
(Jakomin et al., 2008). The same study had raised the possibility that std expression might 
undergo bistability or phase variation. More recently, a study had shown that two products of 
the std operon, StdE anf StdF, downregulated Salmonella pathogenicity island 1 (SPI-1) and 
prevented invasion of epithelial cells (López-Garrido & Casadesús, 2012).  
Based on these antecedents, the initial objective of the Thesis (Objective 1) was to investigate 
whether std expression was subjected to phase variation outside the large intestine. Results 
obtained in this section of the Thesis revealed the existence of StdON and StdOFF 
subpopulations outside the animal intestine. Objective 2 was aimed at understanding the 
molecular mechanisms that control std transcription and generate phase variation. Objective 3 
pursued the characterization of StdON state using transcriptomic analysis, chromatin 
immunoprecipitation, and phenotypic analysis. The main aim of this objective was to 
determine the extent and physiological significance of StdEF-mediated control of Salmonella 
genes outside the std operon. These objectives can be summarized as follows: 
Objective 1. Surveys of std phase variation in S. enterica ser. Typhimurium by single cell 
analysis.  
Objective 2. Molecular analysis of the factors and mechanisms that control std transcription 
and phase variation, with emphasis on the roles of Dam methylation, HdfR, StdE, and StdF. 
Objective 3. Characterization of the StdEF regulon of Salmonella enterica serovar 
Typhimurium.
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Bacterial strains and strain construction 
Salmonella enterica and Escherichia coli strains used in this Thesis are listed in Table M1. 
Salmonella enterica strains belong to serovar Typhimurium and derived from the mouse-
virulent strain SL1344 or ATCC14028. For simplicity, Salmonella enterica serovar 
Typhimurium is often abbreviated as S. enterica. 
Table M 1. Strains of Salmonella enterica and E.coli used in this study.  
Strain 
Name Genotype Reference 
S. enterica 
SL1344 Wild type (Hoiseth & Stocker, 1981) 
SV5367 SL1344 ∆dam231 (Balbontín et al., 2006) 
SV8479 SL1344 stdA::gfp This study 
SV8480 SL1344 ∆dam231 stdA::gfp This study 
SV8481 SL1344 ∆hdfR stdA::gfp This study 
SV9311 SL1344 ∆dam231 ∆hdfR stdA::gfp This study 
SV8528 14028 rcsC11 stdA::gfp This study 
SV5182 14028 stdA::lacZ (Jakomin et al., 2008) 
SV5183 14028 ∆dam231 stdA::lacZ (Jakomin et al., 2008) 
SV9312 14028 ∆dam231 rcsB56N stdA::lacZ This study 
SV9313 14028 ∆dam231 rcsC11 stdA::lacZ This study 
SV9314 14028 ∆dam231 ∆tolB stdA::lacZ This study 
SV9315 14028 ∆dam231 p-rcsB stdA::lacZ This study 
SV5264 14028 ∆dam231  (López-Garrido & Casadesús, 2010) 
SV5815  14028 ∆dam231 rcsB56N This study 
SV9316  14028 ∆dam231 rcsC11 This study 
SV9317  14028 ∆dam231 ∆tolB This study 
SV9318  14028 ∆dam231 p-rcsB This study 
SV8487 SL1344 ∆dam231 hdfR-3xFLAG This study 
SV7889 SL1344 hdfR::lacZ This study 
 SV9319 SL1344 ∆dam231 hdfR::lacZ This study 
SV8188 SL1344 stdA::lacZ This study 
SV8449 SL1344  PLtetOhdfR  This study 
SV8477 SL1344  PLtetOhdfR stdA::lacZ This study 
SV9292  SL1344 PLtetOhdfR stdA::gfp This study 
SV9123 SL1344 pIC552 This study 
SV9124 SL1344 /pIZ2320 This study 
SV9125 SL1344 ∆hdfR /pIZ2320  This study 
SV8192 SL1344  stdA::lacZ /pBR328  This study 
SV8194 SL1344 stdA::lacZ /pIZ2318  This study 
SV9320 SL1344 stdA::lacZ /pIZ2319  This study 
SV8189 SL1344 ∆hdfR stdA::lacZ This study 
SV8193 SL1344 ∆hdfR  stdA::lacZ /pBR328 This study 
SV8195 SL1344 ∆hdfR stdA::lacZ /pIZ2318   This study 
SV9321 SL1344 ∆hdfR  stdA::lacZ /pIZ2319 This study 
SV9322  SL1344 PLtetOstdEF stdA::gfp This study 
SV9323 SL1344 ∆stdEF stdA::gfp This study 
SV9279 SL1344 ∆dam231 ∆stdEF stdA::gfp This study 
SV9001 SL1344 ∆dam231  PLtetOstdEF stdA::gfp This study 
SV8507 SL1344 PLtetOstdEF stdA::lacZ This study 
SV9324 SL1344 ∆dam231  stdE-3xFLAG This study 
SV9325 SL1344 ∆dam231  stdF-3xFLAG This study 
SV8526 SL1344 ptp166 stdA::gfp This study 
SV9205 SL1344 stdE::gfp This study 
SV9207 SL1344 ∆dam231 stdE::gfp This study 
SV9206 SL1344 ∆hdfR stdE::gfp This study 
SV9208 SL1344 ∆pstdA-stdC stdE::gfp This study 
SV6503 14028 PLtetOstdEF (Cmr) (López-Garrido & Casadesús, 2012) 
SV6634 14028 PLtetOΔstdEF (Cmr) (López-Garrido & Casadesús, 2012) 
SV8141 SL1344 PLtetOstdEF (Cmr) This study 
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SV8142 SL1344 PLtetO∆stdEF (Cmr) This study 
SV7553 SL1344 PLtetOstdEF (KmR) This study 
SV7552 SL1344 PLtetO∆stdEF (KmR) This study 
SV7554 SL1344 PLtetOstdEF spvA This study 
SV7555 SL1344 PLtetOΔstdEF spvA This study 
SV7556 SL1344 spvA::tn5dKm This study 
SV4938 SL1344 trg::mudQ  pSLT- (García-Quintanilla & Casadesús, 2011) 
SV7551 SL1344 traB::lacZ This study 
SV7550 SL1344 PLtetOstdEF traB::lacZ This study 
SV7549 SL1344 PLtetOΔstdEF traB::lacZ This study 
SV8152 SL1344 ∆ygiD This study 
SV9326 SL1344 PLtetOstdEF ∆hdfR This study 
SV9327 SL1344 PLtetO∆stdEF ∆hdfR This study 
SV9288 SL1344 flhC::lacZ This study 
SV9289 SL1344 PLtetOstdEF flhC::lacZ This study 
SV9290 SL1344 PLtetO∆stdEF flhC::lacZ This study 
SV9328 SL1344 ∆hdfR flhC::lacZ This study 
SV9329 SL1344 PLtetOstdEF ∆hdfR flhC::lacZ This study 
SV9320 SL1344 PLtetO∆stdEF ∆hdfR flhC::lacZ This study 
SV9331 SL1344 PLtetOstdEF ∆hdfR spvA This study 
SV9332 SL1344 PLtetOΔstdEF ∆hdfR spvA This study 
SV9333 SL1344 ∆hdfR  spvA This study 
SV8185 SL1344 sipB::lacZ This study 
SV8186 SL1344 PLtetOstdEF sipB::lacZ This study 
SV8187 SL1344 PLtetO∆stdEF sipB::lacZ This study 
SV8109 SL1344 ∆flhC sipB::lacZ This study 
SV8110 SL1344 PLtetOstdEF ∆flhC  sipB::lacZ This study 
SV8111 SL1344 PLtetO∆stdEF ∆flhC sipB::lacZ This study 
SV8103 SL1344 fliC::lacZ This study 
SV8104 SL1344 PLtetOstdEF fliC::lacZ This study 
 SV8105 SL1344 PLtetO∆stdEF fliC::lacZ This study 
SV8106 SL1344 ∆flhC fliC::lacZ This study 
SV8107 SL1344 PLtetOstdEF ∆flhC  fliC::lacZ This study 
SV8108 SL1344 PLtetO∆stdEF ∆flhC fliC::lacZ This study 
SV8023 SL1344 ∆flhC traB::lacZ This study 
SV8024 SL1344 PLtetOstdEF ∆flhC  traB::lacZ This study 
SV8025 SL1344 PLtetO∆stdEF ∆flhC traB::lacZ This study 
SV9287 SL1344 PLtetOstdEF-3xFLAG This study 
SV9109 SL1344 PLtetOstdEF ∆flhC This study 
SV9110 SL1344 PLtetOΔstdEF ∆flhC This study 
SV9309 SL1344 PLtetOstdEF PLtetOhilD This study 
SV9310 SL1344 PLtetOΔstdEF PLtetOhilD This study 
SV9113 SL1344 PLtetOstdEF invH::lacZ This study 
SV9114 SL1344 PLtetOΔstdEF invH::lacZ This study 
SV9119 SL1344 PLtetOstdEF PLtetOhilD invH::lacZ This study 
SV9120 SL1344 PLtetOΔstdEF PLtetOhilD invH::lacZ This study 
SV9273 SL1344 ∆dam231  ∆stdEF This study 
SV7890 SL1344 PLtetOstdEF hdfR::lacZ This study 
SV7891 SL1344 PLtetO∆stdEF hdfR::lacZ This study 
TR5878 
galE496 r(LT2)– m(LT2)– r(S)+ ilv-542 metA22 
trpB2 Fels2– fliA66 strA120 xyl-404 metE551 
hspL56 hspS29 
J.R. Roth 
E. coli 
DH5α 
supE44 ∆lacU169 (Φ80 lacZ∆M15) 
hsdR17 recA1 endA1 gyrA96 thi-1 reA1 
(Hanahan, 1983) 
BL-21 F
- dcm ompT hsdS (rB- mB-) gal (malB+) 
K-12 (λS) 
Stratagene 
 BL-21 pET28a-stdE This study 
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Targeted gene disruption was achieved by Datsenko and Wanner method (Datsenko & 
Wanner, 2000). This method is based in the λ Red recombination system. The strategy 
consists in replacing the chromosomal sequence by an antibiotic resistance marker (contained 
in pKD3, pKD4 or pKD13) that is generated by polymerase chain reaction (PCR) using 
oligonucleotides that harbor 40 nucleotides of homology with the sequence to be replaced. λ 
Red recombination gene expression is carried out under an inducible promoter inside a 
thermosensitive low copy number plasmid (pKD46).  
Cultures harbored pKD46 plasmid (this plasmid expresses the λ Red system under the araB 
promoter which is inducible by arabinose) grown in LB with ampicillin at 30ºC were diluted 
1:100 into LB with ampicillin and arabinose 1 mM and incubated in a shaker at 30ºC until 
O.D.600 ~ 0.8. The competent cells were prepared and electroporation was done as further 
described.  
After selection, antibiotic resistance cassettes introduced during strain construction can be 
excised by recombination with plasmid pCP20 (Datsenko & Wanner, 2000). pCP20 plasmid 
can be transduce with P22. This transduction is incubated at 30ºC for 1h and spread in LB 
with ampicillin. To eliminate the plasmid, green plates were prepared without antibiotic and 
incubated at 37ºC. To confirm the excision of the marker, the strains were streaked in plates 
of LB ampicillin and plates of LB with chloramphenicol or kanamycin. The excision of the 
antibiotic marker was checked by colony PCR with external oligonucleotides.  
The oligonucleotides used for gene disruption (named as UP and DO) and allele verification 
(named as E1 and E2) by the polymerase chain reaction (PCR), are listed in Table M2.  
For construction of lac fusions in the Salmonella chromosome, FRT sites generated by 
excision of KmR cassettes with pCP20 (Datsenko & Wanner, 2000) were used to integrate 
either pCE37 or pCE40 (Ellermeier et al., 2002).  
For strain construction operations involving chromosomal markers we used transduction with 
P22 HT 105/1 int201 ((Schmieger, 1972) and G. Roberts, unpublished). The recipient strain 
was transduced using a P22 lysate from a strain with the desirable genetic marker. All the 
markers used in this thesis were selected directly by spreading the transduction mixture on 
selective media.!Transduction protocol is described below. 
 
 Table M 2. Oligonucleotides used in thi study. 
Oligonucleotide name sequence (5’!3’) 
stdA129GFP UP tttcactggtaccatcaccaactcaccctgtgatatcgcataagaaggagatatacatatg 
stdAGFP DO ccgtggacggcttctccctgtcgttatttaccgcgtgaaattatcacttattcaggcgta 
stdA E1 ggaaagttcaggtgcttcg 
stdAE2 gctttcggtgttgtcgtcc 
PLtetOhdfR UP atatcgattagtcgtcgtaaagctttccgccatcctgcacaggcttacccgtcttactgtc 
PLtetOhdfR DO ggaaagtttttaacaattccgtatccactgtgctctccacaaaacctctccataactggg 
hdfR E1 ggagagcacagtggatacgg 
hdfR E2 gattatctgatcaggtaatc 
promotorhdfRBglII FOR agctagatctccgtgacgagagaatccacg 
promotorhdfRXhoI REV agctctcgaggatacgaaagctcaccgcgg 
PLtetOstdEF pStd UP gttttctgctgcaatacccgttactgttacctataactaaaggcttacccgtcttactgtc 
PLtetOstdEF pStd DO tcagggcacataaaacctctccataactgggtaaatgatgtgctcagtatctctatcactgatag 
stdE21GFP UP ccagttatggagaggttttatgtgccctgataatacacactaagaaggagatatacatatg 
stdEGFP DO ttaccgacccggcgttttgataccagcggcggtccggcttttatcacttattcaggcgta 
stdE E1 tgctgcaatacccgttactg 
stdE E2 caggctgcctgtatgcg 
PLtetO sense ttggaacctcttacgtgcc 
mutpStdA-stdC UP  ccttttacttgcattatatccagttttttatgctaccagtgtgtaggctggagctgcttc 
mutpStdA-stdC DO gatgtcgcccctgcgtccttaaacgcgcagttcagggcatcatatgaatatcctccttag 
Km PLtetOUP ttaatgtcatgataataatggtttcttagacgtcgatatcgtgtaggctggagctgcttc 
Km PLtetODO cttggattctcaccaataaaaaacgcccggcggcaaccgacatatgaatatcctccttag 
NdeIstdE-FOR ttttcatatgtgccctgataatacaca 
EcoRIstdE-REV ttttgaattcttatgttccgtcatcctcatcc 
std-PLtetOUP attcacccgcttataattac 
std southern DO cagctaatgcctaatcagttg 
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EMSA-std300 FOR attcacccgcttataattac  
EMSA-std735 FOR cgcattaatatcccccagcc 
EMSA-std REV attacgcatagataatatgtc  
8032 EMSA-Fwd Pdps gcgctattacttcgtc 
8033 EMSA-Rev Pdps  cgggatccctcatatcctcttgatgtttgtgt 
pBR328-Fw actgtccgaccgctttgg 
pBR328-Rv gccagcaaccgcacctg 
ygiD UP ggttatctgagttcttcctctgtgaagaaagcgtatggtggtgtaggctggagctgcttc 
ygiD DO cgccatcgggcaatcattcagcgccttatccggcctaccccatatgaatatcctccttag 
ygiD E1 tatcaatttgccgtccgaacc 
ygiD E2 tcgaaggatagattctcctg 
RT-hilD FOR agtttgctttcggagcggta 
RT-hilD REV agcaccaacatcccaggttc 
RT-promotorstd FOR cattaaaaagtatttctttgatg 
RT-promotorstd REV gaaaattcttattcaaattaaaac 
RT-flgE DIR gacggtacgacaacgaacac 
RT-flgE REV aaaaccgttctggctaatcg 
RT-hilA DIR gaatcttttcatggctggtca 
RT-hilA REV gggtccaattttaaacactcgt 
RT-motA DIR taggggcgttcattgtcg 
RT-motA REV acgggatagctttcatcgtg 
RT-sipB DIR gtaatggtggccgatgaaat 
RT-sipB REV cgcctgctgaataaacgac 
RT-traA DIR gtacggtcaaggcgacattt 
RT-traA REV ccgcgagaataacccactt 
RT-trg DIR cggggtcgtacaaacgat 
RT-trg REV gcggtaatttccgagattttt 
 RT-hdfR DIR ttggcgttatattgcagcag 
RT-hdfR REV ccagccgcagataattgagt 
RT-cheA DIR cggtgatgtcgattcgtatg 
RT-cheAREV tctacctgcttgcccagttt 
RT-cheM DIR gaaggttcggatgcgattta 
RT-cheM REV acgggaagagaggtcggtat 
RT-cheB DIR gctgctcagttcggaaaaac 
RT-cheB REV gcacatgtcggatagcttca 
RT-stdA DIR catcaccaactcaccctgtg 
RT-stdA REV aaatctgtccaaacggaacg 
RT-rfaH DIR tcagccattttgtgcgctt 
RT-rfaH REV tttaggatcgacaacgcctt 
Construction of the relevant strains 
For the construction of the strains SV8479 (stdA::gfp) and SV9205 (stdE::gfp), a fragment 
containing the promoterless green fluorescent protein (gfp) gene and the chloramphenicol 
resistance cassette was PCR-amplified from pZEP07 (Hautefort et al., 2003) using the pair of 
oligonucleotides stdA129GFP UP and stdAGFP DO; and stdE21GFP UP stdEGFP DO 
respectively. The fragment was integrated into the chromosome of S. enterica using the 
Lambda Red recombination system (Datsenko & Wanner, 2000), and verified with the pair of 
oligonucleotides stdA E1 and stdA E2; or stdE E1 and stdE E2. stdA::gfp and stdE::gfp 
transcriptional fusions were formed defective in StdA and StdE synthesis, since only the first 
129nt and 21nt of the genes are kept in the construct.   
The construction of the strains SV8141 (SL1344 PLtetOstdEF) and SV8142 (SL1344 
PLtetOΔstdEF) was performed by transduction of S. enterica SL1344 cells using lysates from 
the previously described strains SV6503 (14028 PLtetOstdEF) and SV6634 (14028 
PLtetOΔstdEF) (López-Garrido & Casadesús, 2012). In both constructions, the PLtetOpromoter 
is inserted upstream stdE on the Salmonella chromosome. Insertion of the PLtetO promoter 
removed the upstream genes in the std operon and the native promoter upstream stdA. A 
chloramphenicol resistance cassette (CmR) is linked to the PLtetO promoter in these cells. For 
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mating experiments described below, the resistance cassette was changed from CmR to 
kanamycin (KmR). To do so, the KmR cassette (including the FRT sites) was amplified from 
pKD4 (Datsenko & Wanner, 2000), with oligos KmPLtetO UP and KmPLtetO DO. The resulting 
PCR product was transformed into SL1344 PLtetOstdEF and SL1344 PLtetOΔstdEF cells 
containing the pKD46 plasmid, and positive clones were selected by their ability to grow in a 
kanamycin containing medium. Finally, the KmR cassette introduced during construction was 
excised by recombination with plasmid pCP20 (Datsenko & Wanner, 2000). 
The same PLtetO insertion upstream stdEF gene was performed but maintaining the upstream 
genes in the std operon together with the native promoter upstream stdA. To do so, we used  
the oligonucleotides PLtetOstdEF pStd UP and PLtetOstdEF pStd DO and verified with PLtetO 
sense and stdE E2. Strains SV9322, SV9001 and SV8507 were generated by transduction.  
Strain SV8449 (PLtetOhdfR) contains the PLtetO promoter upstream hdfR coding region on the 
Salmonella chromosome. PLtetO promoter was used in order to achieve a constitutive and 
moderate expression of hdfR. To construct this strain, the PLtetO promoter was amplified from 
SV7553 (SL1344 PLtetOstdEF (KmR)) with oligos PLtetOhdfR UP and PLtetOhdfR DO. The 
resulting PCR product was integrated into the chromosome of S. enterica using the Lambda 
Red recombination system (Datsenko & Wanner, 2000) by transformation into SL1344 cells 
containing the pKD46 plasmid, and positive clones were selected by their ability to grow in a 
kanamycin containing medium. Finally, the KmR cassette introduced during construction can 
be excised by recombination with plasmid pCP20 (Datsenko & Wanner, 2000). Insertion of 
the PLtetO promoter removed the native promoter of hdfR avoiding transcriptional regulation 
of this gene.  
Bacteriophages  
Bacteriophage P22 H5 is a virulent derivative of bacteriophage P22 that carries a mutation in 
the c2 gene (SMITH & H, 1964) , and was kindly provided by John R. Roth, University of 
California, Davis. For simplicity, P22 H5 is abbreviated as P22.  
 Culture media and growth conditions 
Luria-Bertani broth (LB) was used as standard rich medium (10 g/l tryptone, 5 g/l yeast 
extract and 10 g/l NaCl ). Solid media contained agar at 1.5% final concentration. Green 
plates (Chan et al., 1972) called EBU plates as well, were used to discard the presence of 
lysogenic isolates after transductions are made of LB medium supplemented with 10 ml/l 
K2HPO4 25%, 5 ml/l glucose 50%, 2.5 ml/l fluorescein 1% and 1.25 ml/l Evans blue 1%.  
Salmonella enterica cultures were grown usually at 37ºC, and exceptionally at 30ºC (strains 
containing the thermolabile pKD46 or pCP20 plasmids). Liquid cultures were shaken at 200 
rpm for aeration. Any other conditions of growth would be indicated.  
Antibiotics were used at the final concentrations described previously (Prieto et al., 2004) and 
listed below, in Table M. 3, together with other chemicals employed, as the 5-bromo-4-
chloro-3-indolyl-β-D-galactopyranoside (X-gal; Sigma-Aldrich) used as indicator for 
monitoring β-galactosidase activity in plate test.  
Table M 3. Final concentration of antibiotics and other chemicals used in this Thesis. 
Chemical Final concentration 
Antibiotics  
Ampicillin (Ap) 100 µg/ml 
Chloramphenicol (Cm) 20 µg/ml 
Kanamycin (Km) 50 µg/ml 
Tetracycline (Tet) 5 µg/ml 
Other chemicals  
EGTA 0.004 µg/ml 
X-gal 40 µg/ml 
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Bacterial transduction 
P22 lysates 
To prepare P22 lysates, 4 ml of P22 stock (100 ml NB (3 g/l meat extract and 5 g/l peptone), 
2 ml E50x (300 g/l H3C6H5O7.H2O, 14 g/l MgSO4, 1965 g/l K2HPO4.3H2O, 525 g/l 
NaNH4HPO4.H2O), 1ml glucose 20% and 0.1 ml P22 phage) was mixed with 1 ml of the 
donor strain. The mixture was incubated at 37ºC and 200 rpm for 4-8 h. Bacterial debris was 
removed by centrifugation for 10 min at 4,500 rpm. The supernatant was recovered in a glass 
fresh tube, and 800 µl of chloroform were added and vortexed. The lysates were maintained 
at room temperature for a few hours and then stored at 4ºC. 
Transduction in liquid medium  
100 µl of an overnight culture of the recipient strain and 10-20 µl of the lysate of the donor 
strain were mixed in a sterile 1.5 ml tube. This mixture was incubated at 37ºC (pCP20 
transduction is incubated at 30ºC) and 200 rpm for 30-60 min (depending on the marker to be 
transduced). The mixture was spread on selective plates that were incubated at 37ºC until 
colonies appeared.  
Detection of lysogenic transductants  
Transductants harboring a selective marker could have been infected by P22 phage and 
become pseudolysogenic (the int mutation avoids integration, and delays the formation of 
true lysogens). As time goes on, pseudolysogens become resistant or immune to new P22 
infections and cannot be lysed or transduced again. Pseudolysogeny should thus be avoided. 
To obtain phage-free isolates, transductants were purified by streaking on green plates (with 
antibiotics if necessary), prepared according to Chan et al. (Chan et al., 1972). On these 
plates, pseudolysogens are dark colored and P22-free colonies are light colored. This!color 
difference is due to!cell lysis in the pseudolysogenic colony, which causes acidification of the 
medium and turning of the pH indicator, darkening the agar. A transductant was considered 
P22- free when streaking did not give rise to any dark colony.! 
 P22 sensitivity assay  
In EBU plates, isolates that form light colour colonies could be lysogens that do not undergo 
visible lysis. These isolates are P22-resistant and can be mistaken by real P22-free isolates. 
To avoid this situation, an assay to detect P22-sensitive strains is advisable. A streak with a 
P22 H5 lysate is done on an LB or EBU plate, and air-dried. The test strain is then streaked in 
a perpendicular way to the H5 streak. P22-sensitive strains grow until they reach the H5 
streak, while P22-resistant strains grow over the streak.  
DNA manipulation and transfer 
Plasmids 
Plasmids used in this study are listed in Table M4.  
Table M 4. Plasmids used in this study. 
Plasmid Description Reference 
S. enterica 
pCP20  bla cat cI857 λPR flp pSC101 oriTS, Ap
R, CmR  (Cherepanov & Wackernagel, 1995) 
pIC552 galK' lac+, ApR  (Macián et al., 1994) 
pKD3 bla FRT cat FRT PS1 PS2 oriR6K, ApR, CmR (Datsenko & Wanner, 2000) 
pKD4 bla FRT aph FRT PS1 PS2 oriR6K, ApR, KmR  (Datsenko & Wanner, 2000) 
pKD13 bla FRT aph FRT PS1 PS4 oriR6K, ApR, KmR  (Datsenko & Wanner, 2000) 
pKD46 bla PBAD gam bet exo pSC101 oriTS, Ap
R  (Datsenko & Wanner, 2000) 
pZEP07 pZEP06 derivative, t0T1, CmR (Hautefort et al., 2003) 
pET28a vector used to construct 6His fusions ,ApR  Novagen  
pTP166 Cloned dam gene (Marinus et al., 1984) 
prcsB pUHE2-21 lacIq containing rcsB gene (Pescaretti et al., 2009) 
pIZ2318 pBR328std This work 
pIZ2319 pBR328std∆stdF This work 
pIZ1991 pET28a-stdE-6His  This work 
pIZ2320 pIC552-hdfRpromoter region, ApR  This work 
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For construction of pIZ1991, a DNA fragment containing stdE coding region was amplified 
using oligonucleotides NdeIstdE-FOR and EcoRIstdE-REV and cloned into pET28-a 
(Novagen) using the NdeI and EcoRI sites.   
Plasmid pIC552 is a promoter-less vector used to construct transcriptional lacZ fusions; in 
this plasmid, the lacZ ORF is preceded by the translational start site of galK (Macián et al., 
1994). The galK ribosomal binding sites and this adjacent region guarantee a high efficiency 
of the lacZ translation, so that the β-galactosidase activity is directly proportional to the 
transcriptional activity of the fragment cloned. The suspected promoter region of the hdfR 
gene was amplified using the oligonucleotides promotorhdfRBglII FOR and 
promotorhdfRXhoI REV listed in Table M2, and clone into pIC552 plasmid, generating the 
plasmid pIZ2320 listed in Table M4.  
Extraction of plasmid DNA 
Commercial system GenElute TM Plasmid Miniprep Kit, provided by Sigma-Aldrich Co (St. 
Louis, Missouri, USA) was used for the extraction of plasmid DNA.  
Extraction of genomic DNA 
For the extraction of genomic DNA, 5 ml of cells from a stationary culture (O.D.600∼2) were 
collected and re-suspended in 0.4 ml of buffer lysis (50 mM Tris-HCl pH8, 10 mM EDTA, 
100 mM NaCl and 0.2% SDS ), 4 µl of RNAse (10 mg/ml) were added and the mixture was 
incubated at 37ºC for 30 minutes. After that, 20 µl of proteinase K (20 mg/ml) was added and 
it was incubated for 2 h at 65ºC. Finally, were performed 3 or 4 extractions with 
phenol:chloroform-isoamyl alcohol in a 2:1 proportion. Optionally, one extraction with 
chloroform:isoamyl alcohol (24:1) can be performed. DNA was precipitated al -20º C by 
adding 1/10 volume of sodium acetate 3 M and 2.5 volumes of ethanol. After precipitation, 
genomic DNA was washed with 70% ethanol and re-suspended in 50 µl of water.  
Digestion, modification and ligation of DNA fragments 
Restriction endonucleases were supplied by Roche Diagnotics GmbH (Indianapolis, Indiana, 
USA), New England Biolabs (Beverly, Massachusetts, USA) and Promega Biotech 
(Madison, Wisconsin, USA). Enzymes were used following the manufacturer’s instructions.  
 For ligation of DNA fragments with the appropriated vector (properly digested), 1 U of T4 
DNA ligase (1 U/µl, Roche Diagnosstics) was used in the buffer supplied by the 
manufacturer. Routinely, the mixture was incubated at 16ºC overnight.  
Electrophoresis in an 0.8% agarose (Low Electro Endosmosis agarose-Pronadisa, Conda, 
España) gel made up in TAE 1x buffer (40 mM Tris-acetate and 10 mM EDTA pH7.7) was 
used to test the quality of DNA extraction, to determine DNA fragments after plasmid 
restriction, to estimate the efficiency of endonuclease restriction, etc. The loading buffer used 
was 10X Loading buffer supplied by Takara. The 1 Kb ladder (GIBCO BRL, Life 
Technologies, New York, USA) was used as molecular weight marker. Ethidium bromide 
(0.5 µg/ml final concentration) was added to the gels to make bands visible. Gels were 
illuminated with UV and pictures were taken with Gel DocTM Imager- BioRad.  
Bacterial transformation 
High efficiency E. coli transformation  
Competent cells were prepared using a variation of the Inoue method (Inoue et al., 1990), 
which guarantees high transformation efficiency (5x107 to 5x108 transformants per µg of 
plasmid DNA). An E. coli DH5α/BL-21 overnight culture was diluted 100-1000 times in 200 
ml of SOB (20 g/l tryptone, 5 g/l yeast extract, 0.5 g/l NaCl, 0.19 g/l KCl, adjust with NaOH 
to pH7 and 5 ml MgCl2 2 M after autoclaving), and incubated at 22ºC and 200 rpm until 
OD600 ∼0.5 was reached. The culture was chilled quickly on ice and kept on ice for 10 
minutes. Cells were harvested by centrifugation at 2,500 g and 4ºC for 10 min. The pellet was 
resuspended in 20 ml of cold filtrated TB (10 mM PIPES, 15 mM CaCl2, 250 mM KCl, 
adjust to pH6.7 with KOH, 55 mM MnCl2 ), and 1.5 ml of dimethyl sulfoxide (DMSO) was 
added. After 10 min incubation on ice, aliquots of 0.2-0.5 ml were prepared, freezed in liquid 
nitrogen, and stored at -80º C.  
For transformation, an aliquot of competent cells was slowly thawed on ice and was mixed 
with the plasmid. The mixture was incubated on ice for 30 minutes, subjected to heat shock 
(42oC, 45 s), and cooled on ice for 1 min. One ml of LB was then added. The mixture was 
incubated at 37oC for 1 h; finally, the cells were concentrated in 100 µl and spread on 
selective media.  
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Salmonella electroporation  
An overnight culture was diluted 1/100 in LB and, depending on the strain, was grown at 
37oC or 30oC (strains with a thermolabile plasmid like pKD46) until an OD600 ∼0.8 was 
reached. The cultured was chilled on ice and kept on ice for 5 minutes. 20 ml cells were 
harvested by centrifugation at 4000 rpm for 5 min at 4oC. The supernatant was discarded and 
the bacterial pellet was softly re-suspended in 1 ml of cold ddH2O. Once cells were re-
suspended, 19 ml of cold water were added, and cells were washed again. Finally, cells were 
harvested and re-suspended in 250 µl of water.  
Electroporation was performed by mixing 1 µl of plasmid DNA or 10 µl of PCR product with 
50 µl of competent cells. The mixture was transferred to a cuvette that had 2 mm gap between 
the plates. The cuvette was subjected to an electric discharge in the electroporator (2.5 KV, 
200 Ω and 25 µF). The electroporator employed was a BTX Electrocell Manipulator 600 
(Harvard Apparatus, Holliston, Massachusetts, USA). After the discharge, 1 ml of LB was 
added to the cells, and the mixture was transferred to a 10 ml tube, which was incubated at 
37o C with shaking for 1 h. Finally, cells were concentrated in 100 µl and spread on selective 
media.  
pBR328-based plasmid library genetic screen 
pBR328-based multicopy plasmid library of the Salmonella enterica genome was used to 
search for factors that might activate expression of the std operon in a wild type (Dam+) 
background stdA::lacZ strain (SV5182).  
This library was previously constructed and described (López-Garrido & Casadesús, 2012). 
Briefly, Salmonella enterica Serovar Typhimurium SL1344 was partially digested with 
Sau3A. DNA fragments ranging between 7-11 kb long were ligated to the pBR328 vector, 
previously digested with BamHI and dephosphorylated. Salmonella strain TR5878 was 
transformed with the ligation products, and ampicillin–resistant clones were selected on LB 
with Ap plates. Pools of approximately 1000 independent transformants were collected and 
lysed with phage P22 HT 105/1 int201. As a quality control, the ability of the library pools to 
complement null mutations in araA (required for growth with L-arabinose as the sole carbon 
source) or xylA (required for growth with D-xylose as the sole carbon source) were tested. 
 Lysates that permitted successful complementation were stored and used for plasmid delivery 
to recipient strains in subsequent genetic screens.  
The genetic screen was done by mixing 100 µl of a saturated stdA::lacZ culture with 10 µl of 
each P22 lysate of the pBR328 plasmid library pools. After 45 minutes, the transductions 
were plated in LB Cm and X-gal agar plates and incubated at 37ºC overnight. 10 
transductions were made for each of the 9 different pools (90 transductions total). The 
following day, the stdA::lacZ background colonies with increased X-gal activity were culture 
in LB Cm liquid medium. Minipreps were done to recover the pBR328 plasmid derivatives. 
Positive plasmids were re-transformed into SV5182 to corroborate the positive phenotypes. 
β-galactosidase activity of the selected candidates was tested and the plasmids were sent for 
Sanger DNA sequencing of the inserts using pBR328 specific oligonucleotides that flanked 
the region of the insertion. pIZ2318 and pIZ2319 obtained from the genetic screen are listed 
in Table M4.  
β-galactosidase assays 
Levels of β-galactosidase activity were assayed using the CHCl3-sodium dodecyl sulphate 
permeabilization procedure (Miller, 1972). β-galactosidase activity data are the averages and 
standard deviations from ≥3 independent experiments.  
 Motility assays  
Motility assays were carried out in motility agar plates, containing 10 g/l tryptone (Difco), 5 
g/l NaCl, and 0.25% Bacto-agar (Cano et al., 2002). A sterile stick was soaked in saturated 
bacterial cultures grown in LB, and used to inoculate motility agar plates. Bacterial motility 
halos were compared after growth at 37ºC for 6 hours. 
Phenotypic assays for biofilm formation 
Salmonella strains (SL PLtetOstdEF, SL PLtetOΔstdEF and SL ΔygiD) were tested for their 
ability to produce biofilm in LB medium (Latasa et al., 2012). The culture was grown at 22ºC 
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for 7-10 days in static. For better visualization biofilm was stained with a 0.1% solution of 
crystal violet. 
Matings 
Cultures of the donor and the recipient were grown overnight in LB broth. Cells were 
harvested by centrifugation and washed with LB. 1 ml aliquots of both strains, were sucked 
onto a membrane filter 0.45 mm pore size. The donor/recipient ratio was 1:1. The filters were 
placed on LB plates and incubated during 4h at 37ºC in GasPak microaerophilic jars 
(Camacho & Casadesús, 2002) and microaerophilic conditions were obtained by a GENbox 
Anaer bag, supplied by BioMériex (Marcy l’Etoile, France). An anaerobic indicator was used 
to monitor microaerophilic conditions. Filters were place in 10 ml tubes with 1 ml of fresh 
LB and vortex for recovering the cells. Serial dilutions were done before plating. Conjugation 
frequencies were calculated per donor cell, as previously described (Camacho & Casadesús, 
2002; García-Quintanilla et al., 2008). 
Subcellular fractionation  
Subcellular fractionation was performed as previously described (Pucciarelli et al., 2002), 
with some modifications. Briefly, bacteria were grown in LB medium at 37ºC and spun down 
by centrifugation at 15,000 g for 5 min at 4ºC, then resuspended twice in cold phosphate-
buffered saline (PBS pH 7.4, 0.137 M NaCl, 2,7 M KCl, 4.3 mM Na2HPO4.7H20, 1.4 mM 
KH2PO4). Unbroken cells were further removed by low-speed centrifugation (5,000 g, 5 min, 
4ºC). The supernatant was centrifuged at high speed (100,000 g, 30 min, 4ºC) and the new 
supernatant was recovered as the cytosol fraction. The pellet containing envelope material 
was suspended in PBS with 0.4% Triton X-100 and incubated for 2 h at 4ºC. The sample was 
centrifuged again (100,000 g, 30 min, 4ºC) and divided into the supernatant containing 
mostly inner membrane proteins and the insoluble fraction corresponding to the outer 
membrane fraction. An appropriate volume of Laemmli buffer (SB4x: 0.000125% 
bromophenol blue, 200 mM Tris-HCl pH 6.8, 20% β-mercaptoethanol, 40% glycerol and 8% 
SDS) was added to each fraction. After heating (100ºC, 5 min) and clearing by centrifugation 
(15,000 g, 5 min, room temperature), the samples were analysed for protein content by 
 Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis (SDS-PAGE) described by 
Laemmli (Laemmli, 1970).  
Protein extracts and Western blotting analysis  
Total protein extracts were prepared from bacterial cultures grown at 37ºC in LB medium 
until stationary phase (O.D.600 ~2). A volume containing ~2.5 x 108 cells were collected by 
centrifugation and suspended in 50 µl of Laemmli sample buffer (SB4x: 0.000125% 
bromophenol blue, 200 mM Tris-HCl pH 6.8, 20% β-mercaptoethanol, 40% glycerol and 8% 
SDS). Proteins were resolved by SDS-PAGE (Laemmli, 1970) using 12% gels. Conditions 
for protein transfer have been described elsewhere (Jakomin et al., 2008). Primary antibody 
was anti-Flag M2 monoclonal antibody (1:5,000, Sigma-Aldrich, St. Louis, MO). Goat anti-
mouse horseradish peroxidase-conjugated antibody (1:5,000; Bio-Rad, Hercules, CA) was 
used as secondary antibody. Proteins recognized by the antibody were visualized by 
chemoluminescence using the luciferin–luminol reagents of Supersignal West Pico 
Chemiluminiscent Substrate (Thermo Scientific, Waltham, MA, USA) and developed in a 
LAS3000 mini system (Fujifilm, Tokyo, Japan).  
Purification of StdE protein and antibody generation 
A DNA fragment containing stdE was amplified using oligonucleotides StdEprotUP and 
StdEprotDO, and cloned into pET28a (Novagen) using the NdeI and EcoRI sites. The 
recombinant plasmid (pIZ1991) was verified by restriction analysis and DNA sequencing. 
For 6×His-StdE purification, plasmid pIZ1991 was transformed into E. coli BL-21. BL-
21/pIZ1991 was grown in LB broth containing Kanamycin, and expression of 6×His-StdE 
was induced with 1 mM isopropyl β-D-thiogalactopyranoside (IPTG). After 3 h of induction, 
cells were centrifuged and resuspended in 10 ml of lysis buffer (20 mM Tris, 300 mM NaCl, 
10 mM imidazole) per g of pelleted cells, and were lysed by sonication. The suspension was 
centrifuged at 10,000 rpm for 20 min at 4º C and the supernatant containing the soluble 
fraction of 6×His-StdE was transferred to a HisTrap HP nickel affinity chromatography 
column (GE Healthcare, Wauwatosa, WI, USA). The column was washed 3 times with 4 ml 
of washing buffer (20 mM NaH2PO4·H2O, 0.5 mM NaCl, 30 mM imidazole). Protein elution 
was performed with 3 ml of elution buffer (20 mM NaH2PO4·H2O, 0.5 mM NaCl, 300 mM 
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imidazole). Aliquots of each fractios were loaded in SDS-PAGE gel and stain with 
Coomassie Brilliann Blue R-250 (Sigma-Aldrich) solution (0.25% (w/v) Coomassie Brilliant 
Blue R-250, 10% (v/v) acetic acid and 10% (v/v)  ethanol). Elution fractions enriched in 
6×His-StdE were selected. Imidazole was removed by dialyzing in cellulose membranes with 
PBS 1X. Purified 6×His-StdE protein was sent to Biomedal S.L (Sevilla, Spain) for 
polyclonal antisera production in rabbits. Working dilution was made based on manufacture 
recommendations. 
RNA isolation 
To prepare cells for RNA extraction, 3 ml of fresh LB was inoculated with a 1:100 dilution 
from an overnight bacterial culture, and incubated with shaking at 200 rpm in an Infors 
Multritron shaker at 37ºC. A 2 ml aliquot from a stationary culture (O.D.600∼2) was 
centrifuged at 13000 rpm, 4ºC, during 5 min. The pellet was resuspended in 100 µl of a 
solution of lysozyme (3 mg/ml in water; Sigma Chemical Co.). Cell lysis was facilitated by a 
freeze-thaw cycle. After lysis, RNA was extracted using 1 ml of TRIsure reagent following 
manufacture’s instructions (Bioline, Taunton, Massachusetts, USA). Total RNA was 
resuspended in 30 µl of RNase-free water, and subsequently clean by extraction with acidic 
phenol, followed by a second extraction with chloroform:isoamilic alcohol (24:1). After 
extraction, RNA was precipitated with ethanol and 3 M sodium acetate, and the dried pellet 
was resuspended in RNase-free water. The quantity and quality of the RNA was determined 
using a ND-1000 spectrophotometer (NanoDrop Technologies). 
Quantitative reverse transcriptase PCR (qRT-PCR)  
For qRT-PCR, Salmonella RNA was extracted from stationary phase cultures (O.D.600∼2) as 
described above, and the concentration was determined using a ND-1000 spectrophotometer 
(NanoDrop Technologies). An aliquot of 1 µg of RNA was used for cDNA synthesis using 
QuantiTec® Reverse Transcription Kit (Quiagen) following manufacturer’s instructions. 
Quantitative RT-PCR reactions were performed in a Light Cycler 480 II apparatus (Roche). 
Each reaction was carried out in a total volume of 10 µl on a 480-well optical reaction plate 
(Roche) containing 5 µl SYBR mix, 0.2 µl DYE II (Takara), 4 µl cDNA (1/10 dilution) and 
two gene-specific primers at a final concentration of 0.2 mM each. Real-time cycling 
 conditions were as follows: (i) 95ºC for 10 min and (ii) 40 cycles at 95ºC for 15s, 60ºC for 
1min. A non-RT control was included for each primer set. Triplicates were run for each 
reaction, and the Ct value is averaged from them. Absence of primer dimers was corroborated 
by running a dissociation curve at the end of each experiment to determine the melting 
temperature of the amplicon. Melting curve analysis verified that each reaction contained a 
single PCR product. Gene-specific primers were designed with ProbeFinder software 
(http://www.universalprobelibrary.com) from Roche Applied Science and are listed in Table 
M2. 
For quantification, the efficiency of each primer pair was determined to be between 90%-
110%, following the instructions for efficiency determination described in the “Guide to 
Performing Relative Quantification of Gene Expression Using Real-Time Quantitative PCR” 
(Applied Biosystems). These efficiencies indicate that the amount of DNA is doubled in each 
PCR cycle, and allows for direct comparison between different genes. Relative RNA levels 
were determined using the ∆∆Ct method as described in the above mentioned guide. Briefly, 
each gene Ct value is normalized to the Ct value for the internal control (rfaH), which gives 
the ∆Ct value. This value is then related to a given gene in the reference strain (S. enterica, in 
this case) giving us the ∆∆Ct value. Since the amount of DNA doubles in each PCR cycle, 
the relative amount of input cDNA can be determined by using the formula 2-∆∆Ct. Each ∆∆Ct 
determination was performed at least in three different RNA samples (three biological 
replicates), and the results are representative example of such determinations.  
Analysis of hilD mRNA decay 
Use of quantitative RT-PCR to monitor mRNA decay has been previously described (Baker 
et al., 2007). An overnight LB culture of the strain under study was diluted 100 fold, and 
incubated at 37ºC with shaking until O.D.600∼2). Transcription initiation was stopped by 
adding rifampicin (500 mg/ml). Cultures were kept at 37ºC and aliquots were extracted at 1 
min intervals. Each aliquot was immediately immersed in liquid N2 and kept frozen until 
RNA extraction. RNA was extracted using the standard protocol above described and 
amounts of hilD mRNA were determined with qPCR, using oligos  RT-hilD FOR and RT-
hilD REV as described above. Three independent qRT-PCR reactions were performed. 
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Southern blot  
Genomic DNA was isolated as previously described from stationary cultures in LB (O.D.600 
~2). Forty µg of each DNA sample were digested with SspI (New England Biolabs, Ipswich, 
MA), purified and divided into four fractions, three of which were subsequently digested with 
DpnI, MboI or Sau3AI (New England Biolabs). After digestion the samples were run in a 
denaturing 8% TBE-polyacrilamide (19:1) 8 M urea gel. Electrophoresis was carried out in a 
Hoefer SE400 (Hoefer Scientific Instruments, San Francisco, California) subjected to an 
electric field of 35 mA for 60 minutes.  
DNA was transferred to an Amersham Hybond-N+ membrane (GE Healthcare, Wauwatosa, 
WI, USA) using a semidry Electroblotting system (Thermo Scientific, Waltham, MA, USA). 
The DNA in the membrane was then immobilized by UV crosslinking. A radioactive probe 
was prepared by PCR using dCTP [α-32P] (Perkin Elmer, Waltham, MA) and 
oligonucleotides stdPLtetOUP and std southern DO. After the PCR reaction, non-incorporated 
nucleotides were removed by treatment in a Sephadex G-25 column (Illustra MicroSpin G-25 
columns, GE Healthcare, Wauwatosa, WI) following manufacturer’s instructions. Prior to 
hybridization the double-stranded DNA probe was denatured by heating at 95ºC for 3 min, 
followed by incubation on ice. Hybridization with the probe was performed overnight at 52ºC 
in hybridization buffer (0.5 M sodium phosphate pH 7.2, 10 mM EDTA, 7% SDS). Excess 
probe was removed with washing buffer (40 mM sodium phosphate pH 7.2, 1% SDS) at 48ºC 
(three washes, 30 min each). The membrane was developed using a FLA-5100 Scanner 
(Fujifilm, Tokyo, Japan).  
Microarray procedures and data analysis  
Salmonella enterica comparative transcriptomic analyses were performed in a strain that 
constitutively expressed stdEF (SL1344 PLtetOstdEF- SV8141) and in a control strain carrying 
an in-frame deletion of both genes (SL1344 PLtetO∆stdEF- SV8142). RNA from two 
biological replicates of each strain was isolated and used for the assay.  
Transcriptomic analyses were performed using Salmonella enterica serovar Typhimurium 
SL1344 4X72K array, custom prepared for Dr. Antonio Juarez (Paytubi et al., 2014). 
Hybridation and microarray scanning were performed at the Functional Genomics Core of 
 the Institute for Research in Biomedicine, Baldiri Reixac, Barcelona, Spain 
(http://www.dnaarrays.org/). Normalization of the expression signals was done with RMA 
(Irizarry et al., 2003) using Partek Genomics suite6.5 (6.11.0207). Raw transcriptomic data 
were deposited at the Gene Expression Omnibus, G.E.O, database 
(http://www.ncbi.nlm.nih.gov/geo/) under accession number GSE45488. Raw transcriptomic 
data was analysed building the ratio between the two conditions of interest by subtracting. 
Those genes with a difference higher than 4-fold in expression were further study.  
Chromatin Immunoprecipitation followed by sequencing (ChIP-seq) and 
data analysis 
ChIP-seq assays were used to determine chromosome-wide DNA binding profiles of StdE 
and StdF in Salmonella enterica serovar Typhimurium SL1344. PLtetOstdEF-3xFLAG strain 
(SV9287) was used to perform ChIP-seq experiments. 20 ml of fresh LB was inoculated with 
a 1:100 dilution from an overnight bacterial culture, and incubated with shaking at 200 rpm 
in an Infors Multritron shaker at 37ºC. Cells collected at O.D.600 ∼2 were crosslinked with 
1% formaldehyde (37% solution) at 37ºC for 25 min, following by quenching the unused 
formaldehyde with 450 mM glycine for 5 min. Crosslinked cells were harvested by 
centrifugation at 9000 rpm at 4ºC for 10 min and washed with 10 mL of TBS pH7.6 (2.42 g/l 
Trizma base, 8 g/l NaCl). The washed cells were re-suspended in 1 mL of lysis buffer (10 
mM Tris-HCl pH 8, 20% sucrose, 50 mM NaCl, 10 mM EDTA) and after an additional 
centrifugation step, the cells were re-suspended in 0.5 mL of lysis buffer with lysozyme (20 
mg/ml in water; Sigma Chemical Co.). The cells were incubated for 30 min at 37°C and then 
treated with 4 mL of IP buffer (50 mM HEPES-KOH pH 7.5, 150 mM NaCl, 1 mM EDTA, 
1% Triton X-100, 0.1% Na deoxycholate, 0.1% SDS and 1mg/mL phenylmethylsulfonyl 
fluoride (PMSF). The lysate was then sonicated using a Bioruptor (Diagenode) with 5 cycles 
of 7 minutes (30″ON/30″OFF) at high intensity. Cell debris was removed by centrifugation at 
13000 rpm at 4°C for 201min and the resulting supernatant was used as cell extract for the 
immunoprecipitation. The range of the DNA size resulting from the sonication procedure was 
100 - 500 bp, and the average DNA size was 300 bp.  
To immunoprecipitate StdE-DNA and StdF-DNA complexes, 800 µL of chromatin, 20 µL of 
Ultralink Immobilised protein A/G beads (Pierce) and 2 µL of the corresponding antibody 
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were used. Control sample (mock-IP) was performed with no antibody added. Four samples 
were used for each antibody and four samples for the control. They were then incubated for 
90 minutes at room temperature on a rotating wheel. Beads were transferred to a Spin-X 
column tube (Costar) and centrifuge at 3000 rpm for 1min. Beads were gently re-suspended 
in 500 µL of IP buffer and incubated on wheel for additional 3 min. This step was done 
twice. Beads were washed with 500 µL of IP salt buffer (50 mM HEPES-KOH pH 7.5, 150 
mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% Na deoxycholate, 0.1% SDS, 1mg/mL 
phenylmethylsulfonyl fluoride (PMSF) and 500 mM NaCl), IP wash buffer and TE pH 8.0 
(10 mM Tris-HCl and 1 mM EDTA) by re-suspending and re-centrifuging sample. The 
column was transferred to a fresh tube and the beads were re-suspended in 100 µL of elution 
buffer (50 mM Tris-HCl at pH 7.5, 10 mM EDTA, and 1% SDS) and incubated at 65ºC for 
20 min. After centrifuging at 3000 rpm for 1 min the flow-through was treated with 10 µL of 
40 mg/mL of a mixture of proteases (Pronase, Roche) made up in TBS pH7.6 (2.42 g/l 
Trizma base, 8 g/l NaCl). The samples were heat at 42ºC for 2h and 65ºC for 6 hours. The 
reactions were then kept at 4ºC overnight. The samples were clean up by using a PCR clean 
up Kit (Promega) and re-suspended in 50 µL of H2O. 
  
Figure M. 1 Chromatin Immunoprecipitation (ChIP). The diagram sums up the Chromatin Immunoprecipitation process 
and the final enrichment of the IP sample in the desired DNA fragments (dashed line).  
Input and ChIP DNA samples were sent for sequencing at the Functional Genomics Core 
Facility of the Institute for Research in Biomedicine, Barcelona (Spain). Next generation 
sequencing was carried out using Illumina’s sequencing technology. Ultra DNA Library Prep 
Kit (Illumina) was used for library preparation. Libraries were sequenced on Illumina’s 
Genome Analyzer II system. 50 nucleotides single end reads were obtained strictly following  
manufacturer’s recommendations. Illumina sequencing data were pre-processed with the 
standard Illumina pipeline version 1.5. 
BAM files reported by the sequencing facility of the Functional Genomics Core Facility were 
converted to FASTQ format with the BAM2FASTQ tool 
(http://www.hudsonalpha.org/gsl/information/software/bam2fastq). The quality of the 
sequence reads was examined using FASTQC (Andrews, 2010) that reported the presence of 
Illumina adapters. The adapters were trimmed with the FASTX_CLIPPER tool of the 
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FASTX-Toolkit suite (http://hannonlab.cshl.edu/fastx_toolkit/). Reads shorter than 40 nt 
were discarded. 
NCBI GCA_000210855.2 genome assembly of S.enterica SL1344 was used as reference 
genome. Mapping was performed with Bowtie (Langmead et al., 2009) allowing only two-
mismatches for  unique alignment. 
Peaks were called using CisGenome version 2.0 (Ji et al., 2008) using default parameters. 
The IGV browser (Thorvaldsdóttir et al., 2013) was used for data visualization. Genes closest 
to a ChIP peak were identified using the bedtools suite (Quinlan & Hall, 2010). Peak 
boundaries sequences were extracted from the reference genome using the fastaFromBed 
utility from the BEDTools suite (Quinlan & Hall, 2010).  
Chromatin Immunoprecipitation followed by quantitative PCR (ChIP-
qPCR) 
ChIP-qPCR assays were used to check StdE, StdF and HdfR binding to the std promoter 
region. SL1344 ∆dam stdE-3xFLAG, SL1344 ∆dam stdEF-3xFLAG and SL1344 ∆dam 
hdfR-3xFLAG strains were used to perform ChIP-qPCR experiments. The Chromatin 
Immunoporecipitation protocol used was previously described for ChIP-seq assay. After 
DNA purification, quantitative PCR was performed following the protocol previously 
described and using specific oligonucleotides RT-promotorstd FOR and RT-promotorstd REV 
for the amplification of the std promoter region in both IP sample and mock IP sample.  
Inmunofluorescence microscopy 
Cells from 1.5 ml of an exponential culture (OD600∼ 0.5) of Salmonella enterica SL1344 
were collected by centrifugation, washed, resuspended in 1ml TE buffer and fixed by adding 
the same volume of cold 70% ethanol. Ethanol-fixed cells (100 µl) were stained with 
polyclonal rabbit anti-StdA serum (Baumler’s lab) (1:250). After extensive PBS + Gelatin 
0.02% washing, a goat anti-rabbit antibody conjugated to (Fluorescein isothiocynate) FITC 
(1:500) was used. Inmunostained cells were stained with Hoechst 33258, 1.5 mg ml-1, in 10µl 
mounting medium (40% glycerol in 0.02 M phosphate buffered saline, pH 7.5). 20µl of 
 ethanol-fixed cells was spread onto a poly-L-lysine-coated slide, and dried at room 
temperature. Slides of stained samples were stored at room temperature in the dark. Images 
were obtained by using an Olympus IX-70 Delta Vision fluorescence microscope (Olympus, 
Tokyo, Japan) equipped with a 100X UPLS Apo objective. Pictures were taken using a 
CoolSNAP HQ/ICX285 camera (Roper Technologies, Sarasota, FL) and analysed using 
ImageJ software (Wayne Rasband, Research Services Branch, National Institute of Mental 
Health, MD).  
Flow cytometry  
Bacterial cultures were grown at 37ºC in LB until exponential (O.D.600 ~0.4) or stationary 
phase (O.D.600 ~2). Cells were then diluted in PBS to a final concentration of ~107/ml. Data 
acquisition and analysis were performed using a Cytomics FC500-MPL cytometer (Beckman 
Coulter, Brea, CA). Data were collected for 100,000 events per sample, and were analysed 
with CXP and FlowJo8.7 software. Data are shown either by a dot plot (forward scatter [cell 
size] vs fluorescence intensity) or histograms (% cell counts vs fluorescence intensity).  
Statistical analysis  
The Student’s t test was used to determine if the differences in our experiments were 
statistically significant. 
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Expression of the std operon 
It has been described that the std fimbrial operon is tightly repressed in Salmonella enterica 
in a Dam-dependent manner (Balbontín et al., 2006). Dam– mutants show high expression of 
the std operon (Balbontín et al., 2006), and this expression is dependent on the HdfR protein 
(Jakomin et al., 2008). Moreover, bimodal expression for this operon has been suggested 
(Jakomin et al., 2008), since the authors observed two subpopulations in Dam– and SeqA– 
backgrounds. 
To further understand the expression conditions of the std operon, and based on the 
possibility of heterogeneous expression suggested by Jakomin et al., 2008, single cell 
analysis of stdA expression was performed using an stdA::gfp transcriptional fusion. This 
fusion is defective in StdA synthesis, since only the first 129 nt of the stdA gene are present 
in the construction. However, the downstream genes of the operon are expressed since the 
construct does not contain a transcriptional terminator downstream of the gfp gene. Flow 
cytometry assays were performed using strains stdA::gfp, ∆dam231 stdA::gfp (non-polar 
deletion of dam), ∆dam231 ∆hdfR stdA::gfp, ∆hdfR stdA::gfp. A representative experiment is 
presented in Figure C1. 1.  
 
Figure C1. 1 Regulation of the Dam-dependent std operon and role of HdfR. GFP fluorescence intensity in a strain 
carrying an stdA::gfp fusion in different genetic backgrounds (∆dam, wt, ∆hdfR). The Dam– mutant shows bimodal 
expression of the stdA::gfp fusion and the expression is dependent on HdfR, as described by (Jakomin et al., 2008). In a wild 
type background, a minor subpopulation (0.3% of the cells, StdON) appears to express stdA::gfp. The subpopulation 
disappears in a HdfR- background, underlining the essential role of HdfR in std regulation.  
The experiment shows that std expression is repressed by Dam methylation in a HdfR-
dependent manner as previously described. Just ∼ 0.3 to 3% of cells produce stdA::gfp in a 
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wild type background. As observed for expression in a Dam–  background, this expression is 
also dependent on HdfR. This observation indicates that expression of the std operon occurs 
only in a fraction of the population under laboratory conditions, suggesting bistable 
expression of the operon. 
Also, upon labeling Std fimbriae and under the fluorescence microscope, only a small 
fraction of Salmonella enterica wild type cells appeared to be Std-frimbriated (Figure C1. 2). 
Bacteria were labelled with rabbit anti-StdA serum (obtained from A. Baümler’s lab) and 
goat anti-rabbit IgG FITC conjugate for the detection of Std fimbriae. This observation, along 
with previous studies of phase variation of fimbrial operons (Hernday et al., 2004; Humphries 
et al., 2001; Norris et al., 1998), supports the idea that the std fimbrial operon undergoes 
heterogeneous expression. 
 
Figure C1. 2 Detection of StdA fimbriae in Salmonella enterica. Immunofluorescence microscopy for the detection of 
StdA fimbriae in Salmonella enterica in a wild type background. Left column (panels A and D) shows bacterial cells of 
Salmonella enterica (Hoechst stain). Panel B shows StdA detection with anti-StdA antiserum and goat anti-rabbit antibody 
conjugated to FITC (green signal). In panels C, E and F both channels were merged.   
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Both flow cytometry and fluorescence microscopy approaches reveal that expression of stdA 
(and in consequence, expression of std operon) occurs in a small fraction of the population. 
Based on flow cytometry results, the StdON subpopulation varies from 0.3 to 3% of the 
population depending on the growth phase of the cells. However, no expression was detected 
when using the stdA::lacZ fusion on X-gal plates, despite the fact that the stdA::lacZ fusion 
behaves as expected in a  Dam-  background (∆dam stdA::lacZ ), showing blue colonies on X-
gal plates.  
Transcriptional regulation of the std operon 
The mechanisms that prevent expression of the std operon outside the animal intestine are not 
well understood. It is already well-known that several factors repress std expression, such as 
Dam methylation (Balbontín et al., 2006; Chessa et al., 2008), RosE, an homolog of E. coli 
ArgR, and the GATC-binding protein SeqA (Chessa et al., 2008). On the other hand, the poorly 
known HdfR protein (a LysR-like factor) is required for std expression in S. enterica Dam– 
mutants (Jakomin et al., 2008), and it is also needed for std expression in a wild type 
background.  
During this Thesis, we had the chance of working in collaboration with the group of Dr. 
Mónica Delgado, INSIBIO, CONICET-UNT, Argentina. This group is interested in the 
regulatory mechanism of the signal transduction system RcsCDB. Previous results showed 
that a RcsC11 mutant undergoes constitutive activation of the RcsCDB system, and this 
activation leads to attenuation of S. typhimurium virulence (Costa & Antón, 2001; Mouslim 
& Groisman, 2003; Mouslim et al., 2003; 2004), partially through the repression of hilA, 
invF, sipC and invG genes (Delgado et al., 2006; Mouslim et al., 2004). Unpublished data 
from Delgado’s group reveals that the rcsC11 strain has a defective phenotype of adhesion to 
Caco-2 cells. These observations led us to speculate about a potential relation between 
constitutive expression of rcsB and std operon expression.  
In order to study whether the RcsCDB system controls std operon expression, we used the 
chromosomal stdA::gfp transcriptional fusion mentioned above. The gfp fusion was 
introduced into an RcsC11 background, and the distribution of GFP activity during 
exponential growth (O.D ∼0.8) was determined.  
  
 
Figure C1. 3. Distribution of stdA::gfp activity in wild type and rcsC11 backgrounds. The stdON subpopulation 
disappears in the strain rcsC11 stdA::gfp, indicating repression of std when rcsB is constitutively expressed.   
As observed in Figure C1. 3, constitutive expression of rcsB (in a RcsC11 mutant 
background) eliminates the StdON subpopulation, indicating that RcsB represses std 
expression. In order to further understand the regulatory mechanism that controls std 
expression through rcsB, the β-galactosidase activity assay of the stdA::lacZ translational 
fusion was monitored in different Dam– genetic backgrounds. Note that Dam– background 
was chosen in order to have enough stdA::lacZ expression. From the results summarized in 
Figure C1. 4, we can conclude that constitutive expression of rcsB (RcsC11 mutant) ends up 
in a 10-fold reduction of stdA::lacZ expression in the Dam– mutant.   
 
Figure C1. 4 Regulation of stdA::lacZ expression by RcsB A. β-galactosidase activity of stdA::lacZ translational fusion in 
different genetic backgrounds. B. Relative mRNA levels of stdA in different genetic backgrounds. RNA levels were 
determined for at least 3 biological replicates and a representative experiment is shown.  
GFP fluorescence intensity
Fo
rw
ar
d 
sc
at
te
r
0
500
1000
1500
da
m
da
m
rc
sC
11da
m
rc
sB
56
N
da
m
tol
B da
m
p-
rc
sB da
m
p-
rc
sB
+I
PT
G
stdA::lacZ
M
il
le
r 
U
ni
ts
0 0.5 1 1.5
dam
dam
rcsC11
dam
rcsB56N
dam
tolB
dam
p-rcsB
dam
p-rcsB
+IPTG
2
Relative RNA’s levels 
A B
Chapter I 
85 
In contrast, inactivation of RcsB (the rcsBD56N strain contains a point mutation in the rcsB 
gene that inactivates RcsB by a single amino acid change) in a Dam- background increases 
stdA::lacZ expression two fold compared with the Dam– mutant (Figure C1. 4A).  
Previous reports from Dr. Delgado’s group demonstrated that the RcsCDB system is 
activated by a tolB mutation (TolB is involved in the integrity of cell envelope) and by rcsB 
overexpression from the prcsB plasmid (Mouslim & Groisman, 2003, Pescaretti et al., 2010). 
As we expected, the β-galactosidase activity levels obtained in dam tolB and dam prcsB (+ 
IPTG to overexpress rcsB) strains were similar to those observed in the dam rcsC11 (Figure 
C1. 4A). When IPTG was not added to the culture medium of the dam prcsB strain, the β-
galactosidase activity levels produced were similar to those observed in the Dam- mutant 
(Figure C1. 4A). To further confirm these results, transcription of stdA was monitored by 
qRT-PCR. As shown in Figure C1. 4B, the results correlate well with those obtained by 
monitoring β-galactosidase activity, and the stdA expression levels in dam rcsC11, dam tolB 
and dam prcsB (+ IPTG) strains were significantly lower than those observed in the Dam-
mutant. Moreover, the stdA transcription levels of the Dam- RcsBD56N double mutant were 
higher than those observed in the Dam- mutant. These results, together with the observations 
presented above, indicate that the RcsCDB system downregulates stdA gene expression, both 
in wild type and Dam– backgrounds.  
In addition, we studied whether std downregulation is due to specific binding of RcsB on the 
std promoter region. For this purpose, we first carried out a bioinformatic analysis using the 
std promoter region to identify a putative RcsB-binding site. The architecture of the std 
promoter including the GATC sequences, -10 and -35 modules, and the +1 transcription site 
was described by Jakomin et al. (2008) (Figure C1. 5A). As shown in Figure C1. 5A, a 
consensus RcsB-binding site, already described in other RcsB-regulated genes (Carballès et 
al., 1999; Mouslim & Groisman, 2003; Wehland & Bernhard, 2000), was found overlapping 
the -35 box of the std regulatory region. 
These findings suggest that RcsB binding to the -35 box may prevent binding of RNA 
polymerase, thereby inhibiting transcription of std. Binding of RcsB to this region was further 
confirmed by Dr. Delgado`s group, showing that migration of 300 pb and 735 bp PCR 
products (generated with EMSA-std300 FOR and EMSA-std REV; and EMSA-std735 FOR 
and EMSA-std REV pair of oligonucleotides respectively), both containing the std promoter 
and the putative RcsB-binding site, were retarded in Electrophoretic Mobility Shift Assay 
  
(EMSA) with increasing RcsB concentration (Farizano, JV, personal communication). A 234 
bp DNA fragment was used as a negative control and, as expected, no retardation was 
observed (Figure C1. 5B). Altogether, these observations indicate that RcsB is a repressor of 
std expression, and that it acts by direct binding to the std promoter.  
 
Figure C1. 5 RcsB binds to std promoter A. In silico analysis showing RcsB putative binding sites in the std promoter. In 
blue are highlighted the three GATC sites in the std promoter, in green the start codon of the stdA gene, underlined are 
highlighted the -35, -10 and +1 sites and the RcsB putative binding site is distinct with a box. B. Electrophoretic Mobility 
Shift Assay (EMSA) of the std promoter with increasing concentrations of RcsB protein shows the slow mobility of the 
RcsB-stdA DNA complex compared with the control DNA.   
Expression and autoregulation of the transcription factor HdfR 
HdfR is essential for std expression in both the wild type (this study) and the Dam– 
background (Jakomin et al., 2008). Three GATC sites are present upstream the std promoter, 
in positions -243, -230 and -221 upstream of the transcription start of std. The methylation 
state of GATC sites can be affected by DNA-protein interactions. Therefore, Dam 
TTCACCCGCTTATAATTACATTAAAAAGTATTTCTTTGATGATTATTCTTAAATTACGATCATAATCATCGATCGTATCG
ATCTATTTTTATTGTTTTAATTTGAATAAGAATTTTCTTACAACTGATTAGGCATTAGCTGAAATCAATATTTTTCGATG
GAAAGTTCAGGTGCTTCGTTTAACACCAGGCGTTTATTATTCATACGAATCTTTTCTGAACGCTTTCATTAATACCCTCA
GAGTTGTTTTCAGCCTTTGCAAAATAATTCTCATTCACCCAAAGGACATATTATCTATGCGTAATAAAATAATACTTGCC
ATGGCGGCTGCCGGTATGATGTATGGTGCTTCTGTATTTGCCGCCGATACTACACCCACAGCAGGCCCGTTCGGCTCAGC
 
-35 -10 +1
std-            CCTTTGCAAAATAATTCTCATTC      
ams+            TATATTGAGAATAATCTTAATTT 
ugd+            CGTAATGAAGATAATCTGAATTG 
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methylation can act as a regulator of transcription by influencing binding of RNA polymerase 
or transcriptional factors (Wion & Casadesús, 2006). Previously in the lab, purified HdfR-
His6 was used to study the interaction of HdfR with the std promoter region (from -295 to 
+11) in vitro, and to test the effect of Dam methylation on HdfR binding. Unpublished data 
show that HdfR binds the std regulatory region when the three GATCs of this region are non-
methylated, while it is unable to bind when the three GATCs are methylated or 
hemimethylated.  
Chromatin Immunoprecipitation (ChIP) coupled with quantitative PCR was used to 
investigate HdfR-std promoter interaction in vivo using the strain ∆dam hdfR-3xFLAG. A 
chromatin fragment containing the std promoter was 13 fold enriched in the 
inmunoprecipitated (IP) sample compared with the mock IP sample. Therefore, confirming  
in vitro data, HdfR binds to the non-methylated std promoter (Figure C1. 6).  
                                                
Figure C1. 6 Chromatin Immunoprecipitation (ChIP) coupled with quantitative PCR analysis of HdfR binding to the 
std promoter.   
However, and as shown above, std expression in wild type cells is only detected in a small 
subpopulation, whereas Dam– cells show high level of expression. We wondered if these 
differences in expression were due to a difference in the level of the expression of hdfR. To 
address this question, the β-galactosidase activity of an hdfR::lacZ fusion was measured in 
the wild type and in a Dam– strain in exponential and stationary cultures (Figure C1. 7). No 
significant differences were observed in hdfR expression, indicating that the differences in std 
expression observed between Dam– and wild type Salmonella cannot be explained by 
different hdfR expression levels.  
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Figure C1. 7 β-galactosidase activity of hdfR::lacZ in exponential and stationary phase in a wild type and Dam –  
backgrounds.  
HdfR is a LysR-type transcriptional regulator, and these transcription factors commonly 
activate the expression of target genes but repress their own expression. To investigate 
whether HdfR represses its own expression, the intergenic region between hdfR and the 
upstream gene in the chromosome (yifE), which most likely contains the hdfR promoter, was 
cloned on the promoter-probe vector pIC552 (Macián et al., 1994), generating a 
transcriptional fusion with the lacZ gene (pIZ2320) (Figure C1. 8A). The activity of the 
phdfR::lacZ fusion was monitored in HdfR+ and HdfR– backgrounds to determine whether 
HdfR undergoes autogenous transcriptional regulation. 
 
Figure C1. 8 Autoregulation of hdfR. A. Diagram of the hdfR promoter region. The DNA fragment cloned on pIC552 is 
represented. The fragment contains the hdfR promoter region.  B. β-Galactosidase activities of pIC552 and pIC552 phdfR in 
the presence and in the absence of HdfR. 
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As shown in Figure C1. 8B, HdfR undergoes autogenous repression of the hdfR promoter, in 
a fashion analogous to other LysR-type transcription factors. Autogenous repression might 
ensure a constant intracellular level of the protein. Moreover, as it will be shown in Chapter 
2, we have identified additional factors that affect hdfR expression. 
In order to determine whether high HdfR levels might affect std expression, we placed hdfR 
under the control of the heterologous promoter PLtetO. Despite the fact that PLtetO is a moderate  
promoter, higher hdfR expression levels were obtained (Figure C1. 9A), and the 
autorepression was avoided. The expression of the stdA::gfp and stdA::lacZ fusions was 
monitored by fluorescence analysis and β-galactosidase assays, respectively.  
 
Figure C1. 9 Constitutive expression of hdfR increase stdON subpopulation. A. Constitutive expression from the 
heterologous promoter PLtetO increases 100 fold the expression of hdfR compared with the wild type strain. Data are 
normalized to the RNA level obtained in wild type Salmonella cells (Value for wild type=1; not shown). B. Constitutive 
expression from the heterologous promoter PLtetO increases 10 fold the expression of the stdA::lacZ fusion compared with the 
wild type strain. C. Fluorescence intensity of the stdA::gfp fusion in a PLtetOhdfR  shows an increase of the mean 
fluorescence and an increment of the stdON subpopulation. C.  stdA::lacZ PLtetOhdfR on X-gal plates shows colonies with 
different stdA::lacZ expression (blue colonies pointed with arrows). 
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Increased hdfR expression results in increased stdA transcription (Figure C1. 9B), and in an 
enrichment of the StdON subpopulation (Figure C1. 9C). The latter observation was made not 
only by flow cytometry but also on X-gal plates, where two types of colonies were 
distinguished (Figure C1. 9D). In this case the heterogeneity of the population cannot be due 
to different levels of HdfR in the cells since expression is driven from a constitutive 
promoter. Therefore another factor must govern variability in the expression of std. 
Although several repressors of std expression have been described in previous studies and 
also in this work, the mechanisms that permit std expression inside the animal intestine were 
unknown. To search for factors that might activate expression of the std operon in a wild type 
(Dam+) background, a genetic screen for activators of the std operon was performed using a 
pBR328-based multicopy plasmid library of the Salmonella enterica genome (López-Garrido 
& Casadesús, 2012). A Dam+ strain carrying a stdA::lacZ translational fusion (SV5182; 
(Jakomin et al., 2008)), was used as reporter for the screen. This strain does not show lacZ 
expression at all, since transcription is driven by the std promoter which is strongly repressed 
under laboratory conditions. Strain SV5182 was transduced with 9 pools of the plasmid 
library, each containing around 1,000 independent clones. Transductants were selected on LB 
plates containing chloramphenicol and X-gal. Forty-five colonies with increased β-
galactosidase activity (blue colonies) were chosen, and 22 independent candidates that 
retained high β-galactosidase activity after re-transformation of their plasmid were further 
analyzed. The DNA fragments contained in the plasmid of 15 candidates were sequenced 
using specific primers flanking the insertion site. Surprisingly, DNA sequencing revealed that 
14 candidates contained the std fimbrial gene cluster (pBR328std, annotated as pIZ2318), 
among other neighboring genes, and one candidate contained the std fimbrial operon except 
stdF (pBR328std∆stdF, annotated as pIZ2319). These results indicate that activators of the 
std operon were contained inside the operon itself; in other words, they suggest self-
regulation of the operon. Furthermore, they revealed that the StdF might play a role in 
autogenous activation since stdA::lacZ expression decreased considerably when the 
downstream gene stdF was not present. Expression is dependent on HdfR, highlighting again 
the major role of this protein in std expression (Figure C1. 10).  
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Figure C1. 10 Autoregulation of the std operon. β-galactosidase activity of a stdA::lacZ fusion in the presence of plasmid 
containing the std operon, in HdfR+ and HdfR- genetic backgrounds. 
Interestingly, previous results from our lab had identified the gene products of stdE and stdF 
as repressors of SPI-1 expression (López-Garrido & Casadesús, 2012). These results, 
together with the fact that in other fimbrial operons both structural and regulatory elements 
are encoded in the same operon, fueled further studies on the involvement of StdE and StdF 
in self-regulation of std expression. The strain carrying the stdA::gfp fusion was used to test 
the effect of StdE and StdF on expression of the std operon. For this purpose, we placed the 
heterologous promoter PLtetO (Lutz & Bujard, 1997; McQuiston et al., 2008) upstream of 
stdEF (PLtetOstdEF) to ensure constitutive expression on both genes. (Figure C1. 11A). 
Expression of stdA was monitored by flow cytometry. As observed in Figure C1. 11B, 
deletion of stdEF, PLtetO∆stdEF, results in loss of the cell subpopulation that expresses gfp. In 
turn, constitutive expression of stdEF slightly increases gfp mean fluorescence and 
significantly increases the size of the stdON subpopulation (from 0,3% to 3%). Interestingly, 
in a Dam– background, deletion of stdEF causes a decrease in gfp expression, whereas 
constitutive expression increases gfp expression and results in an altered pattern of expression 
in the cell population (higher heterogeneity) (Figure C1. 11B). The same pattern was 
observed using the stdA::lacZ fusion in a PLtetOstdEF background on X-gal plates: an 
increment of blue colonies was observed, with some of them showing a darker blue (Figure 
C1. 11C).  
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Figure C1. 11 Effect of constitutive expression of stdEF on stdA::gfp expression. A. Diagram showing the construction 
used to monitor stdA::gfp fusion under stdEF constitutive expression. B. Single cell analysis of stdA::gfp-expressing cells in 
different genetic backgrounds. C. PLtetOstdEF stdA::lacZ  on X-gal plates with colonies showing and increase of  stdA::lacZ 
basal expression and some colonies with higher  stdA::lacZ expression (darker blue colonies pointed with arrows). 
These results (Figure C1. 11) confirm that StdE and StdF have a role in the expression of the 
std operon, not only in the wild type strain but also in the Dam– mutant background.   
To determine if StdE and StdF were able to bind the std promoter region, we used Chromatin 
Immunoprecipitation (ChIP) coupled with quantitative PCR to investigate a putative 
StdE/StdF-std promoter interaction in vivo. The strains used were ∆dam stdE-3xFLAG and 
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∆dam stdF-3xFLAG, since the Dam– background ensures a higher expression level of stdE 
and stdF.  
                                            
Figure C1. 12 Chromatin Immunoprecipitation (ChIP) coupled with quantitative PCR analysis of binding to the std 
promoter.  ChIP-qPCR performed with ∆dam stdE-3xFLAG and ∆dam stdF-3xFLAG. 
According to the results presented in Figure C1. 12, the chromatin fragment containing the 
std promoter immunoprecipitated with StdF-3xFLAG is enriched 6 times compared with the 
mock immunoprecipitated sample, indicating that StdF binds to the std promoter in vivo and 
suggesting a pivotal role for StdF in std transcription. However, no binding was observed for 
StdE, which might suggest that this protein is not relevant for expression of the std operon or 
that it plays an indirect role. Note that ChIP-qPCR assay do not allow to distinguish between 
direct or indirect binding to the DNA sequence. On the other hand, these data corroborate the 
major role of StdF unveiled by the genetic screen described above (in which a candidate 
lacking the downstream gene of the operon showed a decreased in stdA::lacZ expression). 
Figure C1. 13 shows a diagram of the players identified in the std regulation. The diagram 
simulates the std operon in the ON state. As it was already known, under these 
circumstances, the Dam methylase does not act over the GATC sites of the std promoter; 
therefore the GATCs are non-methylated and HdfR binds the std regulatory region. In turn, 
stdF expression, as described in this Thesis, supports std expression through an 
autoregulatory positive loop and StdF binds the std promoter region in a Dam-independent 
manner. In addition, wild type levels of RcsB do not bind the std promoter, but high levels of 
RcsB do bind and as shown in Figure C1. 5 repress std expression in Dam– and wild type 
backgrounds.   
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Figure C1. 13 Regulation of the std operon by StdF, HdfR and RcsB. Positive effects are indicated by lines ending in 
arrowheads, whereas blunt lines indicate negative regulatory effects. Dashed lines indicate regulation that do not apply under 
the diagram circumstances. The three black squares represent the three GATC sites in the regulatory region of the std 
operon, that in the circumstances detailed above would be non-mehylated. 
Methylation state of the std operon 
Expression of std  is detected in a Dam– background, whereas in a wild type strain expression 
is strongly repressed (Balbontín et al., 2006; Jakomin et al., 2008). Only a minor 
subpopulation expresses the std operon, according to single cell analysis described above. 
The std promoter region contains three GATC sites in positions -243, -230 and -221 upstream 
of the start of std transcription. Experiments carried out in our laboratory have shown that the 
transcription factor HdfR, needed for std expression, binds to the std promoter region when 
the GATC sites are non-methylated. HdfR is unable to bind either methylated nor 
hemimethylated DNA (unpublished results). These observations raise the possibility that the 
DNA methylation pattern of the std upstream activating sequence (UAS) might be different 
in StdON and StdOFF subpopulations. If this view is correct, only a small number of cells might 
harbor the DNA methylation pattern that allows HdfR binding and, as a consequence, std 
expression. The hypothesis of a different methylation pattern within the population is 
supported by the partial loss of StdON subpopulation upon overproduction of Dam methylase 
(cloned on pTP166) (Figure C1. 14). 
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Figure C1. 14 Regulation of std expression and formation of std subpopulations by Dam methylation. stdA::gfp 
fluorescence intensity in ∆dam, wild type and in a strain that overproduces Dam methylase (pTP166).  
To identify the methylation state of the std promoter in vivo, Southern blot experiments were 
performed. The methylation state of individual GATC sites was inferred from restriction 
analysis using enzymes that cut GATC sequences depending on their methylation state 
(MboI- non methylated, DpnI- methylated, and Sau3AI- methylated and non methylated). A  
Dam- mutant was used as a control (Figure C1. 15A) 
 
Figure C1. 15 Methylation state of GATC sites in the std regulatory region in wild type and Dam- backgrounds. A. 
Diagram of the SspI-SspI fragment and patterns of fragments obtained after cleavage of the different GATC sites. Sample 3 
refers to a wild type strain with the GATC3 mutated and treated with Sau3AI, that results in 97, 76 and 13 bp fragments. 
Another control, sample 1, refers to a wild type strain with the GATC1 mutated and treated with Sau3AI, that results in 110, 
67 and 9 bp fragments. B. Southern blot of genomic DNA obtained from wild type and Dam- cultures and digested with SspI 
(control, NC) and DpnI, MboI or Sau3AI.  
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As shown in Figure C1. 15B, the three GATC sites (GATC1, GATC2, and GATC3) are fully 
methylated in a wild type background. Considering that the majority of the population is in 
an StdOFF state, in the Southern the wild type strain largely corresponds to the StdOFF 
subpopulation.  
These results correlate well with previous assays of HdfR binding to the std promoter, in 
which binding occurred exclusively to non-methylated DNA. Identification of the DNA 
methylation pattern of the StdON subpopulation was difficult due to its small size (only 0,3 to 
3%) of the population.  
StdE and StdF are located in the cytoplasm of Salmonella enterica 
StdE and StdF are homologues of known transcriptional regulators. Specifically, StdE shares 
40-50% identity with the transcriptional activators GrlA from E.coli and CaiF from 
Enterobacter cloacae. In turn, StdF is related to the SPI-1 Salmonella protein SprB, a 
transcriptional regulator that represses the hilD promoter and activates the siiA promoter 
(López-Garrido & Casadesús, 2012). This homology with transcriptional regulators correlates 
well with the data presented in this chapter indicating that these proteins exert autogenous 
regulation of std transcription and also control hdfR expression (see above).  
The subcellular location of StdE and StdF was studied using 3xFLAG-tagged versions of the 
proteins in a Dam- background. Electrophoretic separation of cell fractions (cytoplasm, inner 
membrane and outer membrane) was performed, followed by Western blot analysis of the 
separated protein samples using a commercial anti-FLAG antibody. Based on the results 
obtained, we can conclude that both StdE and StdF are cytoplasmic proteins in Salmonella 
enterica (Figure C1. 16). 
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Figure C1. 16 Subcellular localization of StdE and StdF proteins in S. enterica subcellular fractions. 3XFLAG versions 
of the proteins were localized with anti-FLAG Western hybridization for different subcellular fractions (cytoplasm, inner 
membrane and outer membrane).  
Search for an internal promoter in the std operon 
Because a fraction of the bacterial population expresses the std operon under conditions in 
which the main promoter appears to be inactive, we wondered whether expression of the 
StdE and StdF activators might occur independently of the std main promoter. Previous 
results in the lab had shown that the stdE and stdF genes were transcribed from the std 
promoter (upstream of stdA) in a Dam- background (López-Garrido & Casadesús, 2012). 
However, the same study raised the possibility that an internal promoter might exist that 
allow transcription of these two genes independently. To test this possibility we constructed a 
stdE::gfp fusion, in which the upstream genes (up to stdD) were deleted (together with the 
main promoter) (Figure C1. 17A). As observed in Figure C1. 17 B, low expression is 
observed when cells are run in a flow cytometer. We are confident that this expression, no 
matter if very low, is real, since it was repeatedly observed for 10 biological replicates run in 
different days, and previous studies had reported an expression of stdE that was not detected 
for the remaining std genes (López-Garrido & Casadesús, 2012). This result suggests the 
presence of a promoter that may drive the expression of stdE, and probably also of stdF.  
Several attempts have been done to identify this putative internal promoter. Cloning of 
different gene fragments onto the promoter-probe plasmid pIC552 did not reveal promoter 
activity. 5´RACE experiments performed in wild type and Dam– genetic backgrounds failed 
also in the identification of such promoter. We are currently working an alternative solution 
for this identification since we do think that an std internal promoter exists.  
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Figure C1. 17 Evidence of the existence of an internal promoter upstream stdE. A. Diagram of the ∆pStdA-stdC 
stdE::gfp construction. B. stdE::gfp expression in different genetic backgrounds. Dam- and HdfR- backgrounds are used to 
define stdE::gfp expression.  
 
!
!
!
!
!
!
!
!
!
!
!
!
! !
GFP fluorescence intensity
%
 c
el
l c
ou
nt wt strain (no GFP)
stdE::gfp
∆dam stdE::gfp
∆hdfR stdE::gfp
∆pStdA-stdC stdE::gfp
stdE::gfp
∆pStdA-stdC stdE::gfp
A
B
  
 
Chapter II: Impact of stdE and stdF overexpression in 
Salmonella enterica 
  
  
  
Chapter II 
101 
Transcriptomic analysis of S. enterica cells constitutively expressing stdEF 
In order to identify genes regulated by stdE and stdF, comparative transcriptomic analyses 
were performed in a strain that constitutively expressed stdEF and in a control strain carrying 
an in-frame deletion of both genes. To achieve moderate, constitutive expression of stdE and 
stdF, strain SV8141 was used (PLtetOstdEF). In this strain, transcription of both genes is 
driven by the PLtetO promoter (Lutz & Bujard, 1997; McQuiston et al., 2008). To avoid 
potential artefacts, the native stdA promoter and all the genes upstream of stdE in the std 
operon (Figure C2. 1A) were deleted, and the PLtetO promoter was placed upstream of stdE in 
the chromosome. The control strain contained the same insertion of the PLtetO promoter in the 
chromosome, lacking the upper part of the std operon but carrying also a deletion of stdE and 
stdF (SV8142; PLtetO∆stdEF, (Figure C2. 1B).   
                   
Figure C2. 1. Diagrams of the std operon and of the strains SV8141 and SV8142. A. The std operon and surrounding 
genes in a Salmonella enterica wild type strain. Transcription of the operon is driven by the stdA promoter (PstdA). B. 
Diagrams of the std operon and surrounding genes in the strains used for transcriptomic analysis (PLtetOstdEF; SV8141 and 
PLtetO∆stdEF; SV8142) is shown.  
Transcriptomic analysis was performed using an array custom prepared by Dr. A. Juárez and 
co-workers (Paytubi et al., 2014), with RNA isolated from cells grown to stationary phase 
(OD600~2). Raw data from transcriptomic analysis have been deposited at the Gene 
Expression Omnibus (G.E.O) database (Edgar et al., 2002), with accession number 
GSE45488. 
The results show that, under the conditions used in the study, a large number of Salmonella 
loci showed differences in their RNA levels in an StdEF-dependent manner. Relevant data 
are summarized in Figure C2. 2 in which genes showing a higher than 4-fold difference in 
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their RNA amount are depicted. Complete data from the transcriptomic analysis, along with 
gene descriptions and fold changes, are shown in Supplementary Table SM.1. 
                        
Figure C2. 2 Pie chart summarizing the microarray data obtained. Numbers of genes up- and down-regulated, and 
physiological processes in which they are involved. 
As shown in Figure C2. 2, almost 200 genes showed a difference in expression higher than 4 
fold upon constitutive expression of stdEF. About 85% of these genes appear to be down-
regulated by StdEF, suggesting that these proteins may be often repressors of gene expression 
in Salmonella. Among the down-regulated loci, genes involved in virulence and motility are 
highly represented. Regarding virulence, genes belonging to pathogenicity islands SPI-1 and 
SPI-4 are repressed by StdEF. As mentioned before, motility related genes are also found 
among down-regulated genes. The list includes not only flhDC, which encodes the master 
regulator of flagellar synthesis (Kutsukake et al., 1990), but also the flg, flh, fli, and motAB 
operons (Supplementary Table SM.1) are also repressed. FlhDC has been described as an 
activator of SPI-1 genes (Chubiz et al., 2010; Saini et al., 2008), which might explain the 
presence of strongly down-regulated SPI-1 genes in our transcriptomic analysis and in a 
previous study focused on the involvement of StdEF in Salmonella virulence (López-Garrido 
& Casadesús, 2012). Among down-regulated genes, we also find ygiD, annotated as a 
hypothetical protein, which seems to be involved in biofilm formation (Supplementary 
Table SM.1).  The che operon and the trg and aer genes involved in chemotaxis were also 
found to be down-regulated (Figure C2.2).   
Among the up-regulated loci, we observe a high representation of genes involved in general 
metabolism, along with genes of the tra operon encoded on the pSLT plasmid 
(Supplementary Table SM.1). The only up-regulated gene that may be involved in 
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virulence is the SL0982 locus, annotated as a “Gifsy-2 prophage attachment and invasion 
protein homolog”, which shows a 64-fold increase compared with the control strain. 
Interestingly, we also found yifA among the up-regulated genes, with an 8.4-fold change of 
expression. yifA (henceforth, hdfR) encodes the transcriptional activator HdfR, which is 
responsible for the expression of the std operon not only in a Dam- mutant (Jakomin et al., 
2008) but also in a wild type background, as it was shown in Chapter 1. Regulation of hdfR 
by StdEF defines a positive feedback loop for autogenous control of the std operon. 
Additional results regarding mechanisms of self-regulation of the std operon were presented 
in Chapter 1.  
Validation of transcriptomic data 
To validate the transcriptomic data described above, we performed quantitative RT-PCR 
analysis of some of the genes differentially expressed in the presence of StdEF. We analysed 
expression of genes involved in motility (motA, flgE), conjugation (traA), chemotaxis (trg), 
virulence (hilA, sipB) and the transcriptional regulator of the std operon, hdfR. Data presented 
in Figure C2. 3 show that all the genes analysed undergo a change in expression in cells that 
constitutively express stdEF (PLtetOstdEF), compared with the control (PLtetO∆stdEF) and with 
wild type S. enterica. Changes in gene expression correlate well with those observed in the 
array, with fold-changes higher than 10-fold in all cases.  
                                   
Figure C2. 3 Validation of microarray data. RNA levels for some of the genes under stdEF control identified by 
microarray data in strains PLtetOstdEF and PLtetO∆stdEF. Data are normalized to the RNA level obtained in wild type 
Salmonella cells (Value for wild type=1; not shown). RNA levels were determined for at least 3 biological replicates and a 
representative experiment is shown.  
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Although, as shown in chapter 1, the std operon is tightly repressed under the conditions 
employed in our microarray analysis (lab conditions), the expression levels of the analysed 
genes in the PLtetO∆stdEF strain vary slightly from the normalized Salmonella wild type 
strain. The existence of a small fraction of the population that expresses std (StdON cells) may 
explain this tiny difference, reinforcing the view that std is expressed under laboratory 
conditions in a subpopulation of bacterial cells.  
Functional validation of the transcriptomic data was also performed. In the case of 
Salmonella pathogenicity island-1 (SPI-1), regulation by StdEF had been previously proven 
in a study from our laboratory (López-Garrido & Casadesús, 2012). Constitutive expression 
of stdE and stdF had been shown to down-regulate SPI-1 genes, to decrease invasion of HeLa 
cells in vitro, and to attenuate Salmonella virulence upon infection of BALB/c mice (López-
Garrido & Casadesús, 2012). The results presented in this Thesis correlate well with such 
data since a large number of SPI-1 genes appear to be down-regulated in the transcriptomic 
analysis. As a further functional validation of the transcriptomic analysis, we carried out tests 
of motility, biofilm formation, and conjugation in Salmonella strains that constitutively 
expressed the stdE and stdF genes (Figure C2. 4).  
The three phenotypes under examination respond to stdEF expression. Regarding motility, 
Salmonella cells expressing stdEF show no motility on a soft agar plate, indicating that 
constitutive expression of stdEF impairs motility of S. enterica cells. This phenotype 
correlates well with the transcriptomic data that show down-regulation of flagellar genes. 
Interestingly, the control strain (PLtetO∆stdEF) is more motile than Salmonella wild type cells 
(Figure C2. 4A). Control cells are wild-type cells in which the std operon has been deleted, 
as described in Materials and Methods and shown in Figure C2. 1B. This result confirms a 
role of the std operon in repression of motility, and reinforce the view that the std operon is 
expressed in a small fraction of the population (0.3-3%), under laboratory conditions.  
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Figure C2. 4 Functional validation of the transcriptomic analysis. A. Motility agar plates (see Materials and Methods) 
were used to test the motility of the strains used in this study. The experiments were performed in triplicate, and a 
representative plate is shown. B. The biofilm formed by S. enterica SL1344 (wt) and the strains PLtetO-stdEF and PLtetO-
∆stdEF was stained with crystal violet as described in Materials and Methods. The experiments were performed in triplicate, 
and a representative assay is shown.  C. Effect of stdEF on conjugal transfer of pSLT in microaerobiosis. The recipient was 
SV4938 in all matings. Donors were wild type Salmonella SL1344, and strains PLtetO-stdEF and PLtetO-∆stdEF. Data are 
averages and standard deviations  from 3 independent matings.  
Balbontín et al. described that Salmonella Dam– mutants have a defect in motility (Balbontín 
et al., 2006). Since std overexpression impairs motility in S. enterica cells and std expression 
occurs in a Dam– mutants, we cannot rule out the possibility that Dam-dependent regulation 
of Salmonella motility is mediated by std expression. To corroborate this possibility we 
determined the motility of a Dam– mutant lacking stdEF.  
  
                                                                                 
Figure C2. 5 Dam-dependent regulation of Salmonella motility is partially mediated by std expression. Motility agar 
plates (see Materials and Methods) were used to test the motility of the strains SL1344, ∆dam and ∆dam ∆stdEF used in this 
study. The experiments were performed in triplicate, and a representative plate is shown.  
As shown in Figure C2. 5, the defect in motility observed in a Dam- mutant is, at least, 
partially due to the expression of stdEF, since the motility defect in ∆dam Salmonella is 
partially restored in the absence of StdEF.  
Regarding biofilm formation, we used crystal violet staining to analyse the ability of the 
PLtetOstdEF strain to form biofilm. As observed in Figure C2. 4B, biofilm formation 
decreases in cells that express stdEF (PLtetOstdEF), compared with the wild type and with a 
PLtetO∆stdEF strain. In the transcriptomic analysis, the gene ygiD appears to be down-
regulated. This gene has been annotated as a putative biofilm formation locus in Salmonella 
enterica like its Escherichia coli counterpart (Groisman & Ochman 1997; Kelly et al. 2009). 
To confirm the involvement of ygiD in biofilm formation, we analysed the capacity of an 
YgiD– null mutant to form biofilm. However, the amount of biofilm formed by the mutant 
was similar or identical to that of the wild-type strain. This observation indicates that reduced 
biofilm formation upon stdEF overexpression is not due to ygiD repression only, and that 
more genes that we have not been identified are likely to be involved in the process (Figure 
C2. 6). 
wt
∆dam ∆dam ∆stdEF
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Figure C2. 6 Biofilm formation by S. enterica SL1344 cells (wt), and by the ∆ygiD strain, detected with crystal violet 
staining. Three replicates are shown. 
The performance of the PLtetOstdEF strain in conjugation was also tested (Figure C2. 4C). 
When this strain was used as donor, the frequency of pSLT transfer increased 1.5 orders of 
magnitude. This increase in conjugation ability is probably due to an increase in the 
expression of the tra operon upon constitutive synthesis of StdEF (Supplementary Table 
SM.1). These results were further confirmed by determination of the β-galactosidase activity 
of a traB::lacZ transcriptional fusion in a Salmonella PLtetOstdEF strain, in a PLtetO∆stdEF 
strain, and in the wild type. A four-fold increase in traB::lacZ activity was observed upon 
stdEF expression (Figure C2. 7A).  
It has been described that Dam methylation represses tra operon expression by maintaining 
high levels of FinP RNA in the cell. FinP is an antisense RNA whose target is the traJ 
messenger RNA, while TraJ is an activator of the tra operon expression. Under these 
premises, and since a Dam– mutant has high levels of StdEF, we considered the possibility 
that Dam-dependent regulation of the tra operon might be mediated by StdEF, in a way 
similar to that described for SPI-1 (López-Garrido & Casadesús, 2012). 
wt∆ygiD
  
 
Figure C2. 7 StdEF controls traB lacZ expression and mediates Dam-dependent regulation of tra operon but not finP 
expression. A. β-galactosidase activity of a traB::lacZ fusion. B. RNA levels of traA in wt, dam and dam ∆stdEF 
background .  C. RNA levels of finP in wt, ∆dam and ∆dam ∆stdEF background. Data are normalized to the RNA level 
obtained in wild type Salmonella (Value for wild type=1).  
Figure C2. 7B shows that upregulation of traA expression in a Dam- background is supressed 
in the strain lacking stdEF  (∆dam ∆stdEF), suggesting that StdE, StdF or both are necessary 
for tra operon upregulation in Dam mutants. However, finP repression remains Dam-
dependent in the strain lacking stdEF, indicating that these genes are not required for the 
Dam-dependent control of finP (Figure C2. 7B).   
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StdEF global regulation is independent of the transcription factor HdfR 
Based on the transcriptomic results obtained, we could not rule out the possibility that the 
global regulation observed might be exerted through one or more intermediate regulators. 
One potential regulator was HdfR, whose locus appeared up-regulated in the transcriptomic 
data. HdfR is a LysR-type transcriptional regulator known to be essential for std 
transcription. Other LysR-type proteins are known to be global transcriptional regulators, as 
OxyR or LeuO (Broadbent et al., 2010; Haagmans & van der Woude, 2000). To ascertain 
whether the regulation observed upon constitutive expression of stdEF was indeed caused by 
HdfR we performed qRT-PCR of several genes in wild type and hdfR-null genetic 
backgrounds (Figure C2. 8A). Despite the different expression levels found in wild type and 
∆hdfR backgrounds, the pattern of expression remained the same in both backgrounds, 
suggesting that StdEF-mediated global regulation is independent of HdfR.   
It has been described in E. coli that HdfR binds to the flhDC promoter repressing its 
expression (Ko & Park, 2000). To investigate whether a similar mechanism might operate in 
our system so that stdEF-dependent regulation on flhDC might require HdfR, additional β-
galactosidase assays were performed in appropriate genetic backgrounds using a flhC::lacZ 
transcriptional fusion. As observed in (Figure C2. 8B), the β-galactosidase activity of the 
flhC::lacZ fusion increased slightly in a hdfR null mutant as described for E. coli. However, 
constitutive expression of stdEF caused a similar decrease in flhC:lacZ activity both in the 
wild type and in a ∆hdfR background. We thus conclude that StdEF-mediated regulation of 
the flhC promoter is independent of HdfR.  
Finally we also examined whether conjugation, another traitt regulated by StdEF, was HdfR-
dependent. As observed in Figure C2. 8C, similar rates of plasmid transfer were observed in 
wild type and hfdR-null genetic backgrounds when these strains were used as donors. This 
observation rules out the involvement of HdfR in conjugation control. 
  
 
Figure C2. 8 Role of HdfR in StdEF-mediated regulation. A. RNA levels for StdEF-regulated genes in a ∆hdfR-null 
genetic background. Data are normalized to the RNA level obtained in wild type Salmonella cells (Value for wild type = 1; 
not shown). A representative experiment is shown. B. β-galactosidase activity of a flhC::lacZ fusion in wild type and ∆hdfR-
null backgrounds. C. Conjugation assays using wild type and ∆hdfR-null donors. Data are averages and standard deviations  
from 3 independent matings.  
StdEF regulation of SPI-1 and conjugation is independent of FlhDC. 
Keeping in mind the transcriptomic data described above, another possible regulator that 
might control the plethora of genes regulated by StdEF was FlhDC. The flhDC operon is 
essential for transcription of all the genes in the flagellar cascade. The two operon products, 
FlhD and FlhC, are known to act together in an FlhD2FlhC2 heterotetramer which is the 
master regulator of the flagellar regulon (Claret & Hughes, 2000; Ikebe et al., 1999; Liu & 
Matsumura, 1994). Regarding invasion, StdEF-mediated regulation of SPI-1 expression 
requires post-transcriptional decrease of hilD mRNA. Although the actual mechanism is 
unknown (López-Garrido & Casadesús, 2012), it has been described that FlhDC regulates 
SPI-1 expression through FliZ (Chubiz et al., 2010). Because FlhDC down-regulates FliZ, it 
was conceivable that StdEF-mediated regulation of SPI-1 genes might be mediated by 
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FlhDC. β-galactosidase assays were performed in order to determine whether StdEF-
mediated regulation of SPI-1, tra, and flagellar genes depend on FlhDC. For this purpose, a 
∆flhC genetic background was used. Data presented in Figure C2. 9 indicate that SPI-1 
downregulation mediated by StdEF is independent of FlhDC. The same conclusion was 
obtained for regulation of the tra operon. However, as expected, flagellar regulation requires 
FlhDC.  
    
Figure C2. 9 β-Galactosidase activity of traB::lacZ, sipB::lacZ and fliC::lacZ fusions in different genetic backgrounds.  
Given that, neither HdfR, nor FlhDC mediate the plethora of processes affected by stdEF and 
knowing that StdF binds the std promoter region (Chapter 1), we do not discard, that these 
molecules might have a direct involvement in the global regulation. Therefore, we performed 
Chromatin Immunoprecipitation followed by sequencing (ChIP-seq) analysis to probe this 
hypothesis. 
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ChIP-seq analysis of Salmonella enterica cells constitutively expressing 
StdEF-3xFLAG. 
The strain used for the ChIP-seq experiment expressed stdEF under the control of PLtetO (like 
the strain used in transcriptomic analysis) and contained an StdF variant labelled at its C-
terminal end by a 3xFLAG epitope (PLtetOstdEF-3xFLAG; SV7850). This construction, 
depicted in Figure C2. 10, permitted detection of StdE with a cognate anti-StdE antibody, 
and of StdF using an anti-FLAG antibody. Because StdE is unaltered and StdFx3FLAG 
remains functional, transcription of the stdEF regulon was unaffected. 
               
Figure C2. 10 Diagram of the strain used for ChIP-seq analysis (PLtetOstdEF-3xFLAG). 
Chromatin immunoprecipitation was performed with cultures grown to stationary phase until 
OD600~2 (the same conditions used for microarray analysis). Bound proteins were 
crosslinked to DNA by formaldehyde treatment to form covalent unions. Cells were lysed 
and chromatin was sheared. Fragmentation of chromatin is a key point of ChIP sequencing 
since 300 bp fragments are required for the preparation of an optimal sequencing library, and 
for sequencing of the immunoprecipitated fragments. After immunoprecipitation of the 
specific proteins (and their bound DNA), de-crosslinking of the sample is performed to 
discard the proteins obtaining naked DNA fragments for the sequencing step. It is worth 
noting that the crosslinking step anchors the proteins to the bound DNA but also locks 
protein-protein interactions. Therefore our assays cannot discriminate between direct binding 
of the protein to DNA or indirect binding (through another protein). The controls used for the 
assay were: (i) total sheared and decrosslinked chromatin and (ii) mock IP sample. The mock 
IP is a sample that follows the same protocol as the IP sample but without adding the 
antibody. Despite the fact that the results from both controls were similar, we decided to use 
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the mock IP control for analysis of results because we considered it more reliable than the 
total sheared chromatin. 
From the results shown in Supplementary Table SM.2 we concluded that StdE and StdF are 
able to bind to multiple sites in the Salmonella genome. Figure C2. 11 indicates the numbers 
of binding sites for StdE, StdF and for both StdE and StdF. StdE binds to 316 sites and StdF 
binds to 166 sites. StdE and StdF share the 20% of the sites. A higher number of DNA 
sequence reads were found upon inmunoprecipitation with the specific StdE antibody, 
suggesting that StdE binds to the Salmonella genome more efficiently than StdF, and that 
they bind in an independent manner.  
                                                      StdE               StdF 
 
Figure C2. 11 Number of StdE, StdF and both StdE and StdF binding sites along Salmonella enterica genome. 
Looking at the binding sites for StdE and StdF, we observed that some of such sites may 
permit the interpretation of the data provided by the transcriptomic analysis. In other words, 
the StdEF binding patterns might help to explain StdEF-mediated regulation of a variety of 
physiological processes (e. g., by direct binding of the proteins to promoters or regulatory 
regions of genes). However in Supplementary Table SM.2 we can observe that there are 
also binding sites that do not seem to be involved in transcriptional regulation. A tentative 
explanation may be that the amount of StdE and StdF proteins present in our system is 
relatively high, and this might produce non-specific or non/physiological bindings to the 
DNA. An alternative possibility is that regulation might occur under conditions different 
from those used in this Thesis for transcriptomic analysis.   
  
Repression of the flagellar master operon by StdE and StdF binding 
As shown in Figure C2. 12, a significantly higher number of DNA sequencing reads were 
found in the promoter region of the flhDC genes for both StdE and StdF 
immunoprecipitations. As mentioned above, flhDC is the master operon for flagellar 
regulation (Kutsukake et al., 1990), and we have observed that StdEF–mediated regulation of 
flagellar genes is fully dependent on FlhC (Figure C2. 9). These results suggest that 
transcription of the flhDC operon may be regulated by direct StdE and StdF binding to its 
promoter. 
                              
Figure C2. 12 StdE and StdF regulation of the flagellar system through FlhDC. Chip-seq data show StdE and StdF 
binding peaks at the flhDC promoter. StdE-C and StdF-C denote control reactions (mock IP) for StdE and StdF 
inmunoprecipitations, respectively,  
Regulation of chemotaxis by StdE and StdF is mediated by FlhDC 
Transcriptomic data described above showed that StdE and StdF repress the che operon, as 
well as the trg and aer genes involved in chemotaxis and aerotaxis. Analysis of the ChIP-seq 
results did not show a binding peak close to those operons. However, it is well known that 
chemotaxis regulation is dependent on the flhDC master regulator (Chilcott & Hughes, 2000). 
Based on this fact, we wondered whether regulation by StdEF might be mediated by FlhDC. 
To investigate this possibility, quantitative RT-PCR was performed to evaluate the mRNA 
levels of genes differentially expressed in the presence of StdE and StdF according to the 
transcriptomic data (cheA, cheM, che, and trg) in FlhC+ and FlhC– backgrounds.  
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Figure C2. 13 Regulation of chemotaxis by StdE and StdF is mediated by flhDC. A. ChIP-seq data shows no relevant 
peaks surrounding the che operon. B. Ratios of the mRNA levels of genes involved in chemotaxis between the strains 
PLtetOstdEF and PLtetO∆stdEF. RNA levels were determined for at least 3 biological replicates and a representative 
experiment is shown.  
Data presented in Figure C2. 13B confirm that regulation of chemotaxis by StdEF is actually 
mediated by the flagellar master regulator FlhDC. This observation reminds of results 
described in both Salmonella and E. coli, where FlhDC is the transcriptional activator of σ28  
(fliA) (among other second class operons). FliA drives transcription of class 3 flagellar 
operons, such as tar-tap-cheRBYZ and motAB-cheAW (Chilcott & Hughes, 2000). Similar 
observations have been made in other motility or chemotaxis related genes such as trg and 
aer (Ghigo, 2001; May & Okabe, 2008) whose transcription is dependent on RpoF (fliA-σ28) 
(Fitzgerald et al., 2015). 
StdE binds the hilD-coding region 
StdEF downregulate SPI-1 expression, and downregulation takes place through hilD at the 
post-transcriptional level (López-Garrido & Casadesús, 2012). We examined the data 
obtained from the ChiP-seq analysis in the SPI-1 region, and we found that only StdE appears 
  
to bind within the region, and that binding occurs at the end of the hilD coding region 
(Figure C2. 14). Based on the data from the ChIP-seq analysis (Supplementary Table 
SM.2) other minor binding peaks in SPI-1 region were found in sipB and sipC genes, which 
encode effector proteins. Outside SPI-1, no binding was detected in genes known to code for 
SPI-1 regulators (e. g., hilE).   
 
Figure C2. 14 StdE binding to the hilD coding region.  
Previous work on StdEF-mediated regulation of SPI-1 (López-Garrido & Casadesús, 2012) 
concluded that regulation involved post-transcriptional repression of HilD, and that the main 
player in this regulation was StdE. These data correlate well with our ChIP-seq data: only 
StdE seems to bind the region. Hence, we considered the possibility that binding of StdE to 
the hilD coding region might somehow affect the stability of hilD mRNA. In these 
experiments, expression of hilD was driven by the PLtetO promoter. This choice was based 
upon the fact that the levels of hilD mRNA upon stdEF constitutive expression were very 
low, thereby making difficult the calculation of hilD mRNA half-life. We first verified that 
the strain PLtetOstdEF PLtetOhilD was able to maintain the regulation pattern of SPI-1 genes in 
the same way as when hilD was transcribed from its own promoter. Data in Figure C2. 15A 
show that regulation occurs as expected, and that StdEF-mediated regulation of SPI-1 genes 
does not require hilD to be transcribed from its native promoter. Although the hilD mRNA 
level was lower in the strain that constitutively expressed StdEF, the stability of hilD mRNA 
was similar in both strains (t ½  for PLtetOstdEF PLtetOhilD and PLtetO∆stdEF PLtetOhilD is 2,98  
and 2,82 min respectively), ruling out a mechanism of regulation involving hilD mRNA 
decay (Figure C2. 15B).   
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Figure C2. 15 Stability of hilD mRNA. A. β-Galactosidase activity of the invH::lacZ fusion. B. Stability of hilD mRNA in 
PLtetO∆stdEF PLtetOhilD and PLtetOstdEF PLtetOhilD strains. Values are averages from 3 independent qRT-PCR reactions. Error 
bars are not shown because the estándar deviations were extremely small.  
The mechanism of post-transcriptional regulation of hilD upon StdE binding to its coding 
sequence cannot be easily explained. One speculation is that StdE binding at the downstream 
portion of the coding region might interfere with the DNA-RNA hybrid formed during 
transcription, reducing the transcription rate. Another possibility is that binding of StdE to the 
hilD coding region might regulate the expression of a putative antisense RNA, resulting in a 
decrease of hilD mRNA 
Control of pSLT conjugal transfer by StdEF 
Transcriptomic data (Supplementary Table SM.1) and phenotypic assays (Figure C2. 4C), 
show increased conjugal transfer of the Salmonella virulence plasmid (pSLT) if the donor 
strain constitutively expresses stdEF (SV8141). This increase in plasmid transfer may be 
correlated, at least in part, with up-regulation of tra operon genes upon StdEF constitutive 
synthesis. 
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Figure C2. 16 ChIP-seq data showing pSLT plasmid region.  In the upper part, peaks along the tra operon are shown. 
StdE and StdF binding peaks are detected along tra operon. In the lower part of the figure, the tra operon region is zoomed-
in.  
A closer look to the ChIP-seq data in the tra operon shows an increase of StdE and StdF 
binding peaks, mainly upstream of traA and upstream of traK (Figure C2. 16). In the 
microarray (Figure C2. 17), the most up-regulated gene in the tra operon is traA with a 24-
fold increase. 
Gene Fold change  PLtetOstdEF/PLtetO∆stdEF 
traA 24.3 
traY 16.0 
traL 11.3 
traE 10.6 
traP 6.5 
traB 3.0 
 
Figure C2. 17 Expression of tra genes in PLtetOstdEF vs PLtetO∆stdEF strains.  
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Based on the strength of regulation, the binding peak closer to traA gene might be functional, 
and binding to the traA promoter might activate transcription. Moreover, traB appears as the 
less up-regulated gene in the tra operon, which suggests that the peak upstream traK and traB 
is not functional. StdEF-mediated regulation might thus involved the traA promoter. 
StdE and StdF binding sites identified in hdfR and std promoters  
Transcriptomic data and functional validation congruently indicate that increased StdEF 
synthesis in the strains that carry the PLtetOstdEF construct increase the level of hdfR 
expression, the transcriptional regulator of the std operon. Therefore, std expression increases 
the amount of the transcription factor needed for keeping the transcription of std operon, 
generating a self-regulatory positive loop (see Chapter 1). 
ChIP-seq upon StdE immunoprecipiation identified a peak upstream of the hdfR gene 
(Figure C2. 18), suggesting a direct activation of transcription by the StdE binding to the 
hdfR promoter. 
                                       
Figure C2. 18 ChIP- seq data obtained in the hdfR locus.  
Regarding std autoregulation, a binding peak was found upstream of the std promoter 
(Figure C2. 19), as expected according to the results presented in Chapter 1. However, we 
were lucky to identify this binding site, since the PLtetOstdEF-3xFLAG strain used for the 
ChIP-seq assay was constructed placing the PLtetO promoter upstream of the stdE gene and 
deleting the remaining sequences of operon upstream of stdE (which included the std 
promoter). The binding site identified by ChIP-seq is located 40 nt upstream of the deletion 
  
fragment, and 80 nt upstream of the first GATC site, suggesting a mechanism of 
autoregulation in which binding of StdF in this region favours std transcription. This result 
confirms previous data from the genetic screen (see Chapter 1) that outlined the importance 
of StdF for autoregulation of the std operon. It is interesting to point out that the binding site 
upstream of the std operon is the only one case in which StdF binds independently of StdE. 
The fact that StdF binding sites are mostly shared by StdE suggests a mechanism in which 
StdF binding to DNA might be accessory for regulation. An alternative possibility is that 
StdF does not bind directly DNA and its presence at the site is due to an interaction with 
other DNA-binding proteins (i.e., HdfR). For instance, StdF might act as a chaperone to 
facilitate binding of the regulator to cognate DNA.  
 
Figure C2. 19 ChIP-seq data showing StdF binding to std promoter region.  
Based on the ChiP-seq data, together with the results presented in Chapter 1, we propose a 
mechanism in which StdE binding to the hdfR promoter activates its expression, therefore 
maintaining HdfR levels high enough to allow expression from the std promoter, and to keep 
the autoregulatory loop active. StdF binding to the std promoter favours its transcription, and 
the accessory role of StdF might be either assisting HdfR binding, favouring a positive 
regulation, or by obstructing Dam methylation, which represses expression, therefore 
resulting in the positive regulation observed. Based in the results presented in Figure C2. 20 
it might be suggested that StdF is involved in HdfR binding. In a wild type strain, both HdfR 
and StdF are essential for expression of the std operon. In a Dam– mutant, were there is no 
methylation, HdfR is essential but also StdF. Hence, when no blocking action is needed,  
StdF seems to be still essential for std expression.  
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Figure C2. 20 Role of StdF in std activation. Heat maps represent GFP fluorescence intensity in S. enterica strains carrying 
an stdA::gfp fusion in different backgrounds.  
Based on these results and others described in Chapter 1, we confirm that StdE and StdF have 
a crucial role in autoregulation the std operon (Figure C2. 21). The involvement of these 
regulators takes place at two different levels. StdE binds the hdfR promoter region and 
increases hdfR transcription. It would be interesting to figure out if the increase is due to an 
active StdE action over the hdfR promoter or to blocking HdfR negative loop. On the other 
hand, StdF binds to the std promoter and may act as an auxiliary protein that cooperates with   
HdfR to activate std transcription. 
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Figure C2. 21 Tentative model of std autoregulation. Positive effects are indicated by lines ending in arrowheads, whereas 
blunt lines indicate negative regulatory effects. Dashed lines indicate regulations that do not apply under the diagram  
circumstances. The three black squares represent the three GATC sites in the regulatory region of the std operon, that in the 
circumstances detailed above would be non-mehylated.  
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Variable and unpredictable environments can confer selective value to adaptive phenotypes. 
Traditionally it was assumed that bacteria adapt to changing environments by transcriptional 
and postranscriptional regulation. According to this view, regulatory networks integrate 
signals of environmental alterations, and an improved phenotype may be generated. These 
adaptive procedures are slow, and in certain harsh environments can be insufficient (Turner 
et al., 2009). During the last decade, single cell analysis has provided examples indicating 
that, in certain clonal populations of bacteria, not all the cells show the same phenotype under 
the same selective pressure. Bacterial phenotypic heterogeneity can originate from genetic 
changes, including programmed genetic rearrangement (Silverman et al., 1979) and 
contraction or expansion of DNA repeats at genome regions known as contingency loci 
(Moxon et al., 1994; 2006). Phenotypic heterogeneity can also be epigenetic, without any 
change in the DNA sequence (Casadesús & Low, 2013). Phenotypic variability can increase 
the fitness of the bacterial population either by permitting division of labor or by bet-hedging 
(anticipation of future challenges) (Veening et al., 2008). This view is not merely intuitive: 
game theory analysis supports it (Beaumont et al., 2009; Grafen, 1999; Wolf et al., 2005). 
Relevant examples of non-genetic heterogeneity in isogenic populations involve envelope 
structures such as fimbriae, flagella, and the LPS O-antigen (Cota et al., 2015; Cummings et 
al., 2006; Kingsley et al., 2002; Nicholson & Low, 2000). In the Dam-regulated std fimbrial 
operon of Salmonella enterica (Balbontín et al., 2006), the existence of subpopulations of 
StdON and StdOFF cells was observed in Dam– and SeqA– mutants (Jakomin et al., 2008). 
Results obtained in this Thesis indicate that this phenotypic heterogeneity occurs also in the 
wild type strain, where a large subpopulation StdOFF cells and a small subpopulation of StdON 
cells are found. The existence of bistability is also supported by the visualization of the StdA 
fimbrial protein by immunofluorescence microscopy in a small fraction of the population. 
Bimodal expression had been previously reported for other fimbrial operons such as lpf and 
pef (Kingsley et al., 2002; Nicholson & Low, 2000; Norris et al., 1998). 
The transcriptional factor HdfR had been shown to be essential for std expression in a Dam– 
background (Jakomin et al., 2008), and data presented in this Thesis indicate that HdfR 
activates std transcription in the wild type strain as well. In fact, constitutive expression of 
hdf increases the size of the StdON subpopulation. Given the importance of HdfR availability 
for std expression, one might think that lack of std expression in the wild type (which occurs 
in the majority of cells) might be due to HdfR shortage. Far for being the bottleneck, the 
  
amount of HdfR in the wild type strain is roughly the same as in a Dam– mutant where std 
expression is considerably higher. The maintenance of a steady level of HdfR seems to be 
due, at least in part, to the existence of an auto-regulatory loop that maintains hdfR expression 
at moderate levels. Like other LysR-type transcription factors, HdfR undergoes autogenous 
transcriptional repression. This loop operates both in the wild type and in a Dam– mutant. In 
the latter, however, increased expression of stdEF increases the amount of HdfR because 
hdfR transcription is up-regulated by StdEF (see below). 
Besides Dam and HdfR, SeqA (Jakomin et al., 2008) and RosE (Chessa et al., 2008) have 
been described as regulators of the std transcription. While searching for additional regulators 
of std expression, circumstantial evidence suggested that Std products might be activators of 
std transcription, providing a positive feedback loop for std operon control. Constitutive 
expression of the stdEF genes increases the expression of the std operon and the size of the 
StdON subpopulation. On the contrary, absence of the stdEF genes decreases the size of the 
StdON subpopulation. Based on these observations, we conclude that the products of the two 
downstream genes of the std operon (StdE and StdF) are positive regulators of std 
transcription. However only StdF seems to bind the std promoter (see below).  
With these observations in mind, a model for std operon control may be proposed. The Dam 
methylase, the transcription factor HdfR, and the StdF protein may compete for binding to 
the std regulatory region. In fact, HdfR binds the std UAS when the GATC sites are non-
methylated, protecting them from methylation. As mentioned above, increased levels of 
HdfR increase both the size of the StdON subpopulation and the mean fluorescence of the 
population. In our tentative model, the std-hdfR-std feedback loop can be expected to 
generate amounts of HdfR high enough to unbalance the pulse between Dam and HdfR for 
occupying the std regulatory region. The reason why HdfR excludes the Dam methylase only 
in a fraction of cells remains unknown but a model involving the StdF gene product can be 
presented. The StdF protein binds the std promoter region, and two observations suggest that 
it may cooperate with HdfR, rather than hindering Dam methylation: (1) the presence of the 
StdEF products is still necessary to hinder Dam methylase activity when the expression levels 
of hdfR are high enough (std expression is higher in a PLtetOhdfR background than in a ∆dam 
background); and (2) in the absence of Dam methylation the stdEF genes are still necessary 
for std transcription. Furthermore, analysis of std expression in different backgrounds (wild 
type, Dam–, and PLtetOhdfR) reveals that the StdON subpopulation is always detected when 
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StdE and StdF are present, suggesting that StdF binding to the std UAS may be the key factor 
to generate StdON cells. 
To better understand the mechanisms that converge at the regulatory region, determination of 
the methylation state of the std promoter in StdOFF and StdON cells might provide relevant 
information. However, a handicap emerges here because of the existence of two phenotypic 
subpopulations, one of them tiny. In the major subpopulation (StdOFF), the three GATC sites 
in the regulatory region of the std operon are fully methylated. Based on the changes in std 
expression observed when the main regulators are overexpressed or absent, a different pattern 
can be expected for the StdON subpopulation. This possibility is reinforced by the decrease of 
the StdON subpopulation upon DNA methylase overproduction. However, the methylation 
state of the std UAS in the StdON subpopulation remains to be determined. 
If synthesis of StdE and StdF is low and noisy, differences from cell to cell may explain why 
HdfR-mediated activation and concomitant formation of nonmethylated GATCs occurs in 
certain cells only. An observation that may support this view is the detection of a weak 
internal promoter upon measuring the fluorescence activity of an stdE::gfp fusion in the 
presence and in the absence of the main promoter. Several attempts have been made while 
preparing this Thesis to identify the putative internal promoter. However, cloning of internal 
std fragments onto the promoter-probe vector pIC552 did not reveal the existence of an active 
promoter. Inconclusive results were also obtained by 5´RACE experiments performed in both 
the wild type and a Dam mutant. The experiments performed using the promoter-probe 
plasmid pIC552 may have failed due to the existence of unknown repressors that may control 
stdE expression. In the case of 5’RACE, expression of the stdE gene in the wild type strain 
may be too low to detect the RNA molecules. Unfortunately, a Dam– mutant cannot be used 
in 5'RACE experiments because in this background the main std promoter is active.   
Autoregulation of the std operon by the StdE and StdF products is not a unique example: the 
involvement of fimbrial products in the regulation of fimbrial synthesis had been previously 
reported. To give just an example, expression of the major fimbrial subunit of type 1 fimbriae 
of Salmonella enterica (fimA) is positively regulated by FimY and FimZ (Saini et al., 2009; 
Tinker & Clegg, 2000), and FinM binds the fimA promoter (Yeh et al., 1995).  
Aside from the repressors of the std operon already known (Dam methylation, SeqA and 
RosE), we have identified a new repressor, RcsB, the response regulator of the RcsCBD 
  
signal transduction system. RcsB represses std expression. This regulation takes places not 
only in a Dam– background but also in the wild type strain, decreasing the fraction of StdON 
cells in the population. Based on the results presented here, this regulation is not dependent 
on Dam methylation, since repression is observed both in the presence and in the absence of 
Dam methylation. RcsB may exert transcriptional regulation by binding directly to the std 
promoter region, and in silico analysis has identified a putative binding site for RcsB near the 
-35 module of the std promoter. A footprint assay will be necessary to confirm the existence 
of RcsB binding to the putative binding site identified. The significance of RcsBCD-mediated 
repression of the std operon is difficult to grasp, even in a speculative manner, as the 
environmental signals that activate the RcsBCD signal transduction system remain largely 
unknown (Majdalani & Gottesman, 2005). 
Fractionation assays have identified StdE and StdF as cytoplasmic proteins, and in silico 
information reveals that StdE and StdF are homologues of known transcriptional regulators. 
StdE shares 40-50% identity with the transcriptional activators GrlA from E. coli and CaiF 
from Enterobacter cloacae. In turn, StdF is related to the SPI-1 Salmonella protein SprB, a 
transcriptional regulator that represses the hilD promoter and activates the siiA promoter 
(López-Garrido & Casadesús, 2012). Homology with transcriptional regulators correlates 
well with our results, although no DNA binding motifs were identified in silico. 
In 2012, López-Garrido & Casadesús proposed that the std operon may be the link between 
Dam methylation and SPI-1 regulation: the downregulation of SPI-1 expression observed in 
Dam– mutants (Balbontín et al., 2006) is suppressed upon deletion of two std genes, stdE and 
stdF (López-Garrido & Casadesús, 2012). This antecedent, combined with the fact that this 
Thesis has uncovered an active role of StdE and StdF as transcriptional activators of their 
own operon, led us to wonder whether these products of the std operon might have other roles 
in Salmonella enterica. To our surprise, microarray analysis revealed that StdE and StdF are 
global regulators of transcription, mainly as repressors. Constitutive expression of stdE and 
stdF downregulates not only SPI-1 expression as previously reported (López-Garrido & 
Casadesús, 2012) but also represses loci involved in motility and chemotaxis. On the other 
hand, StdEF activate transcription of the pSLT tra operon and, interestingly, of hdfR.  
Since StdEF activate hdfR expression and LysR-type transcription factors are often global 
regulators, we could not role out the possibility that some or all the global regulatory 
activities of StdE and StdF were actually performed by HdfR. However, we obtained 
Discussion 
129 
evidence that HdfR is not a global regulator but merely one of the many targets within the 
StdEF regulon. With hdfR transcriptional activation, the std operon may ensure its own 
transcription as HdfR is needed for std transcription. This regulatory pattern generates a 
positive feedback loop for std expression. A tempting speculation is that StdEF may increase 
the level of HdfR through direct binding of StdE to the regulatory region of the hdfR gene, 
thereby impairing autogenous repression by HdfR.  
Another possible intermediary in StdEF-mediated global regulation is the FlhDC master 
regulator, known to control invasion, motility and fimbriation (Saini et al., 2010). 
Furthermore FliZ, a product of FlhDC regulatory cascade, has been described as a 
postranscriptional regulator of SPI-1 through hilD (Chubiz et al., 2010). However, our results 
discard FlhDC as the connector between StdEF and their targets. FlhDC does regulate the 
flagellar system as well as chemotaxis (as expected), but none of the other processes under 
StdEF control.   
Because the potential intermediary factors considered above were not involved in global 
regulation by StdEF and we had previously observed that StdF acts as a transcription factor 
promoting std expression, we considered the option of direct regulation by StdEF. ChIP-seq 
analysis was thus performed to ascertain whether StdE and StdF are DNA-binding proteins. 
This analysis confirmed that StdE and StdF have DNA-binding ability, thus supporting the 
possibility that they may directly regulate gene expression. StdE binds twice more frequently 
than StdF but both proteins share 20% of the binding sites. This kind of assay does not 
distinguish direct binding from indirect binding. Hence, in certain cases we cannot rule out 
the involvement of both proteins in regulation.  
Although we cannot propose a mechanism regarding SPI-1 regulation, we have confirmed the 
occurrence of postranscriptional regulation of hilD as previously described (López-Garrido & 
Casadesús, 2012). Moreover, the relevant role that we assigned to StdE in SPI-1 regulation 
correlates well with the data presented by Lopez-Garrido et al. (2012) showing that the 
decrease of SP1-1 regulation is stronger when StdE is present than when only StdF is present. 
As discussed above, the ChIP-seq assay does not allow to distinguish between direct binding 
of a protein to the DNA and indirect binding through another protein. However, it would be 
interesting to study in depth how is it possible that StdE controls hilD expression by 
interacting with the downstream portion of its coding region. An attractive idea involves the 
hybrid DNA-RNA formed during transcription. StdE might impair RNA processing, thereby 
  
affecting translation of the HilD protein. As a consequence, disturbance of SPI-1 regulation 
might occur, and also disruption of the hilD self-regulatory loop. Regulation of the 
expression of a putative antisense RNA can be also considered, but in silico analysis based on 
data provided by Jay Hinton's lab seem to discard the possibility of an additional transcription 
start site aside from those already known in the region.  
Concerning the regulation of motility and chemotaxis, the ChIP-seq data raise the possibility 
that both StdE and StdF bind directly to the flhDC promoter. Regulation at the highest level 
in the hierarchy of the flagellar network (FlhDC) seems to explain why all the operons 
involved in regulation of motility appear to be under StdEF control. Regulation of 
chemotaxis is also controlled through FlhDC, probably involving the Class III transcription 
factor, FliA. A priori, it seems to make sense that the motility system is not active if the 
ability to sense the environment is not working and vice versa. Interestingly, we have 
observed that the regulation of the flagellar system mediated by Dam methylation is, at least 
partially, due to StdEF, in a way reminiscent of the crosstalk previously described for SPI-1 
regulation. 
Even though StdE and StdF appear to be mainly repressors of transcription, it is noteworthy 
that the conjugal transfer operon tra and the hdfR gene are activated by StdEF. We cannot 
propose a mechanism for StdEF-mediated regulation of conjugation, but it is clear that StdE 
and StdF binds massively along the tra operon. We cannot ascertain if one or both proteins 
are involved in tra operon control nor define the specific target(s). However, based on the 
expression level of the target genes, the traA regulatory region might be the most appropriate 
for regulation by StdE, StdF, or both.  
At this point, and considering that the most widespread role of StdE and StdF appears to be to 
act as repressors of transcription, one may consider the possibility that up-regulation 
mediated by stdEF might be actually performed by repressing a repressor. We have already 
mentioned that StdEF-dependent regulation of hdfR may involve impairment of HdfR 
binding to its own promoter. Something similar may happen with StdEF-dependent 
regulation of tra operon. Unfortunately, among the transcriptomic data we have not found an 
appropriate candidate. However, we have observed that Dam methylation-dependent 
regulation of the tra operon is, as described previously for the flagellar regulation, also due to 
StdEF. So StdEF are involved in Dam dependent regulation of SPI-1 (López-Garrido & 
Casadesús, 2012), flagellar synthesis and conjugation. In the case of conjugation, StdEF-
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mediated activation of tra might boost Lrp-mediated activation of traJ (Camacho & 
Casadesús, 2002) and counter or balance FinP-mediated repression (Camacho & Casadesús, 
2005). The latter two mechanisms of conjugation control are also Dam-dependent, albeit in 
opposite ways: Dam methylation activates transcription of finP and represses transcription of 
traJ. The existence of overlapping controls acting in opposite manners may illustrate, like 
many other examples, the complexity of bacterial regulatory networks. 
A major outcome of this Thesis work is that the study provides a novel example of 
phenotypic variation within a clonal population. Two bacterial subpopulations, made of 
fimbriated and non-fimbriated Salmonella cells, appear to exist. Formation of two 
subpopulations may be viewed as a preadaptation of Salmonella enterica to perform two 
types of infection, acute and chronic. Because Std fimbriae permit adhesion to the epithelium 
of the caecum (Weening et al., 2005), StdON cells will be able to colonize the large intestine, 
and this colonization may result in persistent or chronic infection. In turn, StdOFF cells will be 
able to undergo invasion of the small intestine epithelium, causing salmonellosis or systemic 
infection. The fact that the StdON and StdOFF subpopulations differ in additional phenotypic 
traits may contribute to adaptation by fine-tuning the interaction of each subpopulation with a 
specific host environment. 
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1. Populations of Salmonella enterica cells undergo bistable expression of the std fimbrial 
operon. The StdON subpopulation is small in the wild type (0.3-3% cells) under laboratory 
conditions. 
2. Formation of the StdON subpopulation requires the StdE and StdF proteins, which are 
products of the promoter-distal genes of the std operon. StdE is necessary to activate 
transcription of the hdfR gene, which encodes the main transcriptional activator of the std 
operon. In turn, StdF may be necessary to facilitate binding of HdfR to the std promoter. 
3. StdE and StdF are global regulators in Salmonella enterica, and regulate SPI-1 expression, 
flagellar synthesis, chemotaxis, biofilm formation, and conjugal transfer of the virulence 
plasmid.  
4. StdE and StdF are DNA-binding proteins that show homology with other transcriptional 
regulators, and may control transcription by direct binding to DNA. An exception is the hilD 
gene, which undergoes postranscriptional regulation under StdE control. The mechanism 
underlying hilD regulation is unknown. 
5. The StdOFF subpopulation is able to invade epithelial cells, while the StdON subpopulation 
is deficient in epithelial cell invasion. This difference may endowe the StdOFF subpopulation 
with the ability to cause salmonellosis or systemic infection. In turn, production of Std 
fimbriae by the StdON subpopulation may permit adhesion to the caecum, causing chronic 
infection.  
6. As a consequence of global regulation of gene expression by StdEF, the StdON 
subpopulation is nonmotile, and undergoes altered biofilm formation, repression of 
chemotaxis genes, and activation of the conjugation system of the virulence plasmid.  
7. The existence of multiple phenotypic differences between the StdOFF and the StdON 
subpopulations may be viewed as a case of bacterial differentiation during Salmonella 
infection, perhaps as a bet hedging strategy or a division of labour. 
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Table SM. 1 Microarray results 
 
GENES UP-REGULATED BY stdEF OVEREXPRESSION  
STM SL Gene 
fold change  
Description StdEF vs 
ΔstdEF (1) 
 StdEF vs 
ΔstdEF (2) 
VIRULENCE 
1043 SL0982 
 
6,4 6,1 attachment/invasion protein 
CONJUGATION 
 
SLP1_0027 TraP 2,8 2,6 conjugative transfer protein 
 
SLP1_0028 TraB 2,1 1,1 conjugative transfer: assembly 
 
SLP1_0030 TraE 3,7 3,1 conjugative transfer: assembly 
 
SLP1_0031 TraL 3,8 3,1 conjugative transfer: assembly 
 
SLP1_0032 TraA 4,3 4,9 conjugative transfer: fimbrial subunit 
 
SLP1_0033 TraY 4,0 4,0 conjugative transfer: oriT nicking 
METABOLISM 
191 SL0192 fhuA 3,8 3,4 ferrichrome outer membrane transporter 
1343 SL1277 nlpC 3,3 3,5 lipoprotein 
1344 SL1278 ydiV 2,5 1,3 hypothetical protein 
3024 SL3002 yohM 2,1 1,6 nickel/cobalt efflux protein RcnA 
3025 SL3003 stdE 10,3 10,0 
 
30251N SL3004 stdF 10,6 10,5 
 
3128 SL3102 ordL 3,9 3,7 putative oxidoreductase 
OTHERS 
509 SL0502 
 
2,4 1,8 putative outer membrane protein 
3112 SL3096 
 
2,6 1,9 murein transglycosylase C 
3123 SL3097 
 
3,2 2,4 putative arylsulfatase regulator 
3125 SL3099 
 
2,8 1,5 putative cytoplasmic protein 
3126 SL3100 
 
2,7 2,4 putative amino acid transporter 
3127 SL3101 
 
3,0 3,1 putative cytoplasmic protein 
3129 SL3103 
 
4,2 3,3  putative NAD-dependent aldehyde dehydrogenase 
3169 SL3143 
 
3,1 2,6 putative periplasmic dicarboxylate-binding protein 
3170 SL3144 
 
2,6 2,9 putative inner membrane protein 
3171 SL3145 ygiK 2,2 2,5 putative transporter 
3688 SL3653 
 
2,3 2,3 putative cytoplasmic protein 
3805 SL3773 yidH 2,1 1,0 putative inner membrane protein 
3897 SL3858 yifA 3,2 2,9 transcriptional regulator HdfR 
4548 SL4479 bglJ 2,5 1,4 DNA-binding transcriptional activator BglJ 
4549 SL4480 
 
3,0 2,2 putative cytoplasmic protein 
 
SLP2_0078 
 
2,2 1,5 
 
 
SLP2_0079 
 
2,9 1,7 
 
  
 
 
GENES DOWN-REGULATED BY stdEF OVEREXPRESSION  
STM SL gene 
fold change  
Description StdEF/ 
ΔstdEF (1) 
StdEF/Δstd
EF (2) 
VIRULENCE 
1088 SL1027 pipB -2,35261 -2,79374 secreted effector protein 
1090 SL1029 pipC -7,23594 -6,81151 pathogenicity island-encoded protein C 
1091 SL1030 sopB -8,07052 -8,51238 secreted effector protein 
1593 SL1524 srfA -4,63622 -4,43075 putative virulence protein 
1594 SL1525 srfB -3,99769 -4,23264 putative virulence protein 
1595 SL1526 srfC -4,13812 -3,67496 putative virulence protein 
1855 SL1784 sopE2 -3,19064 -3,38909 type III-secreted effector protein 
2066 SL2043 sopA -4,45486 -4,58496 secreted effector protein 
2865 SL2845 avrA -2,9673 -2,92411 secreted effector protein 
2866 SL2846 sprB -4,30304 -3,2128 transcriptional regulator 
2867 SL2847 hilC -4,90612 -4,12935  invasion regulatory protein 
2868 SL2848 orgC -3,76945 -3,71423 putative cytoplasmic protein 
2869 SL2849 orgB -2,49114 -2,97335 needle complex export protein 
2870 SL2850 orgA -6,7807 -6,65603 needle complex assembly protein 
2871 SL2851 prgK -7,63394 -7,46371 needle complex inner membrane lipoprotein 
2872 SL2852 prgJ -8,37266 -8,47918 needle complex minor subunit 
2873 SL2853 prgI -8,53071 -7,79621 needle complex major subunit 
2874 SL2854 prgH -4,87411 -5,62474 needle complex inner membrane protein 
2875 SL2855 hilD -4,34678 -4,29323 invasion protein regulatory protein 
2876 SL2856 hilA -7,13183 -7,21907 invasion protein regulator 
2877 SL2857 iagB -6,66318 -5,83615 invasion protein precursor 
2882 SL2861 sipA -6,38297 -7,45432 secreted effector protein 
2883 SL2862 sipD -8,10815 -7,96644 translocation machinery component 
2884 SL2863 sipC -6,75384 -6,93525  translocation machinery component 
2885 SL2864 sipB -6,98067 -6,70203 translocation machinery component 
2886 SL2865 sicA -6,11606 -6,65031 secretion chaperone 
2887 SL2866 spaS -2,24243 -2,27852 surface presentation of antigens protein SpaS 
2888 SL2867 spaR -3,70299 -3,50458 needle complex export protein 
2889 SL2868 spaQ -4,65043 -3,48878 needle complex export protein 
2890 SL2869 spaP -4,84355 -3,47487 surface presentation of antigens protein SpaP 
2891 SL2870 spaQ -7,1891 -6,74103 surface presentation of antigens protein SpaO 
2892 SL2871 invJ -7,73751 -6,92514 needle length control protein 
2893 SL2872 invI -6,50147 -6,5762 needle complex assembly protein 
2894 SL2873 invC -6,54299 -6,27668 ATP synthase SpaL 
2895 SL2874 invB -7,80109 -7,30746 secretion chaperone 
2896 SL2875 invA -6,29927 -6,23907 needle complex export protein 
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2897 SL2876 invE -5,15772 -4,42613 invasion protein 
2898 SL2877 invG -7,36066 -7,40968 outer membrane secretin precursor 
2899 SL2878 invF -9,005 -8,25772 invasion regulatory protein 
2900 SL2879 invH -5,75796 -5,85947 needle complex outer membrane lipoprotein precursor 
2945 SL2924 sopD -6,04938 -5,80587 secreted effector protein 
4257 SL4193 siiA -4,86275 -3,97478 
 
4258 SL4194 siiB -5,64156 -5,12549 
 
4259 SL4195 siiC -4,48573 -4,22586 
 
4260 SL4196 siiD -6,2381 -5,52023 
 
4261 SL4197 siiE -5,55131 -6,32293 
 
4262 SL4198 siiF -3,85186 -3,66006 
 
FLAGELLUM 
1171 SL1108 flgG -5,71429 -5,21887 flagellar basal body rod protein FlgG 
1172 SL1109 flgM -3,9965 -4,33879 anti-sigma28 factor FlgM 
1173 SL1110 flgA -3,46902 -3,68834 flagellar basal body P-ring biosynthesis protein FlgA 
1174 SL1111 flgB -7,63659 -7,1108 flagellar basal body rod protein FlgB 
1175 SL1112 flgC -9,17839 -8,18843 flagellar basal body rod protein FlgC 
1176 SL1113 flgD -8,29584 -8,09363 flagellar basal body rod modification protein 
1177 SL1114 flgE -8,10062 -7,37697 flagellar hook protein FlgE 
1178 SL1115 flgF -7,55285 -6,77852 flagellar basal body rod protein FlgF 
1179 SL1116 flgG -7,06958 -6,1296 flagellar basal body rod protein FlgG 
1180 SL1117 flgH -5,68632 -5,07144 flagellar basal body L-ring protein 
1181 SL1118 flgI -5,76343 -5,37619  flagellar basal body P-ring protein 
1182 SL1119 flgJ -6,11105 -5,34008 peptidoglycan hydrolase 
1183 SL1120 flgK -7,62081 -7,72774 flagellar hook-associated protein FlgK 
1184 SL1121 flgL -6,80263 -6,42102 flagellar hook-associated protein FlgL 
1912 SL1847 flhE -5,17649 -4,25584  flagellar protein 
1913 SL1848 flha -4,43008 -3,93142 flagellar biosynthesis protein FlhA 
1914 SL1849 flhB -2,60218 -2,42441 flagellar biosynthesis protein FlhB 
1912 SL1847 flhE -5,17649 -4,25584  flagellar protein 
1913 SL1848 flha -4,43008 -3,93142 flagellar biosynthesis protein FlhA 
1914 SL1849 flhB -2,60218 -2,42441 flagellar biosynthesis protein FlhB 
1915 SL1850 flhZ -6,96302 -5,87415 
 
1916 SL1851 flhY -7,81919 -6,54635 
 
1922 SL1857 motB -7,33594 -7,39911 flagellar motor protein MotB 
1923 SL1858 motA -7,02063 -7,2536 flagellar motor protein MotA 
1924 SL1859 flhC -4,19042 -4,08165 transcriptional activator FlhC 
1925 SL1860 flhD -3,70422 -4,19309 transcriptional activator FlhD 
1955 SL1884 fliZ -5,94152 -6,62262 protein FliZ 
1956 SL1885 fliA -7,98073 -8,08624 flagellar biosynthesis sigma factor 
1958 SL1887 fliB -6,30407 -6,61295  lysine-N-methylase 
  
      
1959 SL1888 fliC -6,07778 -6,55312 flagellin 
1960 SL1889 fliD -8,24866 -9,03107 flagellar capping protein 
1961 SL1890 fliS -6,72678 -7,00214 flagellar protein FliS 
1962 SL1891 fliT -6,45004 -6,44869  flagellar biosynthesis protein FliT 
1968 SL1897 fliE -4,40061 -3,87333  flagellar hook-basal body protein FliE 
1969 SL1898 fliF -4,52256 -4,49656  flagellar MS-ring protein 
1970 SL1899 fliG -5,80939 -5,364 flagellar motor switch protein G 
1971 SL1900 fliH -5,15984 -4,3348 flagellar assembly protein H 
1972 SL1901 fliI -4,60108 -3,78864 flagellum-specific ATP synthase 
1973 SL1902 fliJ -7,35072 -7,3361 flagellar biosynthesis chaperone 
1974 SL1903 fliK -4,67108 -4,68336 flagellar hook-length control protein 
1975 SL1904 fliL -3,70536 -2,52217 flagellar basal body-associated protein FliL 
1976 SL1905 fliM -5,91778 -5,91502 flagellar motor switch protein FliM 
1977 SL1906 fliN -6,10392 -5,42285 flagellar motor switch protein FliN 
1978 SL1907 fliO -4,86694 -4,27314 flagellar biosynthesis protein FliO 
1979 SL1908 fliP -2,35408 -1,64851 flagellar biosynthesis protein FliP 
2771 SL2756 fljB -6,99806 -7,45804 flagellin 
CHEMOTAXIS 
1917 SL1852 cheB -6,79446 -6,055 chemotaxis-specific methylesterase 
1918 SL1853 cheR -6,644 -6,09016 chemotaxis methyltransferase CheR 
1919 SL1854 cheM -8,83596 -8,75253 methyl accepting chemotaxis protein II 
1920 SL1855 cheW -7,31736 -6,24275  purine-binding chemotaxis protein 
1921 SL1856 cheA -7,97546 -7,29865 chemotaxis protein CheA 
3217 SL3190 aer -6,54713 -6,34625 aerotaxis sensor receptor 
1626 SL1556 trg -7,06638 -7,19467 methyl-accepting chemotaxis protein III 
METABOLISM 
781 SL0758 modA -2,42126 -2,48426 molybdate transporter periplasmic protein 
782 SL0759 modB -2,4873 -2,4489 molybdate ABC transporter permease protein 
783 SL0760 modC -2,68069 -2,87297 molybdate transporter ATP-binding protein 
800 SL0776 slrp -2,19948 -2,52212 leucine-rich repeat-containing protein 
2548 SL2510 asrA -2,44988 -2,84987 anaerobic sulfide reductase 
2549 SL2511 asrB -2,95773 -1,98773 anaerobic sulfite reductase subunit B 
2550 SL2512 asrC -2,30442 -1,36859 anaerobic sulfide reductase 
2558 SL2520 cadB  -3,2369 -2,8327  lysine/cadaverine antiporter 
2559 SL2521 cadA -2,92782 -2,81164 lysine decarboxylase 1 
 
SL2674 sopE -9,40074 -9,35711 
 
2773 SL2758 iroB -3,84752 -3,49264  putative glycosyl transferase 
2774 SL2759 iroC -3,47552 -2,68924 putative ABC transporter protein 
2775 SL2760 iroD -2,19228 -1,41579 enterochelin esterase=-like protein 
2776 SL2761 iroE -2,35303 -1,39884 putative hydrolase 
2878 SL2858 sptP -2,89798 -3,0085 protein tyrosine phosphatase/GTPase activating protein 
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3189 SL3163 ygiD -2,39064 -2,08937 
hypothetical protein-seems to be involved in biofilm 
formation 
3240 SL3212 tdcG -2,02863 -1,36615  L-serine deaminase 
3241 SL3213 tdcE -2,67232 -1,6187 pyruvate formate-lyase 4/2-ketobutyrate formate-lyase 
3577 SL3542 tcp -8,57565 -8,41645 
 methyl-accepting transmembrane citrate/phenol 
chemoreceptor 
3578 SL3543 yhhP -3,28923 -3,91009 cell developmental protein SirA 
3611 SL3576 yhjH -6,16238 -6,69775 EAL domain-containing protein 
OTHERS 
1301 SL1236 
 
-2,67513 -2,89511 
 
1328 SL1263 
 
-6,18503 -5,68145 
 
1330 SL1265 
 
-2,2161 -1,42279 
 
 
SL1501 
 
-2,01195 -1,10347 
 
1596 SL1527 ydcX -2,25657 -1,78552 putative inner membrane protein 
1629 SL1559 steB -3,45928 -2,85784 
 
1798 SL1726 ycgR -6,24285 -6,25779 putative inner membrane protein 
1934 SL1867 
 
-2,27948 -2,08313 
 
1915 SL1879 sliA -2,62839 -2,6717 
 
1967 SL1896 
 
-2,22395 -1,96412 
 
2314 SL2283 
 
-7,64248 -7,17453 
 
2879 SL2859 sipP -3,56567 -3,63951 
 
2881 SL2860 iacP -6,58496 -6,92133 
 
3112 SL3112 
 
-6,15379 -6,18479 
 
3151 SL3125 yghW -2,84758 -2,29981 putative cytoplasmic protein 
3152 SL3126 
 
-5,78976 -5,54493 
 
3154 SL3128 
 
-3,41389 -2,63399 
 
3155 SL3129 
 
-2,94511 -3,59618 
 
3156 SL3130 
 
-3,87149 -4,01726 
 
3216 SL3189 
 
-8,24609 -8,31326 
 
3604 SL3569 
 
-3,16878 -2,62134 
 
4263 SL4199 yjcB -2,02875 -1,72748 putative inner membrane protein 
4310 SL4247 
 
-2,93994 -2,68906 
 
4312 SL4248 
 
-3,24214 -3,42733 
 
4313 SL4249 
 
-4,27317 -4,01976 
 
4314 SL4250 
 
-4,38762 -3,91761 rtsB 
 
SL4251 
 
-5,67293 -5,46996 
 
 
SL4464 
 
-6,92337 -7,12987 
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Table SM. 2 ChIP-seq results 
S. enterica Peak start Peak end Map position Gene description Strand 
StdE binding peaks 
SL1344 133850 133999 133829 133915 WP_001575587.1_leu_operon_leader_peptide - 
SL1344 139700 140049 139950 140408 WP_000488294.1_transcriptional_regulator_MraZ + 
SL1344 174750 175049 173384 174754 WP_000378215.1_aromatic_amino_acid_transporter - 
SL1344 216850 217049 217026 217730 WP_000899412.1_sugar_fermentation_stimulation_protein_A - 
SL1344 223500 223799 223735 225924 WP_000113220.1_ferrichrome_outer_membrane_transporter + 
SL1344 242800 243049 242841 244358 WP_000146443.1_deoxyguanosinetriphosphate_triphosphohydrolase + 
SL1344 247700 247849 247314 247700 WP_000272193.1_hypothetical_protein - 
SL1344 250050 250249 250139 252811 WP_001094519.1_uridylyltransferase - 
SL1344 259000 259099 257842 259038 WP_000811905.1_1-deoxy-D-xylulose_5-phosphate_reductoisomerase + 
SL1344 265850 265949 265401 266426 WP_001139265.1_UDP-3-O-(3-hydroxymyristoyl)glucosamine_N-acyltransferase_lpxD + 
SL1344 288800 289099 288235 288801 WP_001051726.1_D-glycero-beta-D-manno-heptose-1,7-bisphosphate_7-phosphatase + 
SL1344 304200 304299 304258 304334 tRNA-Asp_tRNA-Asp + 
SL1344 368100 368299 368274 368349 tRNA-Thr_tRNA-Thr + 
SL1344 386200 386549 385794 386294 WP_001539242.1_hypothetical_protein + 
SL1344 403400 403699 402817 404775 WP_000910371.1_type_III_restriction-modification_system_StyLTI_enzyme_mod + 
SL1344 413700 413849 412167 414257 WP_001526309.1_ferrioxamine_B_receptor + 
SL1344 414850 415049 414298 414930 WP_000433131.1_transporter - 
SL1344 434800 435099 435083 436294 WP_000446768.1_permease + 
SL1344 454400 454499 454138 455508 WP_001555879.1_proline-specific_permease_ProY_proY + 
SL1344 461150 461549 461457 461789 WP_000007628.1_preprotein_translocase_subunit_YajC_yajC + 
SL1344 498400 498499 498086 499561 WP_000098481.1_AmpG_family_muropeptide_MFS_transporter_ampG - 
SL1344 507800 508149 507591 507863 WP_001043544.1_DNA-binding_protein_HU-beta + 
SL1344 527350 527649 527619 527837 WP_001280991.1_hemolysin_expression-modulating_protein_Hha - 
  
SL1344 531750 532149 531907 533100 WP_001039202.1_MexE_family_multidrug_efflux_RND_transporter_periplasmic_adaptor_subunit - 
SL1344 555350 555649 555572 556366 WP_000421859.1_hypothetical_protein - 
SL1344 643500 643649 643490 644704 WP_000656600.1_enterobactin/ferric_enterobactin_esterase + 
SL1344 660450 660699 660167 660580 WP_000637965.1_proofreading_thioesterase_EntH + 
SL1344 677300 677499 676860 677288 WP_000278499.1_universal_stress_protein_G - 
SL1344 677300 677499 677511 678749 WP_000646113.1_dehydrogenase + 
SL1344 692200 692549 692403 692612 WP_000034826.1_cold-shock_protein + 
SL1344 701350 701699 701433 703334 WP_000828700.1_penicillin-binding_protein_2 - 
SL1344 725850 726049 726021 726746 WP_000631369.1_glutamate/aspartate_ABC_transporter_ATP-binding_protein_artP - 
SL1344 738000 738349 738051 738127 tRNA-Met_tRNA-Met - 
SL1344 749000 749149 748945 750351 WP_001258803.1_chitoporin_chiP + 
SL1344 749800 749999 748945 750351 WP_001258803.1_chitoporin_chiP + 
SL1344 765400 765699 765386 765499 WP_000862019.1_hypothetical_protein + 
SL1344 768550 769049 766424 769108 WP_000997487.1_two-component_system_sensor_histidine_kinase_KdpD - 
SL1344 797050 797199 796608 796994 WP_010988982.1_membrane_protein + 
SL1344 808350 808449 808940 810508 WP_000884369.1_cytochrome_BD_oxidase_subunit_I + 
SL1344 822850 823049 823028 824080 WP_001109234.1_phospho-2-dehydro-3-deoxyheptonate_aldolase + 
SL1344 827300 827549 826600 827526 WP_001538325.1_LysR_family_transcriptional_regulator - 
SL1344 847500 847749 847453 848271 WP_000127031.1_pyridoxal_phosphate_phosphatase - 
SL1344 865300 865499 863688 865709 WP_000042502.1_UvrABC_system_protein_B + 
SL1344 869650 870049 869893 870882 WP_000168180.1_cyclic_pyranopterin_monophosphate_synthase_moaA + 
SL1344 878400 878599 878496 878906 WP_000871970.1_membrane_protein + 
SL1344 904200 904299 904297 905889 WP_000961478.1_heme_ABC_transporter_ATP-binding_protein + 
SL1344 913600 913999 913046 913945 WP_000576947.1_pyruvate_formate_lyase_activating_enzyme - 
SL1344 964050 964299 964160 965593 WP_000069000.1_hypothetical_protein - 
SL1344 965450 965599 964160 965593 WP_000069000.1_hypothetical_protein - 
SL1344 974900 975099 974052 975002 WP_001519667.1_virulence_protein_VirK - 
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SL1344 978650 978849 978884 979204 WP_000520789.1_ATP-dependent_Clp_protease_adapter_protein_ClpS_clpS + 
SL1344 1017750 1018049 1018042 1019130 WP_000079584.1_phosphoserine_aminotransferase + 
SL1344 1022000 1022349 1021561 1022244 WP_000125006.1_cytidylate_kinase_cmk + 
SL1344 1043350 1043449 1041587 1043428 WP_000925872.1_murein_transpeptidase + 
SL1344 1043850 1044099 1043688 1044236 WP_000357052.1_outer_membrane_protein + 
SL1344 1050000 1050299 1050105 1050338 WP_000301921.1_hypothetical_protein - 
SL1344 1068800 1069049 1068940 1069257 WP_010989004.1_hypothetical_protein + 
SL1344 1086800 1087199 1086605 1087138 WP_000877926.1_Superoxide_dismutase_[Cu-Zn]_1 - 
SL1344 1089650 1090049 1089344 1092694 WP_000033415.1_host_specificity_protein_J + 
SL1344 1110650 1110749 1110249 1111502 WP_000333148.1_paraquat-inducible_protein_A + 
SL1344 1113800 1113899 1113963 1114130 WP_001537784.1_ribosome_modulation_factor + 
SL1344 1115900 1116199 1114817 1116577 WP_000156453.1_lon_protease - 
SL1344 1131500 1131799 1131644 1131731 tRNA-Ser_tRNA-Ser + 
SL1344 1158750 1159049 1158770 1159393 WP_000876693.1_DSBA_oxidoreductase + 
SL1344 1167950 1168199 1163919 1167881 WP_000537528.1_bifunctional_protein_PutA_putA - 
SL1344 1183450 1183699 1183644 1184126 WP_001546652.1_membrane_protein + 
SL1344 1192350 1192599 1192541 1194094 WP_000681121.1_glucan_biosynthesis_protein_D_mdoG + 
SL1344 1262600 1262749 1261987 1262898 WP_000291338.1_N-acetyl-D-glucosamine_kinase + 
SL1344 1289850 1290099 1290067 1290143 tRNA-Arg_tRNA-Arg + 
SL1344 1306350 1306599 1306474 1306623 WP_000908464.1_hypothetical_protein - 
SL1344 1309700 1310099 1309991 1310239 WP_000512149.1_membrane_protein + 
SL1344 1326600 1326849 1326883 1327296 WP_001519539.1_peptide_methionine_sulfoxide_reductase_MsrB + 
SL1344 1383250 1383449 1382251 1383297 WP_001082196.1_phospho-2-dehydro-3-deoxyheptonate_aldolase_Trp-sensitive - 
SL1344 1399850 1400149 1399804 1401015 WP_000797677.1_transporter - 
SL1344 1482900 1483049 1482592 1483197 WP_000765727.1_glutathionine_S-transferase - 
SL1344 1491950 1492249 1491858 1492298 WP_000214061.1_membrane_protein - 
SL1344 1510850 1511099 1511078 1512022 WP_000769294.1_hypothetical_protein - 
  
SL1344 1544700 1544849 1544840 1545526 WP_000215563.1_hypothetical_protein - 
SL1344 1550600 1550949 1550924 1551019 WP_000901531.1_membrane_protein - 
SL1344 1556950 1557099 1557061 1557933 WP_000366538.1_LysR_family_transcriptional_regulator - 
SL1344 1589900 1590099 1588983 1589990 WP_000201080.1_transcriptional_regulator + 
SL1344 1611850 1612099 1612026 1613114 WP_000769035.1_porin + 
SL1344 1615100 1615599 1615267 1615845 WP_000121043.1_TetR_family_transcriptional_regulator + 
SL1344 1637850 1638049 1637948 1640929 WP_000960833.1_virulence_factor_SrfB + 
SL1344 1643250 1643599 1643115 1643288 WP_000171943.1_hypothetical_protein - 
SL1344 1658450 1658649 1658651 1659769 WP_000144617.1_aminopeptidase + 
SL1344 1706800 1706949 1707001 1707984 WP_000387373.1_zinc_transporter_ZntB_zntB - 
SL1344 1725400 1725549 1724854 1725567 WP_000171963.1_oxidoreductase + 
SL1344 1736100 1736199 1735781 1737178 WP_000825847.1_ATPase - 
SL1344 1743250 1743549 1743130 1744020 WP_001146150.1_peptide_ABC_transporter_permease + 
SL1344 1749900 1750149 1749977 1751110 WP_000434197.1_hypothetical_protein + 
SL1344 1759850 1759999 1759544 1759852 WP_000876301.1_membrane_protein - 
SL1344 1764650 1764949 1764839 1764967 WP_001138871.1_hypothetical_protein - 
SL1344 1802000 1802349 1799981 1802659 WP_000301678.1_acetaldehyde_dehydrogenase + 
SL1344 1803850 1804049 1804136 1804549 WP_001287383.1_DNA-binding_protein_H-NS + 
SL1344 1834000 1834299 1833497 1834348 WP_000988246.1_4-diphosphocytidyl-2-C-methyl-D-erythritol_kinase + 
SL1344 1837200 1837349 1835686 1837371 WP_001037181.1_transporter + 
SL1344 1837600 1837799 1837416 1837694 WP_000823878.1_membrane_protein - 
SL1344 1863400 1863649 1862742 1863461 WP_000234826.1_fatty_acid_metabolism_regulator_protein - 
SL1344 1893350 1893799 1893337 1893480 WP_001537930.1_hypothetical_protein - 
SL1344 1894500 1894749 1894487 1894630 WP_000714547.1_PhoP_family_transcriptional_regulator - 
SL1344 1901600 1901899 1901554 1902051 WP_001518229.1_GAF_domain_protein - 
SL1344 1930600 1930799 1929373 1931424 WP_000936999.1_protease - 
SL1344 1935150 1935399 1935189 1937000 WP_001069113.1_phosphogluconate_dehydratase - 
Supplementary Data 
167 
SL1344 1979550 1980099 1979284 1979625 WP_001518146.1_flagellar_transcriptional_regulator_FlhD - 
SL1344 1980200 1980549 1980421 1980849 WP_000122606.1_universal_stress_protein_C + 
SL1344 1983000 1983399 1982263 1983066 WP_000830110.1_trehalose-phosphate_phosphatase - 
SL1344 2034450 2034599 2034188 2034454 WP_001521850.1_membrane_protein - 
SL1344 2039600 2039849 2039277 2039438 WP_000500831.1_hypothetical_protein - 
SL1344 2059350 2059549 2058604 2060337 WP_000088182.1_terminase - 
SL1344 2064750 2064899 2064878 2065501 WP_000188927.1_hypothetical_protein - 
SL1344 2133550 2133799 2133740 2134912 WP_000925042.1_D-alanyl-D-alanine_carboxypeptidase - 
SL1344 2134850 2135149 2135036 2135800 WP_001092547.1_thiosulfate_reductase_cytochrome_B - 
SL1344 2139050 2139249 2139285 2141633 WP_000703998.1_E3_ubiquitin--protein_ligase + 
SL1344 2147100 2147249 2147330 2148229 WP_000886607.1_ATP_phosphoribosyltransferase_hisG + 
SL1344 2153950 2154199 2153855 2154466 WP_000954848.1_histidine_biosynthesis_bifunctional_protein_HisIE + 
SL1344 2155300 2155399 2154547 2155530 WP_000215261.1_chain_length_determinant_protein - 
SL1344 2177050 2177299 2176672 2177565 WP_000981469.1_UTP--glucose-1-phosphate_uridylyltransferase - 
SL1344 2198800 2198949 2198772 2199221 WP_000482224.1_protein-tyrosine_phosphatase - 
SL1344 2211500 2211749 2210207 2211559 WP_000469629.1_chaperone + 
SL1344 2234750 2234899 2233987 2235258 WP_000858692.1_nucleoside_permease + 
SL1344 2255700 2255849 2255678 2256625 WP_000569166.1_ABC_transporter_ATP-binding_protein - 
SL1344 2264450 2264699 2264354 2264941 WP_001017057.1_transporter - 
SL1344 2266300 2266599 2266545 2267981 WP_001081453.1_lipoprotein - 
SL1344 2276650 2276949 2276882 2277766 WP_000553526.1_cytidine_deaminase + 
SL1344 2286900 2287149 2287003 2288145 WP_001526153.1_membrane_protein - 
SL1344 2289600 2289699 2289158 2290015 WP_000425488.1_S-formylglutathione_hydrolase + 
SL1344 2305050 2305299 2303940 2305070 WP_000487287.1_multiphosphoryl_transfer_protein - 
SL1344 2311150 2311399 2311374 2311946 WP_000241015.1_membrane_protein_spr + 
SL1344 2317850 2318149 2317871 2319460 WP_000203622.1_microcin_C_ABC_transporter_ATP-binding_protein_YejF + 
SL1344 2332500 2332899 2332550 2333077 WP_001215679.1_tail_protein - 
  
SL1344 2357000 2357449 2356870 2357361 WP_000228070.1_ferredoxin - 
SL1344 2373950 2374199 2371427 2374063 WP_001281271.1_DNA_gyrase_subunit_A - 
SL1344 2384150 2384299 2384252 2385130 WP_000176719.1_LysR_family_transcriptional_regulator + 
SL1344 2387600 2388149 2387952 2389580 WP_000857292.1_sn-glycerol-3-phosphate_dehydrogenase_subunit_A_glpA + 
SL1344 2406000 2406249 2405788 2406687 WP_000169761.1_4-deoxy-4-formamido-L-arabinose-phosphoundecaprenol_deformylase_ArnD + 
SL1344 2437500 2437749 2437609 2437761 WP_001522276.1_hypothetical_protein - 
SL1344 2445400 2445499 2444860 2445315 WP_000106617.1_membrane_protein - 
SL1344 2450350 2450599 2449296 2450816 WP_000117932.1_hypothetical_protein + 
SL1344 2475150 2475449 2475070 2476338 WP_000792275.1_bifunctional_folylpolyglutamate_synthase/_dihydrofolate_synthase - 
SL1344 2499800 2499949 2499456 2499740 WP_000030904.1_hypothetical_protein - 
SL1344 2508800 2509249 2508217 2509491 WP_031602386.1_ABC_transporter_substrate-binding_protein - 
SL1344 2509400 2509649 2509454 2509672 WP_000279836.1_hypothetical_protein - 
SL1344 2522750 2523149 2523019 2524221 WP_000376347.1_nucleoside_permease + 
SL1344 2526750 2526999 2526772 2526847 tRNA-Ala_tRNA-Ala - 
SL1344 2539750 2539899 2538804 2539790 WP_000983110.1_cell_division_protein_ZipA - 
SL1344 2541850 2542099 2542037 2542162 WP_000718558.1_hypothetical_protein - 
SL1344 2582450 2582599 2581216 2583216 WP_000087323.1_transketolase + 
SL1344 2595600 2595999 2595410 2596537 WP_001277825.1_succinyl-diaminopimelate_desuccinylase + 
SL1344 2602550 2602799 2602783 2603355 WP_000189061.1_glycine_cleavage_system_transcriptional_regulator_gcvR + 
SL1344 2610200 2610399 2609749 2610375 WP_000706208.1_uracil_phosphoribosyltransferase_upp - 
SL1344 2618650 2618949 2618927 2619118 WP_000075924.1_hypothetical_protein + 
SL1344 2623600 2623899 2623795 2625144 WP_000953165.1_exodeoxyribonuclease_7_large_subunit_xseA + 
SL1344 2647300 2647549 2646325 2648517 WP_000252220.1_intimin - 
SL1344 2661250 2661649 2660629 2663007 WP_001521637.1_DMSO_reductase_subunit_A - 
SL1344 2681950 2682149 2681302 2682033 WP_000940032.1_tRNA_(cytidine/uridine-2'-O-)-methyltransferase_TrmJ - 
SL1344 2705350 2705599 2703891 2705276 WP_001542313.1_two-component_system_sensor_histidine_kinase - 
SL1344 2706400 2706499 2705971 2709858 WP_000970045.1_phosphoribosylformylglycinamidine_synthase - 
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SL1344 2718850 2719049 2718443 2719369 WP_001022463.1_LysR_family_transcriptional_regulator + 
SL1344 2759600 2759849 2759753 2760316 WP_000211410.1_antirepressor - 
SL1344 2760450 2760599 2760589 2761266 WP_001097241.1_antitermination_protein - 
SL1344 2762700 2762799 2762220 2762822 WP_000929790.1_hypothetical_protein - 
SL1344 2768350 2768599 2768366 2768833 WP_000169863.1_regulator + 
SL1344 2790150 2790349 2790293 2792953 WP_000082639.1_protein_lysine_acetyltransferase_Pat + 
SL1344 2792900 2793049 2790293 2792953 WP_000082639.1_protein_lysine_acetyltransferase_Pat + 
SL1344 2802200 2802649 2802529 2805102 WP_001235094.1_chaperone_protein_ClpB - 
SL1344 2807750 2808149 2808081 2808419 WP_000178449.1_translation_inhibitor_protein_RaiA + 
SL1344 2821400 2821649 2820345 2822183 partial;pseudo_partial;pseudo + 
SL1344 2838150 2838249 2837672 2838154 WP_001518569.1_SsrA-binding_protein_smpB + 
SL1344 2855100 2855499 2853874 2855064 WP_000700669.1_secretion_protein_HlyD + 
SL1344 2887950 2888199 2887497 2888522 WP_000155500.1_recombinase + 
SL1344 2935050 2935349 2935199 2935738 WP_000388997.1_repressor_of_phase_1_flagellin_gene - 
SL1344 2956900 2957049 2956337 2957011 WP_001237934.1_two-component_system_response_regulator - 
SL1344 2973900 2974099 2973730 2974161 WP_000209813.1_alkylhydroperoxidase + 
SL1344 3041050 3041249 3040412 3041341 WP_000432699.1_transcriptional_regulator_hilD + 
SL1344 3050450 3050599 3050433 3051662 WP_000909019.1_cell_invasion_protein_SipC - 
SL1344 3084250 3084549 3084385 3085149 WP_000613185.1_DeoR_family_transcriptional_regulator + 
SL1344 3089450 3090199 3089110 3090243 WP_001272632.1_murein_hydrolase_activator_NlpD_nlpD - 
SL1344 3137150 3137399 3137007 3137789 WP_000890027.1_tRNA_pseudouridine_synthase_C - 
SL1344 3138100 3138599 3138274 3138486 WP_000988723.1_hypothetical_protein - 
SL1344 3139050 3139149 3138730 3139275 WP_000343990.1_protein_Syd - 
SL1344 3156400 3156949 3155734 3156651 WP_000044409.1_transcriptional_regulator - 
SL1344 3162300 3162549 3161221 3162318 WP_000678626.1_murein_transglycosylase_mltA - 
SL1344 3166600 3166799 3165738 3167573 WP_000155129.1_exonuclease_V_subunit_alpha_recD - 
SL1344 3181050 3181199 3180280 3181155 WP_000204645.1_prolipoprotein_diacylglyceryl_transferase - 
  
SL1344 3184300 3184549 3184511 3184657 WP_001752593.1_hypothetical_protein - 
SL1344 3205500 3205949 3205639 3206475 WP_000503692.1_cobalt_transporter              yohM + 
SL1344 3215550 3215899 3215876 3216274 WP_000911336.1_tRNA(fMet)-specific_endonuclease_VapC - 
SL1344 3242700 3243149 3243022 3243618 WP_001520956.1_5-formyltetrahydrofolate_cyclo-ligase + 
SL1344 3243550 3243799 3243022 3243618 WP_001520956.1_5-formyltetrahydrofolate_cyclo-ligase + 
SL1344 3247250 3247349 3247215 3247466 WP_001112716.1_hypothetical_protein + 
SL1344 3253650 3253949 3252597 3253643 WP_000218338.1_D-erythrose-4-phosphate_dehydrogenase_gapA - 
SL1344 3259700 3260099 3259380 3260138 WP_000701830.1_metalloprotease + 
SL1344 3267550 3267699 3267369 3267485 WP_001738517.1_racemase + 
SL1344 3291950 3292099 3290856 3291941 WP_000976289.1_murein_transglycosylase_mltC + 
SL1344 3330950 3331099 3329490 3331193 WP_000083044.1_hydrogenase_2_large_subunit - 
SL1344 3341350 3341549 3341439 3341576 WP_001518378.1_membrane_protein - 
SL1344 3350700 3350999 3349642 3351813 WP_001274458.1_radical_SAM_protein - 
SL1344 3383000 3383299 3383264 3384697 WP_000867682.1_bifunctional_protein_HldE - 
SL1344 3385050 3385499 3384745 3387588 WP_000188309.1_glutamate--ammonia-ligase_adenylyltransferase - 
SL1344 3394450 3394849 3394760 3394975 WP_001144069.1_30S_ribosomal_protein_S21_rpsU + 
SL1344 3399500 3399849 3399709 3399784 tRNA-Met_tRNA-Met + 
SL1344 3409000 3409249 3409059 3410195 WP_000019989.1_ribosomal_RNA_large_subunit_methyltransferase_G - 
SL1344 3424950 3425049 3424056 3425387 WP_000443187.1_membrane_protein - 
SL1344 3434600 3434749 3433178 3434116 WP_001094910.1_transcriptional_regulator - 
SL1344 3435800 3435999 3435915 3437060 WP_000706459.1_glycerate_kinase - 
SL1344 3443000 3443149 3442143 3442976 WP_001118363.1_DeoR_family_transcriptional_regulator - 
SL1344 3447250 3447649 3447534 3448805 WP_000658628.1_tagatose-1,6-bisphosphate_aldolase + 
SL1344 3452000 3452249 3452174 3452947 WP_001083896.1_galactitol_utilization_operon_repressor + 
SL1344 3468800 3469049 3468958 3469842 WP_000802069.1_lipoprotein_NlpI - 
SL1344 3469200 3469749 3468958 3469842 WP_000802069.1_lipoprotein_NlpI - 
SL1344 3479100 3479549 3479208 3479284 tRNA-Met_tRNA-Met - 
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SL1344 3511700 3511949 3511909 3514245 WP_000809815.1_aerobic_respiration_control_sensor_protein_ArcB - 
SL1344 3515550 3515699 3515802 3516017 WP_001546060.1_hypothetical_protein - 
SL1344 3522550 3522749 3522035 3523138 WP_000184315.1_hypothetical_protein + 
SL1344 3530400 3530699 3530564 3531355 WP_000382926.1_transcriptional_regulator_NanR - 
SL1344 3532700 3532849 3532871 3533665 WP_000505557.1_hypothetical_protein - 
SL1344 3550150 3550299 3550283 3550546 WP_000695693.1_outer_membrane_protein + 
SL1344 3578500 3578649 3578064 3578948 WP_000642611.1_methyltransferase + 
SL1344 3593550 3593749 3593756 3593947 WP_016696011.1_hypothetical_protein - 
SL1344 3597750 3598299 3597162 3598286 WP_000124529.1_hypothetical_protein - 
SL1344 3618000 3618349 3617701 3618012 WP_001181005.1_30S_ribosomal_protein_S10_rpsJ - 
SL1344 3636800 3637099 3636416 3636820 WP_001148919.1_hypothetical_protein - 
SL1344 3643350 3643549 3643554 3644735 WP_000185211.1_protein_TsgA + 
SL1344 3664250 3664549 3663746 3664267 WP_000818621.1_shikimate_kinase_aroK - 
SL1344 3671300 3671549 3670820 3671383 WP_000045725.1_adenosine_nucleotide_hydrolase_nudE - 
SL1344 3677700 3678099 3678085 3679704 WP_001265689.1_phosphoenolpyruvate_carboxykinase_[ATP] + 
SL1344 3685200 3685499 3685412 3685639 WP_001160955.1_ferrous_iron_transporter_A_feoA + 
SL1344 3698350 3698449 3698422 3701127 WP_000907029.1_transcriptional_regulator + 
SL1344 3714950 3715149 3713815 3714924 WP_000258838.1_glycerol_dehydrogenase_gldA - 
SL1344 3736700 3736949 3736939 3737427 WP_001290288.1_acetyltransferase + 
SL1344 3749800 3749949 3749623 3749844 WP_001520924.1_prevent-host-death_family_protein - 
SL1344 3758050 3758399 3758349 3759404 WP_001081707.1_cell_division_protein_FtsX_ftsX - 
SL1344 3796650 3796899 3796899 3798548 WP_000934257.1_trehalase_treF + 
SL1344 3804050 3804349 3802998 3804026 WP_000191231.1_membrane_protein + 
SL1344 3829450 3829799 3829506 3829613 WP_001669334.1_hypothetical_protein - 
SL1344 3837250 3837499 3835747 3837354 WP_000028047.1_peptide_ABC_transporter_substrate-binding_protein - 
SL1344 3841750 3841949 3841901 3843592 WP_001269259.1_phosphoethanolamine_transferase_EptB - 
SL1344 3857550 3857749 3857754 3857966 WP_000014594.1_cold-shock_protein + 
  
SL1344 3871550 3871749 3871475 3871846 WP_000254414.1_hypothetical_protein + 
SL1344 3896100 3896599 3896582 3898498 WP_000093287.1_PTS_mannitol_transporter_subunit_IIABC + 
SL1344 3902950 3903399 3902543 3906928 WP_001079584.1_membrane_protein + 
SL1344 3912600 3912799 3912770 3913966 WP_001218249.1_L-talarate/galactarate_dehydratase + 
SL1344 3921900 3922099 3921719 3922681 WP_001135518.1_hypothetical_protein + 
SL1344 3945900 3946299 3946033 3946491 WP_000976078.1_deoxyuridine_5'-triphosphate_nucleotidohydrolase + 
SL1344 3951700 3951949 3951856 3952473 WP_000924334.1_membrane_protein + 
SL1344 3957300 3957549 3957500 3958189 WP_001068438.1_tRNA_methyltransferase + 
SL1344 3999850 4000099 3998699 3999891 pseudo;old_locus_tag=SL1344_3741_pseudo;old_locus_tag=SL1344_3741_nepI - 
SL1344 4006550 4006699 4005752 4006495 WP_000854956.1_GntR_family_transcriptional_regulator - 
SL1344 4019000 4019399 4019024 4019122 WP_001541152.1_ilvB_operon_leader_peptide - 
SL1344 4045350 4045949 4044666 4045850 WP_001230254.1_trimethylamine_N-oxide_reductase_cytochrome_C_subunit - 
SL1344 4058750 4058949 4057949 4059139 WP_000705615.1_MR-MLE_family_protein + 
SL1344 4066700 4066999 4066999 4067139 WP_000831330.1_50S_ribosomal_protein_L34_rpmH + 
SL1344 4072450 4072549 4071657 4072364 WP_001738600.1_recombinase + 
SL1344 4101950 4102249 4101487 4101867 WP_000116685.1_F0F1_ATP_synthase_subunit_I - 
SL1344 4126700 4126949 4126913 4126988 tRNA-Trp_tRNA-Trp + 
SL1344 4127900 4128049 4128045 4128383 WP_000840996.1_hypothetical_protein  hdfR + 
SL1344 4130150 4130449 4130280 4130378 WP_001311244.1_IlvGMEDA_operon_leader_peptide + 
SL1344 4146700 4147149 4147129 4148388 WP_001054532.1_transcription_termination_factor_Rho_rho + 
SL1344 4167700 4167899 4167912 4170458 WP_000281718.1_adenylate_cyclase_cyaA + 
SL1344 4196200 4196449 4196409 4197170 WP_000045169.1_uridine_phosphorylase + 
SL1344 4227150 4227549 4226273 4227181 WP_000196890.1_acyltransferase - 
SL1344 4230250 4230499 4227569 4230355 WP_000249972.1_DNA_polymerase_I + 
SL1344 4231650 4231799 4231562 4231786 WP_001541209.1_hypothetical_protein + 
SL1344 4238550 4238899 4238822 4240645 WP_000572067.1_GTP-binding_protein + 
SL1344 4244000 4244249 4243537 4244412 WP_000282794.1_membrane_protein - 
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SL1344 4252950 4253299 4253044 4254285 WP_000870946.1_sulfoquinovose_isomerase - 
SL1344 4280300 4280449 4280503 4281339 WP_000217112.1_transcriptional_activator_RhaS + 
SL1344 4283500 4283849 4283840 4283965 WP_000183584.1_hypothetical_protein + 
SL1344 4284700 4284999 4284831 4286138 WP_000566800.1_membrane_protein - 
SL1344 4321150 4321249 4320588 4321919 WP_001293360.1_ATP-dependent_protease_ATPase_subunit_HslU_hslU - 
SL1344 4348350 4348749 4348739 4349818 WP_000661597.1_PTS_fructose_transporter_subunit_IIC + 
SL1344 4381250 4381449 4381377 4381452 tRNA-Thr_tRNA-Thr + 
SL1344 4384150 4384499 4384436 4384864 WP_001085926.1_50S_ribosomal_protein_L11 + 
SL1344 4385450 4385699 4384868 4385572 WP_001096676.1_50S_ribosomal_protein_L1 + 
SL1344 4407800 4408099 4407263 4407853 WP_000940092.1_hypothetical_protein + 
SL1344 4415600 4415949 4416006 4417559 16S_ribosomal_RNA_16S_ribosomal_RNA + 
SL1344 4471800 4472149 4470620 4471810 WP_000695417.1_maltose-binding_periplasmic_protein_malE - 
SL1344 4479250 4479499 4477472 4479892 WP_000017359.1_glycerol-3-phosphate_acyltransferase - 
SL1344 4497400 4497549 4497295 4497411 WP_001600633.1_hypothetical_protein + 
SL1344 4523150 4523349 4522829 4523110 WP_000719058.1_membrane_protein - 
SL1344 4524150 4524299 4523673 4525274 WP_000083640.1_hypothetical_protein + 
SL1344 4537050 4537149 4537151 4537297 WP_001576543.1_entericidin_B_precursor + 
SL1344 4544800 4545049 4544308 4545618 WP_000793278.1_proton_glutamate_symport_protein + 
SL1344 4569700 4569899 4569886 4570152 WP_010989095.1_hypothetical_protein - 
SL1344 4572450 4572599 4571185 4572816 WP_000682911.1_sensor_histidine_kinase - 
SL1344 4587200 4587299 4587160 4587235 tRNA-Phe_tRNA-Phe - 
SL1344 4593000 4593299 4592995 4593117 WP_000614819.1_hypothetical_protein - 
SL1344 4594850 4595199 4593838 4595079 WP_001670701.1_transporter - 
SL1344 4639450 4639599 4638946 4640109 WP_000943932.1_glutathionylspermidine_synthase + 
SL1344 4642300 4642699 4642267 4642596 WP_000586836.1_transporter - 
SL1344 4650900 4651049 4650793 4651023 WP_001621821.1_hypothetical_protein + 
SL1344 4651600 4651699 4651496 4651810 WP_001519453.1_primosomal_replication_protein_n + 
  
SL1344 4655150 4655299 4654512 4655132 WP_000235161.1_peptidyl-prolyl_cis-trans_isomerase + 
SL1344 4704200 4704499 4703860 4704246 WP_001232231.1_soluble_cytochrome_b562 + 
SL1344 4719850 4720149 4718940 4719887 WP_001181297.1_transcriptional_regulator_treR - 
SL1344 4749550 4749649 4748546 4749577 WP_000453340.1_L-idonate_5-dehydrogenase - 
SL1344 4776350 4776599 4776160 4776417 WP_001054380.1_hypothetical_protein - 
SL1344 4810450 4810599 4810665 4812326 WP_000919519.1_methyl-accepting_chemotaxis_protein + 
SL1344 4836200 4836449 4836462 4837079 WP_000178963.1_hypothetical_protein + 
SL1344 4838900 4839199 4838563 4839336 WP_000119016.1_deoxyribonuclease + 
SL1344 4841750 4841999 4840204 4841751 WP_001111692.1_hypothetical_protein - 
pSLT 29800 30149 29946 30512 WP_000399768.1_conjugal_transfer_protein_TraE - 
pSLT 46500 46649 46488 47762 WP_000457541.1_DNA_polymerase_V_subunit_UmuC + 
pSLT 47150 47599 46488 47762 WP_000457541.1_DNA_polymerase_V_subunit_UmuC + 
pSLT 78150 78349 78078 78459 pseudo_pseudo - 
pSLT 91950 92149 91997 92164 WP_001691570.1_DNA_replication_protein - 
pCol1B9 200 549 455 1486 WP_000907875.1_replication_initiation_protein_PK-repZ + 
pCol1B9 1350 1599 455 1486 WP_000907875.1_replication_initiation_protein_PK-repZ + 
pCol1B9 8000 8199 6669 8015 WP_001132021.1_hypothetical_protein + 
pCol1B9 30000 30249 30112 30366 WP_000774889.1_hypothetical_protein - 
pCol1B9 33800 33949 33969 34301 WP_001281051.1_hypothetical_protein + 
pCol1B9 65800 65949 66007 66591 WP_000977522.1_conjugal_transfer_protein_TraG - 
pCol1B9 86250 86649 85922 86158 WP_000483804.1_conjugal_transfer_protein_TraA - 
pRSF1010 5350 5649 3338 5467 WP_001395566.1_mobilization_protein_A - 
pRSF1010 7200 7449 7015 7851 WP_000480968.1_aminoglycoside_phosphotransferase_APH(6)-I - 
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SL1344 23050 23349 23335 24039 WP_000738617.1_hypothetical_protein + 
SL1344 33800 33999 33364 34368 WP_001247395.1_LysR_family_transcriptional_regulator + 
SL1344 256950 257199 257144 257701 WP_000622423.1_ribosome-recycling_factor_frr + 
SL1344 288850 289049 288235 288801 WP_001051726.1_D-glycero-beta-D-manno-heptose-1,7-bisphosphate_7-phosphatase + 
SL1344 386250 386399 385794 386294 WP_001539242.1_hypothetical_protein + 
SL1344 388200 388349 388268 389011 WP_000081378.1_transcriptional_regulator + 
SL1344 492150 492299 491265 492758 WP_000595924.1_hypothetical_protein + 
SL1344 531400 531499 528735 531884 WP_001132508.1_multidrug_efflux_RND_transporter_permease_subunit - 
SL1344 555450 555549 555572 556366 WP_000421859.1_hypothetical_protein - 
SL1344 692350 692549 692403 692612 WP_000034826.1_cold-shock_protein + 
SL1344 701400 701599 701433 703334 WP_000828700.1_penicillin-binding_protein_2 - 
SL1344 749450 749549 748945 750351 WP_001258803.1_chitoporin_chiP + 
SL1344 768650 769099 766424 769108 WP_000997487.1_two-component_system_sensor_histidine_kinase_KdpD - 
SL1344 792600 792699 791133 793082 WP_000367426.1_glycosyl_transferase + 
SL1344 822850 822999 823028 824080 WP_001109234.1_phospho-2-dehydro-3-deoxyheptonate_aldolase + 
SL1344 840250 840399 839835 840851 WP_001265465.1_UDP-glucose_4-epimerase - 
SL1344 847500 847699 847453 848271 WP_000127031.1_pyridoxal_phosphate_phosphatase - 
SL1344 855000 855149 854223 855908 WP_001115209.1_urocanate_hydratase + 
SL1344 873350 873549 873495 874202 WP_000529073.1_membrane_protein + 
SL1344 874500 874599 874235 874834 WP_000512322.1_membrane_protein + 
SL1344 898600 898799 898795 899310 WP_000716763.1_outer_membrane_protease_ompX + 
SL1344 913600 913999 913046 913945 WP_000576947.1_pyruvate_formate_lyase_activating_enzyme - 
SL1344 931500 931699 931284 932174 WP_000545327.1_LysR_family_transcriptional_regulator - 
SL1344 965500 965649 965604 966605 WP_000566344.1_threonine_aldolase - 
SL1344 974950 975049 974052 975002 WP_001519667.1_virulence_protein_VirK - 
  
SL1344 1033900 1034099 1033973 1034776 WP_001154025.1_S-adenosyl-L-methionine-dependent_methyltransferase + 
SL1344 1068750 1069049 1068940 1069257 WP_010989004.1_hypothetical_protein + 
SL1344 1086550 1086799 1086605 1087138 WP_000877926.1_Superoxide_dismutase_[Cu-Zn]_1 - 
SL1344 1089850 1089999 1089344 1092694 WP_000033415.1_host_specificity_protein_J + 
SL1344 1096850 1097199 1096293 1097261 WP_001533476.1_secreted_effector_protein_SseI + 
SL1344 1099650 1099949 1099845 1100036 WP_000497441.1_DNA-damage-inducible_protein_I - 
SL1344 1112600 1112749 1111507 1113147 WP_000433414.1_paraquat-inducible_protein_B + 
SL1344 1115900 1116099 1114817 1116577 WP_000156453.1_lon_protease - 
SL1344 1135700 1135949 1134553 1136238 WP_001166946.1_inositol_phosphate_phosphatase_SopB_sopB - 
SL1344 1172850 1172999 1172764 1174260 WP_000628082.1_acetylneuraminate_ABC_transporter - 
SL1344 1189450 1189799 1189629 1191116 WP_000976323.1_hypothetical_protein + 
SL1344 1270000 1270099 1269559 1270788 WP_000359410.1_peptidase_T + 
SL1344 1289850 1289999 1289672 1289843 pseudo_pseudo - 
SL1344 1290250 1290399 1290067 1290143 tRNA-Arg_tRNA-Arg + 
SL1344 1309800 1309999 1309991 1310239 WP_000512149.1_membrane_protein + 
SL1344 1368100 1368299 1366940 1368163 WP_000905564.1_O-antigen_polymerase - 
SL1344 1446800 1446949 1446884 1447132 WP_001574409.1_type_III_secretion_system_protein_SsaI + 
SL1344 1484900 1485149 1483302 1484807 WP_000100911.1_dipeptide_and_tripeptide_permease_A_tppB - 
SL1344 1550650 1551149 1550924 1551019 WP_000901531.1_membrane_protein - 
SL1344 1577150 1577299 1576636 1578126 WP_001519903.1_PhoPQ-regulated_protein - 
SL1344 1601700 1602049 1602034 1602249 WP_000495700.1_protein_bdm + 
SL1344 1649700 1649799 1649034 1649984 WP_001122927.1_secreted_effector_protein_SifB_sifB + 
SL1344 1665600 1665799 1664695 1665897 WP_000848076.1_L-lactate_oxidase - 
SL1344 1706800 1706999 1707001 1707984 WP_000387373.1_zinc_transporter_ZntB_zntB - 
SL1344 1734300 1734599 1733034 1734575 WP_001235493.1_transcriptional_regulator - 
SL1344 1764850 1765049 1764839 1764967 WP_001138871.1_hypothetical_protein - 
SL1344 1893400 1893699 1893337 1893480 WP_001537930.1_hypothetical_protein - 
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SL1344 1894500 1895149 1894788 1895027 WP_001236777.1_hypothetical_protein + 
SL1344 1902100 1902249 1902180 1903463 WP_001207294.1_membrane_protein + 
SL1344 1935050 1935299 1935189 1937000 WP_001069113.1_phosphogluconate_dehydratase - 
SL1344 1979600 1979999 1979284 1979625 WP_001518146.1_flagellar_transcriptional_regulator_FlhD - 
SL1344 1980500 1980699 1980421 1980849 WP_000122606.1_universal_stress_protein_C + 
SL1344 1983150 1983349 1983289 1983471 WP_000202368.1_sugar_ABC_transporter_permease - 
SL1344 1995500 1995599 1993986 1995818 WP_001289464.1_UvrABC_system_protein_C_uvrC - 
SL1344 2064750 2064949 2064878 2065501 WP_000188927.1_hypothetical_protein - 
SL1344 2072150 2072299 2072244 2072939 WP_001020636.1_transcriptional_regulator + 
SL1344 2079450 2079549 2078785 2079774 WP_000532847.1_integrase + 
SL1344 2140300 2140399 2139285 2141633 WP_000703998.1_E3_ubiquitin--protein_ligase + 
SL1344 2165100 2165549 2165334 2166335 WP_000908622.1_abequosyltransferase_RfbV - 
SL1344 2167550 2167749 2167714 2168613 WP_000143399.1_CDP-abequose_synthase - 
SL1344 2291900 2292149 2291982 2292869 WP_000022915.1_phosphoserine_phosphatase + 
SL1344 2292650 2292999 2292902 2294224 WP_000023807.1_hypothetical_protein + 
SL1344 2332500 2332899 2332550 2333077 WP_001215679.1_tail_protein - 
SL1344 2335700 2336049 2335540 2336871 WP_000894640.1_NTPase + 
SL1344 2336700 2336949 2336900 2337265 WP_001204799.1_antitermination_protein_Q - 
SL1344 2357100 2357399 2356870 2357361 WP_000228070.1_ferredoxin - 
SL1344 2388000 2388099 2387952 2389580 WP_000857292.1_sn-glycerol-3-phosphate_dehydrogenase_subunit_A_glpA + 
SL1344 2450350 2450449 2449296 2450816 WP_000117932.1_hypothetical_protein + 
SL1344 2508950 2509149 2508217 2509491 WP_031602386.1_ABC_transporter_substrate-binding_protein - 
SL1344 2509400 2509649 2509454 2509672 WP_000279836.1_hypothetical_protein - 
SL1344 2595700 2596049 2595410 2596537 WP_001277825.1_succinyl-diaminopimelate_desuccinylase + 
SL1344 2618700 2618899 2618611 2618748 WP_001540598.1_hypothetical_protein - 
SL1344 2623700 2623799 2623795 2625144 WP_000953165.1_exodeoxyribonuclease_7_large_subunit_xseA + 
SL1344 2681950 2682199 2682152 2682955 WP_000553467.1_inositol-1-monophosphatase +
  
SL1344 2684350 2684649 2684160 2685203 WP_000985204.1_sulfite_reductase_subunit_alpha + 
SL1344 2695850 2696249 2694348 2695892 WP_001187150.1_transcriptional_regulator + 
SL1344 2705450 2705599 2703891 2705276 WP_001542313.1_two-component_system_sensor_histidine_kinase - 
SL1344 2726750 2727099 2726717 2728186 WP_001526392.1_type_III_secretion_system_protein + 
SL1344 2727950 2728299 2726717 2728186 WP_001526392.1_type_III_secretion_system_protein + 
SL1344 2759600 2759799 2759753 2760316 WP_000211410.1_antirepressor - 
SL1344 2802300 2802399 2802529 2805102 WP_001235094.1_chaperone_protein_ClpB - 
SL1344 2807850 2807999 2807072 2807809 WP_000197660.1_outer_membrane_protein_assembly_factor_BamD + 
SL1344 2821400 2821549 2820345 2822183 partial;pseudo_partial;pseudo + 
SL1344 2855200 2855499 2855616 2855834 WP_000980498.1_hypothetical_protein - 
SL1344 2879150 2879299 2879070 2879447 WP_000698372.1_hypothetical_protein - 
SL1344 2888750 2889049 2888519 2889730 WP_000834152.1_hypothetical_protein + 
SL1344 2924550 2924699 2924046 2925920 WP_001521074.1_membrane_protein + 
SL1344 2929950 2930199 2929642 2929908 WP_001224043.1_transposase - 
SL1344 2935450 2935649 2935199 2935738 WP_000388997.1_repressor_of_phase_1_flagellin_gene - 
SL1344 2951200 2951399 2950949 2951878 WP_000178733.1_VirG_localization_protein_VirK + 
SL1344 3041900 3042049 3042432 3044093 WP_001120085.1_transcriptional_regulator_HilA + 
SL1344 3051500 3051699 3051690 3053471 WP_000245788.1_cell_invasion_protein_SipB - 
SL1344 3089650 3089999 3089110 3090243 WP_001272632.1_murein_hydrolase_activator_NlpD_nlpD - 
SL1344 3117550 3117699 3118020 3118691 WP_001199961.1_7-carboxy-7-deazaguanine_synthase - 
SL1344 3138150 3138599 3138274 3138486 WP_000988723.1_hypothetical_protein - 
SL1344 3156800 3156899 3156998 3157225 WP_000750393.1_lipoprotein - 
SL1344 3205450 3205999 3205639 3206475 WP_000503692.1_cobalt_transporter  yohM + 
SL1344 3208000 3213699 3209943 3212432 WP_000705483.1_fimbrial_usher_protein - 
SL1344 3214050 3214299 3213855 3214487 WP_000835265.1_hypothetical_protein - 
SL1344 3242800 3243099 3243022 3243618 WP_001520956.1_5-formyltetrahydrofolate_cyclo-ligase + 
SL1344 3259750 3260099 3259380 3260138 WP_000701830.1_metalloprotease + 
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SL1344 3338700 3338899 3338755 3339159 WP_000665657.1_hypothetical_protein + 
SL1344 3383050 3383149 3383264 3384697 WP_000867682.1_bifunctional_protein_HldE - 
SL1344 3469300 3469599 3468958 3469842 WP_000802069.1_lipoprotein_NlpI - 
SL1344 3479200 3479399 3479208 3479284 tRNA-Met_tRNA-Met - 
SL1344 3511750 3511899 3511909 3514245 WP_000809815.1_aerobic_respiration_control_sensor_protein_ArcB - 
SL1344 3522500 3522749 3522035 3523138 WP_000184315.1_hypothetical_protein + 
SL1344 3532700 3532849 3532871 3533665 WP_000505557.1_hypothetical_protein - 
SL1344 3552600 3552799 3551420 3553387 WP_000510913.1_p-hydroxybenzoic_acid_efflux_pump_subunit_AaeB - 
SL1344 3578450 3578749 3578064 3578948 WP_000642611.1_methyltransferase + 
SL1344 3597800 3598349 3597162 3598286 WP_000124529.1_hypothetical_protein - 
SL1344 3677800 3678099 3678085 3679704 WP_001265689.1_phosphoenolpyruvate_carboxykinase_[ATP] + 
SL1344 3685250 3685449 3685412 3685639 WP_001160955.1_ferrous_iron_transporter_A_feoA + 
SL1344 3743600 3743849 3743652 3744068 WP_000826041.1_outer_membrane_protein + 
SL1344 3758150 3758349 3758349 3759404 WP_001081707.1_cell_division_protein_FtsX_ftsX - 
SL1344 3768750 3768999 3768246 3768911 WP_000187489.1_membrane_protein + 
SL1344 3829550 3829749 3829506 3829613 WP_001669334.1_hypothetical_protein - 
SL1344 3837250 3837399 3835747 3837354 WP_000028047.1_peptide_ABC_transporter_substrate-binding_protein - 
SL1344 3853150 3853399 3851635 3853968 WP_000148453.1_biotin_sulfoxide_reductase - 
SL1344 3873850 3873999 3871846 3873873 WP_000761305.1_alpha-amylase_malS + 
SL1344 3962350 3962649 3962566 3963957 WP_000115428.1_xanthine_permease + 
SL1344 3974900 3975149 3975383 3976000 WP_000984806.1_hypothetical_protein + 
SL1344 4045300 4045849 4044666 4045850 WP_001230254.1_trimethylamine_N-oxide_reductase_cytochrome_C_subunit - 
SL1344 4126800 4126899 4126828 4126904 tRNA-Asp_tRNA-Asp + 
SL1344 4146800 4147099 4147129 4148388 WP_001054532.1_transcription_termination_factor_Rho_rho + 
SL1344 4167550 4167899 4167912 4170458 WP_000281718.1_adenylate_cyclase_cyaA + 
SL1344 4227200 4227649 4227569 4230355 WP_000249972.1_DNA_polymerase_I + 
SL1344 4252950 4253199 4253044 4254285 WP_000870946.1_sulfoquinovose_isomerase - 
  
SL1344 4283600 4283849 4283840 4283965 WP_000183584.1_hypothetical_protein + 
SL1344 4284650 4285049 4284831 4286138 WP_000566800.1_membrane_protein - 
SL1344 4336050 4336299 4335722 4336720 WP_000406820.1_membrane_protein - 
SL1344 4407550 4407949 4407263 4407853 WP_000940092.1_hypothetical_protein + 
SL1344 4415650 4415949 4416006 4417559 16S_ribosomal_RNA_16S_ribosomal_RNA + 
SL1344 4501850 4502049 4501156 4502475 WP_001541306.1_ABC_transporter + 
SL1344 4504850 4505049 4503766 4520445 WP_000527217.1_membrane_protein + 
SL1344 4523400 4523549 4523673 4525274 WP_000083640.1_hypothetical_protein + 
SL1344 4582500 4582799 4582602 4582823 WP_001576552.1_hypothetical_protein - 
SL1344 4595050 4595299 4593838 4595079 WP_001670701.1_transporter - 
SL1344 4607600 4607749 4606676 4607653 WP_000004794.1_elongation_factor_P--(R)-beta-lysine_ligase + 
SL1344 4642350 4642549 4642267 4642596 WP_000586836.1_transporter - 
SL1344 4797100 4797299 4796855 4797556 WP_001237610.1_membrane_protein - 
SL1344 4838700 4838799 4838563 4839336 WP_000119016.1_deoxyribonuclease + 
pSLT 12650 12849 11189 14011 WP_001007087.1_conjugal_transfer_protein_TraG - 
pSLT 29800 30099 29946 30512 WP_000399768.1_conjugal_transfer_protein_TraE - 
pSLT 33100 33249 33259 33729 WP_014344446.1_lytic_transglycosylase + 
pSLT 34400 34599 34589 34858 WP_001677523.1_protein_32_protein_of_plasmid - 
pSLT 41300 41449 41218 41652 WP_001200150.1_hypothetical_protein - 
pSLT 46000 47699 46488 47762 WP_000457541.1_DNA_polymerase_V_subunit_UmuC + 
pSLT 48000 48449 47844 48818 WP_000064272.1_chromosome_partitioning_protein_ParB - 
pSLT 48900 49149 48818 50023 WP_000427676.1_chromosome_partitioning_protein_ParA - 
pSLT 78750 78899 79178 79480 WP_000979451.1_hypothetical_protein + 
pSLT 91950 92149 91997 92164 WP_001691570.1_DNA_replication_protein - 
pCol1B9 1600 1799 455 1486 WP_000907875.1_replication_initiation_protein_PK-repZ + 
pCol1B9 15300 15499 15468 16442 WP_001217836.1_hypothetical_protein + 
pCol1B9 32000 34899 32467 33315 WP_001077019.1_hypothetical_protein + 
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pCol1B9 35150 35449 34396 37011 WP_000128933.1_hypothetical_protein + 
pCol1B9 44400 44599 43906 44568 WP_000653334.1_ethanolamine_utilization_protein_EutE - 
pCol1B9 65800 65949 66007 66591 WP_000977522.1_conjugal_transfer_protein_TraG - 
pCol1B9 72300 72599 71003 72295 WP_001417545.1_Shufflon_protein_A' - 
pCol1B9 75050 75299 75248 76801 WP_000362202.1_ATP-binding_protein - 
pRSF1010 5300 5749 5666 5950 WP_000238497.1_mobilization_protein_C + 
  
